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ABSTRACT
Wan, Qiaoqiao. Ph.D., Purdue University, August 2016. The Role of Mechanical
Loading in Chondrocyte Signaling Pathways. Major Professor: Sungsoo Na.
Chondrocytes are a predominant cell type present in articular cartilage, whose
integrity is jeopardized in joint degenerative diseases such as osteoarthritis (OA). In
the chondrocytes of patients with OA, the elevated levels of inflammatory cytokines
such as interleukin 1β (IL1β) and tumor necrosis factor α (TNFα) have been re-
ported. These cytokines contribute to degradation of cartilage matrix by increasing
activities of proteolytic enzymes. In addition to their contribution to proteolytic en-
zymes, these cytokines adversely affect anabolic activity of chondrocytes by inhibiting
the production of proteoglycans and type II collagen. Therefore, blocking the action
of these cytokines is a potential strategy to prevent cartilage degradation. Accu-
mulating evidence suggests that mechanical loading contributes to the regulation of
cartilage homeostasis. However, the underlying mechanisms are not clear as to how
varying magnitudes of mechanical loading trigger differential intracellular signaling
pathways at sub-cellular levels, which consequently lead to selective matrix synthe-
sis or degradation. Furthermore, it is not known whether the loading-magnitude
dependent responses are linked to degenerative diseases such as OA.
Tyrosine kinases such as Src and focal adhesion kinase (FAK) are known to play
a crucial role in OA progression. We hypothesized that mechanical loading regulates
the sub-cellular activation pattern of Src/FAK, and acts as a suppressor of the OA- or
inflammatory cytokine-driven signaling activities. We used live cell imaging approach
in conjunction with fluorescence resonance energy transfer (FRET)-based biosensors
to investigate real-time molecular events at the sub-cellular level in live chondrocytes.
Using two-dimensional (2D) cell culture and shear stress application, we found that
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Src is activated by inflammatory cytokines (i.e., IL1β and TNFα), and is regulated
by shear stress in a magnitude-dependent manner. Importantly, the cytokine-induced
Src activation can be suppressed by moderate shear stress (5 dynes /cm2) and the
ER stress inhibitor.
Next, to investigate the sub-cellular activation pattern of Src and FAK in response
to inflammatory cytokines and mechanical loading, we used lipid raft-targeting (Lyn-
FAK and Lyn-Src) and non-lipid raft-targeting (KRas-FAK and KRas-Src) biosen-
sors. We also developed a three-dimensional (3D) cell culture system using collagen-
coupled agarose gels to mimic the physiologically relevant cell microenvironment. The
activities of Lyn-Src, KRas-Src and Lyn-FAK were up and down regulated by high
(> 10 μl/min) and moderate (5 μl/min) interstitial fluid flow, respectively, but KRas-
FAK did not respond to the flow. We also found that Src activation by loading was
blocked by inhibition of FAK, while inhibition of Src did not affect FAK activities,
suggesting that FAK is necessary for interstitial fluid flow-induced Src activity. In
contrast, Src was necessary for inflammatory cytokine-induced FAK activation. Fur-
thermore, we developed a 3D ex vivo system that uses murine cartilage explants. This
system in conjunction with 3D FRET imaging allowed us to visualize sub-cellular sig-
naling activities of Src and FAK that closely mimic in vivo setting. We found that
intermediate loading can inhibit inflammatory cytokine-induced activities of Lyn-Src,
KRas-Src and Lyn-FAK, but not KRas-FAK.
AMP-activate kinase (AMPK) is a master regulator of cellular energy balance
that activates when the ratio of (AMP+ADP)/ATP increases. Imbalance of AMPK
regulation contributes to the development of diabetes, cardiovascular diseases, can-
cer, and found most recently, OA. In healthy cartilage, the treatment of IL1β and
TNFα decreases AMPK activity, while how mechanical loading influences AMPK
activities needs to be clarified. The recent design of FRET-based AMPK biosensors
that can target various subcellular compartments (PM-AMPK targets plasma mem-
brane, Cyto-AMPK target cytosol, Nuc-AMPK targets nucleus, ER-AMPK targets
endoplasmic reticulum (ER), Golgi-AMPK targets Glogi apparatus, and Mito-AMPK
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targets mitochondria) enable the study about the regulation of AMPK compartmen-
talization by physical stimulus. The AMPK activities were upregulated by shear
stress in 2D environment, while only Nuc- and PM-AMPK are responsive to loading
in 3D environment, suggesting culture dimensionality alters the mechanosensitivity
of chondrocytes. To examine potential factors responsible for discrepancies between
different culture models, we evaluated roles of cytoskeleton in mechanotransduction
in 2D and 3D cultures and found that the differential cytoskeletal networks contribute




OA is currently the most common form of arthritis, and is associated with various
risk factors, including overuse of joint and overt inflammation [1,2]. The chondrocytes
that sparsely distributed in cartilage are constantly exposed to a combination of
compression [3], shear stress [4], and hydrostatic pressure [5]. Physiological loading
is associated with reduced expression of MMPs [6, 7], while pathological loading, on
the other hand, induces elevated production of matrix metalloproteinases (MMPs)
and reduced expression of extracellular matrix (ECM) components, such as Type II
collagen and aggrecan [8, 9].
FAK and Src play both direct and indirect roles in regulation of signaling cascades
responsible for cell survival [10], differentiation, proliferation [11], mobility, mechan-
otransduction [4], and inflammatory signaling activities [12]. Upon the stimulation
by chemical or mechanical factors, FAK is autophosphorylated at Tyr397 to unmask
SH2 binding domain for the binding of Src. The formation of Src and FAK com-
plexes enables FAK to phosphorylate other downstream molecules, such as paxillin,
p130Cas, and α-actinin, to activate subsequent signaling pathways [13]. FAK and
Src are known to respond to cytokines and mechanical stimulations, resulting in an-
abolic [14,15] or catabolic [16] reponses in chondrocytes. Interestingly, recent reports
indicate that distinct signaling mechanisms are responsible for their activation at dif-
ferent subcellular compartments [17–19]. However, to this date, it is still unknown
how various stimulations differentially regulate FAK and Src activities at different
subcellular locations, and subsequently leads to the progression or alleviation of OA.
In chapter 2, we utilized the live cell imaging approach in conjugation with FRET-
based biosensors to investigate real-time molecular events in C28I2 human chondro-
2
cytes in 2D setup. We found that fluid flow and the inhibition of ER stress selectively
regulate subcellular Src kinases, and appear to interact with Src-mediated signaling
pathways that are important for cartilage health. In the chapter 3, we further em-
ployed a 3D in vitro cell culture system as well as a 3D ex vivo system using murine
cartilage explants to maintain C28I2 human chondrocytes in a physiologically rele-
vant microenvironment. The effect of different magnitudes of fluid flow and cytokines
on Src/FAK signaling at subcellular levels was examined. Our findings demonstrated
that the integrin activity is required for and highly localized with FAK activity in
lipid rafts, which is essential to further activate Src signaling by fluid flow; while
under cytokine treatment, FAK is a downstream molecule of Src. The proline-rich
tyrosine kinase 2 (Pyk2) depletion and moderate loading suppress cytokine-activated
Src/FAK activities, suggesting their potential therapeutic roles in OA.
We observed discrepancies between signaling activities in 2D versus 3D culture. To
elucidate potential factors contributing to the difference, in the Chapter 4, we tested
roles of cytoskeleton in signaling transduction. The imbalance of AMP-activate kinase
(AMPK) activity has been recently found to contribute to OA development. AMPK
is a master regulator of cellular energy balance that get activated when the ratio
of (AMP+ADP)/ATP increases [20]. In healthy cartilage, the treatment of IL1β
and TNFα decreases AMPK activity [21], while how mechanical loading influences
AMPK activity is not well understood. In chapter 4, we utilized new-developed
FRET-based AMPK biosensors that can specifically target subcellular compartments
of cells to visualize the response of AMPK activities under various stimuli at different
locations. We found culture dimensionality results in differential signaling activities of
chondrocytes in response to loading, and the cytoskeleton is one of factors responsible
for the distinct cellular activities in different culture environments.
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1.2.1 The structure of articular cartilage
Although the composition of articular cartilage can vary among species, it consists
of the same components and the same structure. Articular cartilage can be vertically
divided into four unique, and highly ordered zones: the superficial zone, the middle
(transitional) zone, the deep zone, and the calcified zone (Figure 1.1). The compo-
sition, mechanical properties of the matrix, and cell functions differ with the depth
from the cartilage surface. Recent studies found the existence of this highly organized
structure significantly improves the function of cartilage [22]. The thinnest articular
cartilage zone, superficial zone, makes up ∼10 to 20 % of articular cartilage thickness
and has the highest collagen content [23] and consists of two layers. The first layer
is a clear sheet containing little polysaccharide but no chondrocytes. It covers the
joint surface. The second layer has a higher collagen concentration but a lower pro-
teoglycan concentration as compared to other zones. In this layer, the collagen fibrils
are organized parallelly to the cartilage surface to resist the strong shear stress that
generated during articulation of joints and to regulate the travel of molecules in and
out of cartilage. The damage of collagen fibrils at this layer will alter the mechanical
behavior of the tissue and is the first sign of OA development [24]. The middle zone
is located inside of superficial zone and makes up ∼40 to 60 % of cartilage thickness.
Chondrocytes in this zone are characterized for highly active synthetic organelles,
like ER and Golgi apparatus. As compared with superficial zone, it contains higher
concentration of proteoglycans; lower concentration of water and collagen; but inter-
estingly, lager diameter collagen fibrils. This zone is the first layer in cartilage that
absorb compressive forces [25]. The deep zone occupys ∼30 % of cartilage thickness.
In the deep zone, chondrocytes align perpendicular to the joint surface. This zone
is featured for the largest diameter of collagen fibrils, the highest concentration of
proteoglycans, and the lowest concentration of water. These properties collectively
enable cartilage to resist great compression and maintain the integrity of cartilage
under normal loading environments [23]. The calcified zone is a very thin layer of
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calcified cartilage that lies between the deep zone and the subchondral bone. In the
calcified zone, chondrocytes are smaller than those in other zones, and have smaller
numbers of ER and Golgi apparatus, suggesting the lower level of synthetic activity
of chondrocytes. The collagen fibrils in this zone tightly bound to subchondral bone
to secure the cartilage to the bone [22]. Taken together, chondrocytes in different
zones experience distinct microenvironments and are exposed to various types and
magnitudes of mechanical loading in daily activities.
1.2.2 Extracellular matrix
Adult articular cartilage does not contain blood vessels, nerves, or lymphatics,
which consequently leads to limited ability to self-repair and regrow. Chondrocyte
is the only cell type in healthy cartilage and occupys less than 5 % of the cartilage
volume. The remainder 95 % is ECM, consisting of tissue fluid (65-80 %), collagen
(∼10 %), proteoglycans (10-15 %) and a small amount of non-collagenous proteins
and glycoproteins. The structural macromolecules form networks that shape the
tissue and gain articular cartilage the ability to withstand significant mechanical
loads, in some cases, can be more than multiple times of body weight. The tissue
fluid contains water, gases, small proteins, metabolites, and a large amount of cations
to neutralize the negative charge brought by proteoglycans. Most of the water is
maintained within the matrix by the large aggregating proteoglycans and can not
move freely. The confined water contributes to the resistance to compression, while
upon the application of compression, the free-moving water generates shear stress
along the joint surface that stimulates chondrocyte cellular activities [26].
There are three classes of structural macromolecules in articular cartilage, col-
lagen, proteoglycans, noncollagenous proteins and glycoproteins. Collagen is dis-
tributed evenly throughout the depth of cartilage, and is the structural backbone of
ECM by mechanically trapping water and proteoglycans in collagenous meshwork.
Some noncollagenous proteins are involved to organize and stabilize the collagenous
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meshwork, and also serve as connectors assisting the interaction between chondrocytes
and ECM. The most abundant collagen in articular cartilage is the type II collagen,
which is specifically exist in cartilage and is a biomarker of chondrocyte differenti-
ation [27]. Collagen II contains a high content of hydroxylysine as well as glucosyl
and galactosyl residues. These two components are required for the connection be-
tween collagen and proteoglycan to form ECM networks [28]. There are two types
of proteoglycans in articular cartilage: aggrecans (consists of 90 % of proteoglycan
mass) and smaller proteoglycans (consists of 10 % of proteoglycan mass). Aggrecans
contain a protein core filament, and large amounts of chondroitin sulfate and ker-
atin sulfate chains, which noncovalently associated with hyaluronic acid and other
noncollagenous proteins on the core filament to form large proteoglycan aggregates.
These aggregates can have sizes ranged from hundreds to more than ten thousands
nm [29]. The smaller proteoglycans do not directly contribute to the mechanical
behavior of cartilage; instead, their binding to other macromolecules might affect
chondrocyte functions. Articular cartilage contains a wide variety of noncollagenous
proteins, while only a small part of them have been identified and studied. Some of
these molecules have been found can help to organize the structure of matrix, secure
chondrocytes to ECM [30], and get involved in inflammatory signaling [31].
1.2.3 The mechanical behaviors and properties of cartilage
The mechanical properties of cartilage are determined using a confined compres-
sion test with a creep mode or a relaxation mode. In the creep mode, the load applied
on cartilage tissue is constant and the displacement is measured; and in the relax-
ation mode, the displacement applied on tissue is constant and the force is measured.
In the creep test, the displacement is rapid at the initial time points, then the rate
of deformation will slow down and the displacement reaches its maximum (Figure
1.2). The proteoglycan is negatively charged due to its sulfate and carboxyl groups,
and the repulsive force generated by these negative charges spread out proteoglycan
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aggregates, which consequently occupy a large volume and hold a large amount of
tissue fluid in cartilage. The collagen framework confines the swelling proteoglycan
aggregates. In the creep test, upon the application of compression on cartilage, the
negatively charged aggrecans are squeezed together, while in this process, the repul-
sive force increases, leading to the increase of cartilage stiffness. The proteoglycan is
considered responsible for the constant displacement at later time points. Therefore,
the loose collagen framework and nonaggregated proteoglycan in damaged cartilage
will lead to compromised tissue stiffness. The measurements in creep test can be
used to obtain two material properties, the stiffness and the permeability. The typ-
ical Youngs modules of cartilage is in the range of 0.45 to 0.80 MPa, which is really
soft as compared to the values of steel is 200 GPa and wood is 10 GPa. Using Darcys
law, the permeability of typical cartilage is in the range of 10−15 to 10−16 m2 [32].
Values can change through the depth of the tissue: the permeability is highest near
the surface of the joint, and is lowest in the deep zone [33].
1.2.4 Chondrocytes
The chondrocyte is the only cell type that sparsely distributed in articular carti-
lage. In different zones of cartilage, chondrocytes differ in cell size, morphology and
metabolic activities, but all of them encapsulated with ECM and do not have cell-cell
contacts. The number of chondrocytes in matrix is much lower than cell numbers in
other tissues, while they are responsible for the maintenance and repair of ECM in its
vicinity via balancing the degradation of the macromolecules by degradative enzymes
with their replacement by synthesizing matrix components, including proteins and
glycosaminoglycan side chains. To perform these functions, chondrocytes sense the
biochemical signals and mechanical changes of the cartilage. In health cartilage, chon-
drocytes are responsible for the synthesis of appropriate macromolecules, which will
be further assembled to be highly organized framework [25]. With aging or obesity,
the production level of ECM by chondrocytes decreases dramatically, and thereby
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contributes to the onset of OA. The mutations in genes for cartilage-specific proteins,
including aggrecans, link proteins, and type II collagens have been correlated with
heritable disorders of cartilage.
Due to the lack of blood vessels in cartilage, chondrocytes obtain nutrients and
oxygen primarily by diffusion from the synovial fluid or subchondral bones, which
limits the number of cells that can survive in cartilage. To survive and perform func-
tions under low oxygen (the oxygen tension in deep layers is 1 % as compared with
24 % in atmosphere) and malnutrition tensions, chondrocytes prefer anaerobic path-
ways that metabolizing glucose to lactate [34]. The metabolic state of chondrocytes
in healthy human cartilage is maintained at minimum level, resulting in very limited
self-healing ability of cartilage. Moreover, chondrocytes have very limited potential
for division and replication in healthy adult articular cartilage [22,35]. In this regards,
the maintenance of cartilage is paramount to maintain the joint integrity and health.
1.3 Osteoarthritis
OA is the most common form of progressive joint diseases. It impairs the phys-
ical movement of 27 million Americans. Joint pain, stiffness and swelling are most
common clinical symptoms associated with OA. Normal chondrocytes maintain the
balance between ECM synthesis and degradation; but in OA chondrocytes, the ex-
cessive expression of MMPs, aggrecanases and other enzymes [36] compromises ECM
integrity. At the level of clinical signs, OA patients are not suffered from the overt
inflammation as compared to those with rheumatoid arthritis, while an elevated ex-
pression level of cytokines has been found in the synovial tissue of OA [1]. At the
cellular level, it has been found that OA chondrocytes express genes typical of inflam-
matory responses [37]. Therefore, even though the cause of OA is still under debate,
multiple factors that lead to inflammation are regarded to contribute to the early
development of OA. Additionally, factors that result in the overuse of joint, including
joint instability, obesity, aging, intra-articular mineral deposition, and joint muscle

10
Fig. 1.3.: The comparison between normal and OA cartilage. The black box denotes
cartilage defect. The arthroscopic view shows the difference between healthy cartilage
and OA cartilage. The healthy cartilage present smooth and rigid surface, while the
OA cartilage shows obvious cartilage loss and wear at the medial femoral condyle and
tibia [38].
weakness, increase the expression levels of cytokines and MMPs [2] and are considered
as risk factors of OA. However, the underlying mechanisms are still undetermined as
to how inflammatory cytokines and varying types of mechanical forces differentially
regulate chondrocyte intracellular signaling and ultimately alter cartilage matrix.
1.3.1 The initiation and progression of OA
The ECM of cartilage is highly dynamic and undergoes constant remodeling. At
the initial state of ECM degradation, the chondrocyte will activate anabolic mech-
anism to counteract the degeneration process. This stage is featured for increased
chondrocyte proliferation rate, intracellular metabolic activities, and synthesis of
ECM components. The loss of cartilage integrity greatly increases the diffusibil-
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ity of growth factors that have been found to be responsible these repair activities.
Moreover, advanced lesions in cartilage are capable to increase the expression level
of growth factor by chondrocytes to further activate repair process. Eventually, the
repair and degradation will reach a new balance, in which the increased anabolic ac-
tivities equal catabolic activities. Nevertheless, the cartilage has very limited repair
ability, and might not be able to reach another new balance if the newly established
balance is broken again, which consequently leads to the progression of OA, ultimately
causing symptoms that experienced by patients.
During the progression of OA, the degeneration of ECM by proteinases exceed the
synthesis, resulting in a net loss of cartilage matrix. In this process, the content of
ECM is considerably decreased, including type II collagen and proteoglycan, and the
distribution of proteoglycan becomes uneven in OA cartilage (Figure 1.3). In addition
to the reduced content, the shorter collagen fibers that degenerated by proteinases
in OA cartilage lead to reduced elastic modules, fibrillation and fissure formation
[39]. Moreover, the organization of collagen meshwork is disoriented, and collagen
fibrils are found widely separated. As the result of the changed collagen II and the
impaired ECM networks during OA development, the mechanical microenvironment
of chondrocytes is significantly changed, influencing cellular functions of chondrocyte
[40]. The loose ECM structure transfers greater loads to the underlying subchondral
bones and stimulates the growth of subchondral bones towards the articular surface
[41], preceding the cartilage damage. This feedback loop consequently drives the
progression of OA. Therefore, it is paramount to develop chemical and mechanical
therapies that prevent collagen II degradation and loss; and the understanding of




MMPs produced by chondrocytes or synovial cells are mainly responsible for the
degeneration of the ECM. MMP1 degrades type I, II and III collagen; MMP2 digests
gelatins, type IV, V, VII, X, and XI collagen, fibronectin and proteoglycans; MMP3
cleaves proteoglycans, type IV, VII, IX and XI collagen, and fibronectin. MMP9,
MMP8 and MMP13 also play crucial roles in the degradation of cartilage matrix.
ADAMs is another group of proteinases that can degrade the aggrecans core pro-
teins [42]. The excessive expression of MMP genes has been found in the initiation
of OA in animal models as well as in human patients. In healthy cartilage, the syn-
thesis and activation of MMPs are under strict control by chondrocytes, while in
OA cartilage, MMPs excessively degrade endogenous ECM as well as newly synthe-
sized ECM components. The uncontrolled degradation of these newly produced ECM
molecules might induce a total loss of cartilage integrity and initiate inflammatory
responses [43]. Tissue inhibitors of MMPs (TIMPs), including TIMP1, 2, 3 and 4,
are capable to control the cartilage degradation by inhibiting the activities of MMPs.
Most interestingly, both TIMP1 and TIMP2 also promote the growth of chondro-
cytes, which might assist matrix turnover in the early stage of OA [44]. However,
with the development of OA, the expression level of MMPs in cartilage will be sub-
stantially higher than that of TIMP, and the activities MMPs can not be rescued by
the insufficient amount of TIMP [42].
1.3.3 Inflammatory cytokines
OA development is characterized by cartilage erosion as well as synovial inflamma-
tion. An increased expression of inflammatory cytokines, such as IL1β and TNFα, has
been reported using immunolocalization technology in OA cartilage by Tetlow [45];
abnormal mechanical and oxidative stresses are possible factors that promote the
cytokine production. IL1β and TNFα excessively produced by synoviocytes, or chon-
drocytes substantially elevate MMPs expression, while on the other hand, inhibit
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ECM production by chondrocytes. Moreover, the expression level of natural an-
tagonists of the IL-1 receptor (IL-1Ra), competing with IL1 for the IL receptor, is
downregulated in OA cartilage, which further enhances the catabolic effect of IL-1 on
ECM.
IL1β and TNFα contribute to the catabolic processes in OA progression by signifi-
cantly increasing the expression of matrix degrading enzymes such as MMP1, MMP3,
MMP13 and an disintegrin and metalloproteinase with thrombospondin-1 domains
(ADAMTS)4 [37, 46–49]. These digestive enzymes degrade collage type II fibrils in
superficial layers of cartilage, and this denaturation of collagen is regarded as the
first sign of OA development. In addition to promoting the production of MMPs
and other proteinases by chondrocytes, IL1β and TNFα elevate the expression of
prostaglandin E2 (PGE2) and nitric oxide (NO) via mitogen-activated protein ki-
nases (MAPK) and nuclear factor κB (NFκB) signaling pathway [50]. On the other
hand, these cytokines adversely reduce anabolic activity of chondrocytes by reduc-
ing the gene expression of proteoglycans and type II collagens [47, 51, 52]. Moreover,
IL1 has been reported to contribute to other cytokines production such as TNFα,
IL1 and LIF (leukaemia inducing factor) [53, 54], inducing additive effects that fur-
ther promote proteinase production and suppress matrix synthesis. TNFα also has
been found to promote the production of IL1, IL6 and IL8, and activates sensory
neurons that induce pains [55]. The inhibition of these inflammatory actions using
anti-inflammatory drugs is a strategy to prevent OA progression. IL1 receptor an-
tagonist has been shown prevent OA progression in animal models as well as clinical
trials [56]; and the anti-TNFα treatment has been found can reduce the pain and
the inflammatory process in OA. Although the significant roles of IL1 and TNFα in
cartilage health are well known, the signaling involved in inflammation of cartilage
needs further studies.
IL1β is a member of IL-1 family. Its active form exists in extracellular space
and consists of 153 amino acid residues [58]. During the inflammation of cartilage,
chondrocytes, osteoblasts, synoviocytes, and mononuclear cells elevate the synthesis
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Fig. 1.4.: TNFα and IL1β induced signaling pathways [57].
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of IL1β, and release it to the synovial fluid, synovial membrane, cartilage, and the
subchondral bone layer [59]. The IL1β binds to IL1 receptor families that are called
the Toll and IL1 receptor (TIR) family, including IL-1R1 and IL-1R2, and initiates
inflammatory signaling cascades. The expression of IL-1R1 is elevated on the surface
of chondrocytes in OA patients. The interaction between IL1β and IL-1R1 triggers
mechanisms as shown in Figure 1.4A, while the binding of IL1β on IL-1R2 have no
ability to activate further intracellular signal [60].
Two pathways form the essential core of IL1β-induced intracellular signaling cas-
cades: MAPKs and NFκB [50]. The MAPK pathways coordinate activation of gene
transcription, protein synthesis, cell cycle machinery, cell apoptosis, and cell differ-
entiation. All MAPK pathways involve a three-tiered signaling module. The first
titer is MAP kinase kinase kinases (MEKKs). MEKKs are serine/threonine-specific
kinases and can activate MAP kinase kinases (MKKs). The second titer is MKKs.
MKKS phosphorylate both hydroxyamino acids of the Thr-X-Tyrosin motif (TEY
in extracellular signal regulated kinase (ERK)1/2,TPY in c-Jun N-terminal kinases
(JNKs), TGY in p38 kinases) on MAPKs, which is the third titer [61]. Three types of
MAPKs, including ERK1/2, JNKs and p38, are ubiquitously expressed and are capa-
ble to phosphorylate a wide selection of transcription factors. The p38 pathway also
stabilizes the mRNAs and enables mRNA translation by activating MAPK-activated
protein kinase (MAPKAPK)-2. NF-κB, a key element in proinflammatory signaling
pathway, regulates genes that encoding cytokines (IL1,IL2, IL6, IL12, and TNFα),
chemokines (IL-8 and MIP-1α), and inducible effector enzymes (inducible-nitric oxide
synthases (iNOS) and cyclooxygenase-2 (COX-2)) [62].
Upon the binding of IL1β to TIR, the adapter protein MyD99 is recruited, which
further activate TRAF6 protein, leading to the activation of Tp12, MEKK3 and
TGFβ-activated kinase (TAK)1. Tp12 activates ERK pathway; MEKK3/TAK1 acti-
vates JNK and p38MAPK; and TAK1 regulates the phosphorylation of the IκB kinase
complex (IKK), thereby activates NF-κB [63]. In recent years, the MEKK2, as well
as MAPK- and stress kinase-activated protein kinase (MSK) have been found can
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increase the transcriptional activity of NF-κB p65 [64], suggesting the NFκB path-
way is cross-linked with MAPK pathways in IL1β-induced inflammatory signaling, as
shown in Figure 1.4. The activation of these signaling pathways blocks the synthesis
of ECM components, such as type II collagen and aggrecans; activates the synthesis
of enzymes, including MMP-1, MMP-3, MMP-13, ADAMTS-4, which have deleteri-
ous effects on cartilage integrity; induces its secretion of other cytokines, for example,
TNFα, IL-6, IL-8 and CCL5 chemokine, and activates a number of other compounds,
including NO, phospholipase A2 (PLA2), cyclooxygenase-2 (CPX-2), prostaglandin
E2 (PGE2), and reactive oxygen species (ROS).
TNFα is a member of tumour necrosis factors family (TNF superfamily). TNFα
is produced by the same group of cells that synthesize IL1β, and is secreted to the
same elements as IL1β [65]. Basically, TNFα activates the same MAPK signaling
as IL1β, though via a different mechanism (Figure 1.4B). There are two isotypes
of TNF receptors located on the plasma membrane of chondrocytes. TNF-R1 (p55,
CD120a, and TNFRSF1a) can bind to TNF in both soluble and membrane forms,
and TNF-R2 (p75, CD120b, and TNFRSF1b) can only be activated in membrane
form [66]. The binding of TNFα to TNF-R1 forms the TNF-TNFR complex, which
will further couple with TRADD adapter protein and other adapter proteins, such as
TRAF2, c-IAP1, c-IAP2, and RIP1, to form a complex. This complex binds TAK1,
TAB1, and TAB2, resulting in the activation of the most two important transcription
pathways, NF-κB and ERK/MAPK [67]. Additionally, the interaction of TNFα and
TNF-R1 changes the conformation of the complex, recruit FADD and pro-Caspase
8, and eventually leads to cell death [68]. The binding of TNFα to the TNF-R2
receptor activates the interaction of TRAF2, TRAF3, c-IAP1, and c-IAP2, which
further activate JNK and NF-κB signaling pathways [67]. Progranulin (PGRN),
an anti-inflammatory growth factor, has been shown to incorporate both TNF-R1
and TNF-R2. The elevated expression level of PGRN in OA patients indicates its
potential roles as a natural antagonist of TNF interfering with the TNFα-induced
inflammatory signaling [69]. The major difference between IL1β- and TNFα-induced
17
signaling is that the TNFα also activates apoptotic pathways [70,71]. The improved
understanding of signaling nodes may benefit in developing a therapeutic strategy
that specifically inhibits inflammatory signaling with less side effects and alleviates
OA symptoms.
1.3.4 Anti-inflammatory cytokines
Several cytokines have anti-inflammatory functions, such as IL-4, IL-10 and IL-13,
which are capable to inhibit the inflammatory effects of both IL1β and TNFα.
IL4 has been found have a strong chondroprotective effect by inhibiting the pro-
duction of MMPs and preventing the variation in proteoglycan synthesis in OA pro-
gression. The increased expression levels of IL4 in synovial fluid and its receptors
in blood have been identified in OA patients as compared to the healthy control
group [72]. With the treatment of IL4, the synthesis of inflammatory cytokines, in-
cluding IL1β, TNFα, IL6, and other inflammatory mediators, such as PGE2, COX-2,
PLA2, and iNOS, are inhibited in chondrocyte cultures [73]. However, the sensitivity
of OA chondrocytes to IL4 is decreased, which impairs the ability of IL4 to prevent
the rapid erosion of the cartilage [74]. IL4 shares a same group of receptors with
IL13, including IL-4Rα, IL-13Rα1, and IL-2Rγc. The formation of IL-4Rα and IL-
2Rγc complexes (complex I) is required for the binding of IL4, and the attachment of
IL-4Rα and IL-13Rα1 (complex II) promotes the binding of both IL4 and IL13. The
interaction of complex I and IL4 is associated with the activated phosphorylation of
JAK1/STAT3/STAT6 cascades [75].
Similar to IL4, IL10 shows chondroprotective effect in OA cartilage. It stimulates
the production of ECM components, such as type II collagen and aggrecans, down-
regulates the expression of TNFα and IL1β, inhibits the synthesis of MMPs, and
inhibits the apoptosis of chondrocytes [76]. The attachment of IL10 to the subunit of
IL-10R1 changes its conformation to enable the binding of this complex to IL-10R2
subunit [77], and the intracellular signaling cascade is started, leading to the acti-
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vation of SMAD1/SMAD5/SMAD8, ERK1/2 MAP, and consequently elevates the
synthesis of bone morphogenetic protein 2 and 6 (BMP-2 and 6). BMP proteins are
capable to induce mesenchymal cells transform to chondrocytes, and stimulate their
proliferation [78].
IL13 has been found have strong anti-inflammatory and chondroprotective effects
on chondrocytes in OA articular cartilage and synovial membrane. IL13 has inhibitory
effects on the production of IL1β, TNFα, and MMPs; elevates the expression of IL-
1Ra, which competes with IL1β to binding receptors, leading to inhibited effects
of IL1β; and blocks the synthesis of COX-2 and PGE2 [79]. As stated in paragraph
about IL4, the interaction of IL-4Rα and IL-13Rα1 is required for the binding of IL13.
Upon its attachment to receptors, IL13 activates the cascades IL-4Rα/JAK2/STAT3
and IL-13Rα1/TYK2/STAT1/STAT6 [80].
1.3.5 Mechanical loading affects cartilage health









Hydrostatic Pressure 3-10MPa [5]
Osmotic Stress
Tensile
Chondrocytes live in a complex and harsh mechanical environment, and they are
exposed to a combination of compression, shear stress, hydrostatic pressure, osmotic
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stress, and tensile stretch (Table 1.1). The compression experienced by chondrocytes
during standing is ∼3.5 MPa and during stair climbing is 10-20 MPa [3, 81]. The
compression applied on cartilage induces synovial fluid flow along the surface and
eventually results in shear stress [4]. The hydrostatic pressure due to the retained
fluid by charged proteoglycans is ranged from 3 to 10 MPa [5]. Osmotic stress is usu-
ally resulting from the sudden changes in solute concentration around chondrocytes
during joint movement [82]. Tensile only occurs in some stretch activities. Upon me-
chanical stimulation, chondrocytes sense mechanical stresses and convert them into
the intracellular signaling cascades; and consequently change metabolic activities of
chondrocytes. Accumulating evidences demonstrate that mechanical loading has ei-
ther anabolic or catabolic effect on chondrocyte activities.
Moderate exercises prevent OA progression
Besides pain relief treatment and joint replacement, there is no non-invasive ther-
apy can completely prevent the progression of OA [25]. Recently, moderate exercises
have been recommended to OA patients as an alternative physical therapy, consider-
ing the fact that it significantly benefits in the health of articular cartilage. At clinic
level, exercises have been shown can decrease the risk of knee OA [83], and improves
function in OA [84]. A recent research investigated the effects of anti-inflammatory
drugs, simple analgesics and exercises on OA. Results demonstrated that the effect
sizes (ESs) of pain and function for exercises are comparable to estimates for drugs
(Table 1.2) [85]. Therefore, the exercise is regarded as a potential therapeutic strat-
egy of managing OA conditions and the improved understanding of how moderate
loading influence chondrocyte functions is demanding [86].
At tissue level, physiological loads promote the integrity of ECM, increase the con-
tent of glycosaminoglycan in cartilage [87], and enhance the cartilage repair by chon-
drocytes [2,88]. The goal of physical therapies is to impede joint damage by inhibiting
catabolic activity and activating anabolic activity. Experiments using cartilage ex-
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Oral NSAIDs 0.29 1
Topical NSAIDs 0.44 0.36
plants, 3D cultures and monolayer cultures have shown that dynamic compression,
shear stress and hydrostatic pressure at moderate intensities are able to promote
chondrocyte anabolic activities by increasing expression levels of aggrecan and type
II collagen [63, 89–95] and adversely decreasing the production of degenerative en-
zymes (Table 1.3). The study using animal models with antigen-induced arthritis
found that moderate loads not only inhibited IL1β or TNFα-induced transcriptional
activation of COX-2, PGE2, NO, MMPs and ADAMTS-5, but also upregulated the
production of anti-inflammatory cytokine IL-10, suggesting the anti-inflammatory ef-
fect of physiological loading on cartilage [96, 97]. In addition to increased anabolic
activities, the proliferation of chondrocytes was also elevated in response to moder-
ate mechanical stimulation [98–100]. But the duration and intensity of stimulation
required for the beneficial responses appears to be dependent on a number of factors,
including loading type, frequency, intensity and duration.
Injurious loading promotes OA progression
On the contrary to the physiological loading, the injurious loading is one major
factor of OA onset and progression. Overuse of joints results in catabolic effects
by directly damaging the cartilage ECM and breaking the balance of chondrocytes
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Table 1.3: The effect of physiological loading on chondrocytes




↓ GAG degradation, COX-2, MMP1, and IL1β




↓ MMP3 and ADAMTS5 [89]




↓ NO, IL1β-induced NO, COX-2, and PGE2
↑ Aggrecan expression [90, 91]
20% strain Rat chondrocytes ↓ IL1β-induced MMPs [92]
activities [101]. The aberrant expressions of proinflammatory cytokines, proteolytic
enzymes and ECM components induced by overloading have been reported in nu-
merous studies (Table 1.4), and are regarded as evident signs of arthritis [8]. The
application of osmotic stress upregulated the production of MMP-3 and -13 [102];
the strain at high rates (0.1 and 1/sec, 50 % strain, peak stress at 12 MPa) reduced
protein biosynthesis [103]; the repetitive impact loading of 5 MPa at 0.3 Hz resulted
in collagen structure damage and chondrocyte apoptosis [104, 105]; a single impact
load at 4.5 MPa leaded to chondrocyte apoptosis in bovine cartilage explants; and a
load at 7-20 MPa induced degradation of cartilage ECM [106, 107]. The MAPK and
Rac/MKK7/c-Jun signaling pathways have been found are responsible for loading-
induced upregulation of MMP3/ADAMTS5 and COX-2, respectively [108]. In ad-
dition to its direct effect on chondrocyte catabolic activities, the deleterious loading
also stimulates the production of vascular endothelial growth factor (VEGF), which
is capable to upregulate the expression of ADAMTS5 and MMPs and downregulate
the expression of TIMPs [109,110]. Taken together, these chronic or acute high loads
might consequently initiate and promote OA development. To adopt exercises as
therapeutic strategies that can relieve the inflammation symptoms of OA, a better
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understanding of the intracellular activities in chondrocytes under different magni-
tudes and types of loading is required.
Table 1.4: The effect of deleterious loading on chondrocytes
Loading type Model Effect
50 % Compression Bovine cartilage
↑ MAPKs, COX-2, MMP3, and ADAMTS5
↓ Type II collagen, Fibronectin [96]
20 dyne/cm2 stress Human chondrocytes ↑ COX-2, Rac, c-Jun, and JNK2 [111]
15 % strain Rabbit chondrocytes ↑ IL1β, NO, and NF-κB [63]
50 % compression Bovine cartlage ↑ VEGF, MMP1, 3, 13, and ↓ TIMP [109]
1.3.6 ER stress promotes OA progression
In addition to cytokines and mechanical loading, inappropriate induction of cellu-
lar stress to the ER is deleterious to cartilage. The ER stress-induced accumulation
of abnormal proteins leads to adaptive cellular responses, including suppression of
mutant protein synthesis, elevated expression of molecular chaperones , which in-
crease the probability of correcting unfolded or misfolded proteins, and activation
of degradative enzymes to remove abnormal proteins [112]. The phosphorylation of
eukaryotic translation initiation factor 2 subunit alpha (eIF2α) is upregulated by ER
stress to reduce overall translation in the cell and the synthesis of mutant misfolded
proteins [113]. Notably, some genes escape the block imposed by eIF2α phosphory-
lation and get upregulated; one of these is MMP. A recent study found that salubri-
nal, a small molecule that can alleviate ER stress by selectively dephosphorylating
eIF2α [114], inhibits IL1β- and TNFα-induced MMP activities [115]. Although the
dephosphorylation of eIF2α inhibits MMP activities, little has been known about the
role of eIF2α in cytokines- and mechanical loading-induced signaling.
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1.4 Signaling mechanisms for mechanotransduction in chondrocytes
Mechanical loading plays a crucial role in cartilage homeostasis and remodeling.
The mechanical force-induced cell responses can be acute responses that occur within
seconds to minutes, including changes in calcium and cAMP levels, and regulation of
membrane ion channels, or long-term changes that occur over hours to months, such
as changes in cell morphology, and regulation of ECM production [116]. With the
increasing interest in mechanotransduction in chondrocytes, different model systems
have been developed. These include studies on monolayer cultures subjected to stretch
or shear stress, and both static and dynamic compression of cartilage explants or
cells in 3D scaffolds. Molecular mechanisms considered for mechanotransduction in
chondrocytes include MAPK/ERK pathway, Ca2+ ion channel and integrin-mediated
signaling.
1.4.1 MAPK/ERK signaling
As discussed in earlier paragraph, MAPK/ERK pathway play pivot roles in cytokine-
induced signaling pathways in chondrocytes. Moreover, it is further identified as
highly responsive to mechanical stimulation. In response to continuous pressure of
90 kPa for 60 min, the expression of ERK increased by 73 %, and the application of
pressure for 360 min leaded to 32 % increase of ERK expression [117]. A study found
that the application of fluid flow on chondrocytes reduced the gene expression of ag-
grecans by activating ERK pathway [118]. Another study using microarray analysis
showed that p38 MAPK and ERK1/2 pathways were involved in a wide variety gene
expression in chondrocytes under hyperosmotic stress [119].
1.4.2 Calcium channel
Ca2+ is a key second messenger that controls many cellular functions, like cell
metabolism, cell proliferation, gene transcription, cell contraction as well as mechan-
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otransduction. Many studies have identified that Ca2+ signaling can be regulated
by compression [120, 121], fluid flow [122], hydrostatic pressure [123], and osmotic
stress [124]. The transient receptor potential vanilloid 4 (TRPV4) channel is the
most well studied Ca2+ channel. It was first found can be activated by hypotonicity-
induced cell swelling. A recent study showed that the blocking of TRPV4 diminished
the chondrocyte responses to hypoosmotic stress, and TRPV4 activation promoted
chondrocyte responses. Moreover, the activation of TRPV4 was capable to restore
the defective cell volume caused by IL-1 [125].
1.4.3 Integrin-mediated mechanotransduction
Integrin is a group of transmembrane glycoprotein consisting of an α and a β sub-
unit. The combination of 16 types of α and 8 types of β subunits form more than 20
different kinds of integrin receptors. Some receptors have specific binding to ligands:
for example, α5β1 and αVβ1 bind fibronectin, α6β1 and α6β4 bind laminin; αVβ3
binds vitronectin andosteopontin; α1β1, α2β1, and α11β1 bind type II and type VI
collagen. In chondrocytes, α1β1, α5β1, α10β1 and αVβ5 are highly expressed [126].
Each subunit contains an extracellular domain, providing the binding site for ECM;
a transmembrane domain, and a cytoplasmic tail, transducing the mechanical signals
to intracellular signaling molecules or the actin cytoskeleton. Adapter proteins, like
paxillin, Src and tensin connect the cytoplasmic tail of integrin with cytoskeleton and
other signaling molecules (Figure 1.5). The interaction between integrin and ECM
is required for the integrin-mediated mechanotransduction. The absence of ECM
components or the inhibition of integrin activity totally abolishes integrin response
to shear stress [127]. The composition of ECM also determines the transduction of
mechanical signal and the regulation of cellular response. It has been found that
chondrocytes binding to fibronectin show a maximal response to mechanical stimu-
lation, while the binding to type II collagen shows a less degree of response, and the
binding to poly-l-lysine gives the minimal response [128]. Chondrocytes attached to
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fibronectin showed a higher degree of membrane hyperpolarization induced by 0.33
Hz mechanical stimulation than cells adherent to type II collagen. This hyperpolar-
ization response was abolished by blocking α5β1 integrin [128]. The rigidity of ECM
is another significant factor of integrin-mediated FAK activity. The phosphorylation
level of Tyr 397 increased with the elevated rigidity of a 3D collagen matrix [129].
Upon the binding of integrin to ECM ligands, the actin cytoskeleton interacts
with β integrin and other adapter proteins, to form actin stress fibers. The actin
filaments transmit mechanical signaling through the cell. The importance of actin
in mechanotransduction has been shown that the Cytochalasin D (selective actin in-
hibitor) abolishes the mechanical stimulation-induced hyperpolarization [131]. The
remodeling of F-actin has been observed in response to hydrostatic pressure in chon-
drocytes in monolayer culture, or dynamic compression in chondrocytes in 3D agarose
scaffolds [132]. The cyclic pressure of 15 MPa impairs the intact actin network, and
30 MPa almost totally abolishes actin structure, leading to cell retraction [133]. 10-
15 % compression on chondrocytes results in punctate actin network as compared to
the uniform cortical actin structure in non-loaded cells [134]. The increased punctate
actin structure was also observed in chondrocytes in 3D agarose gels under cyclically
compression [135].
Upon the formation of stress fibers, the Rho-associated protein kinase (ROCK)
and downstream Rho GTPases are activated. Rho GTPases are important regulators
of chondrocyte development and maturation. RhoA, Rac1 and Cdc42 are three most
common types of Rho GTPases. In chick chondrocytes, elevated Rac1 expression
induced chondrocyte enlargement and MMP13 overexpression [136], while inhibition
of Rac1 blocked MMP-13 production [137]. Ren and colleagues [138] showed that
periodical mechanical stress field in the range of 0 to 200 kPa at 0.1 Hz elevated Rac1
activities in chondrocytes. RhoA also plays roles in cartilage degradation. A recent
OA rodent study showed that cartilage damage was alleviated with the treatment of
Rho kinase inhibitor AS1892802 [139]. Using 0.5 Hz unconfined dynamic compression,
results showed that loading upregulated iNOS gene expression in a RhoA-dependent
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manner, suggesting RhoA may be involved in OA initiation in response to abnormal
mechanical stimuli [135].
To transduct mechanical forces to nucleus, the linkers of the nucleoskeleton to
the cytoskeleton (LINC) complex is required. The crucial roles of LINC complex has
been identified recently. It regulates cell division, cytoskeletal organization, organelle
positioning and cell proliferation [140]. The LINC complex physically link the nu-
clear envelop with the cytoskeleton to transmit physical forces. The LINC complex
contains SUN proteins, nesprins, and Klarsicht/ANC-1/Syne homologue (KASH) do-
main proteins. On the nucleoplasmic side, the SUN domains interact with the lamina;
on the cytoplasmatic side, the KASH domains bind to cytoskeleton via nesprins [141].
Although the importance of LINC complexes has been recognized, how mechanical
stimuli activate transcriptional genes are not well understood.
1.5 FAK and Src
The further integrin clustering brought with the reorganization of actin cytoskele-
ton forms focal adhesion complex (FAC). The formation of FAC, containing enzymes
and their substrates, accelerates the reaction rate and increases the reaction oppor-
tunity (Figure 1.5). FAK is the first molecule that is recruited to the location of
forming FAC. Upon activation, it autophosphorylates and create a Src-homology-2
(SH2) binding domain, which allows the binding of Src and Fyn. The newly formed
complex of Src-FAK phosphorylates other molecules near FAC [142]. FAK and Src
have been found play crucial roles in mechanotransduction in many organs and tissues,
including bone, cartilage, heart, lungs, and blood vessels. Additionally, the loading-
induced integrin activation leads to the activation of protein kinase C (PKC), which
play roles in regulation of MAPK signaling pathways [143],suggesting the possible
cross-link between integrin/Src/FAK and MAPK signaling.
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1.5.1 FAK and Src as targets for OA treatment
The physiological functions of FAK/Src signaling have been explored. It regulates
chondrocytes proliferation, differentiation, apoptosis, mobility, and ECM production
[144]. A study found that the silence of FAK by siRNA decreased cell proliferation
rate and prevented chondrocyte differentiation [11]; and FAK inhibitor significantly
reduced chondrocyte viability [10]. Additionally, FAK and Src can upregulate the
gene transcription of MMPs, iNOS and NO. It has been shown that reduced MMP
expression has been observed with the treatment of FAK antisense [145,146]; and the
treatment of Src inhibitor completely abolished iNOS expression and NO production
in chondrocytes [144,147].
Recent studies showed that integrin/Src signaling plays a major role in MAPK/ERK
and Rho GTPases signaling [144, 148]. Blockage of integrin activity downregulates
Rho/ROCK gene expression and prevents cytoskeleton formation in chondrocytes
[149]; and in FAK knock-out mice, the loss of FAK abolished GTPase Rho regula-
tion by fibronectin [150]. Therefore, a deeper understanding of FAK/Src signaling is
important, and can be a potential strategy for OA prevention and treatment.
1.5.2 structure of FAK and Src
FAK consists of three major domains, an N-terminal FERM (band 4.1, ezrin,
radixin, moesin homology) domain, a central kinase domain, and a C-terminal do-
main. The FERM domain localizes FAK to the plasma membrane, facilitates the
binding of epidermal growth factor receptor (EGFR) and the platelet-derived growth
factor receptor (PDGFR) to FAK, and promotes further activation of FAK by binding
to actin- or membrane-associated adaptor proteins. The C-terminal domain contains
two proline-rich subunits that are binding sites for SH3 domains. The association of
SH3 binding domain and p130Cas is required for the cell migration by activating Rac
at membrane. The C-terminal domain also consists a FAT region, which connects
FAK to focal adhesions (FAs) by binding to paxillin and talin. And it also bind to
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the activator of Rho-family GTPases, including p190 RhoGEF [130]. There are nine
members in the Src family, including Src, Lck, Hck, Fyn, Blk, Lyn, Fgr, Yes, and
Yrk. All family members share the same SH1, SH2, SH3, and SH4 domains, while at
their N-terminus, there are 50-70 residues that are divergent among family members.
Src contains a very short C-terminal tail, which contains an autophosphorylation site.
At inactive state, the interaction motifs of these domains stay inward and lock the
kinase via intramolecular interactions [151].
1.5.3 The interaction between FAK and integrin
The interaction between FAK and integrin was first found from the studies shown
that the phosphorylation of FAK was induced by cell attachment to fibronectin or
integrin activation by antibodies [152]. A latter study showed that the existence of
β cytoplasmic domain of integrin is required for FAK activation mediated by inte-
grins [153], suggesting a very simple model that the FAK directly associate with the
cytoplasmic domain of integrins upon activation. Nevertheless, the membrane distal
amino acid in the cytoplasmic domain has been found is necessary for integrin-induced
FAK activation in vivo [152], indicating the first model is too simple to explain FAK-
integrin interation. Another model is proposed and suggests that cytoskeleton and
cytoskeletal proteins, including talin, paxillin and tesin, transduce the activation of
integrin that in turn activate FAK. A study supports the second model showing
that the treatment of Cytochalasin D, an actin cytoskeleton inhibitor, abolishes FAK
phosphorylation and activation induced by integrin clustering, while calcium is not
directly involved in FAK phosphorylation induced by integrin, as to the depletion of
calcium using thapsigargin fails to alter FAK activity [154].
1.5.4 The association of FAK and Src
Growth factors as well as the binding of integrins to ECM can activate the FAK
phosphorylation. Upon the activation of FAK, the autophosphorylation of Tyr-397
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site on FAK generates a binding site for the SH2 domain of Src to form complexes
[155]. The binding of Src to FAK activates Src activity by altering the interaction
of SH2 domain and C-terminal regulatory tyrosine residue [156]; and additionally
prevents dephosphorylation of FAK by cellular tyrosine phosphatases [157]. The
activated Src would further phosphorylate FAK on other tyrosine residues (like Tyr-
576 and Tyr-577) and create more binding sites for SH2 domains [158]. The C-
terminal Src kinase could negatively regulate the activity of FAK/Src complex by
releasing Sh2 domain of Src from FAK [159].
1.5.5 TNFα or IL1β-induced FAK/Src signaling
The FAK/Src signaling is essential for TNFα- and IL1β-induced cell motility,
survival [160] and inflammatory gene expression [12]. The TNFα-induced MMP pro-
duction is regulated by FAK and Src activities. FAK-deficient cells exhibited much
lower MMP9 secretion as to normal cells, and JNK might be involved in this FAK-
mediated MMP regulation [161]. In a mice model, the expression level of TNFα
shared a similar pattern to those of MMP2 and MMP9; and the inhibition of FAK
and ERK blocked the TNFα-stimulated MMP2 and MMP9 production [162,163]. It
also has been found that the phosphorylation of Src mediated TNFα-induced MMP
production through ERK signaling pathway [164]. However, the mechanisms are un-
der debate as to how FAK and Src transduce signals to downstream molecules in
inflammatory signaling. A recent finding showed that FAK inhibition significantly
prevented TNFα-induced MAPK activation, and subsequently reduced the produc-
tion of vascular cell adhesion molecule-1 (VCAM-1), which plays important roles
in inflammation [165]. Moreover, it has been found that although FAK is essen-
tial for MAPK activation, but it is not required for NFκB or JNK activation by
TNFα [166]. Interestingly, contradictory results have been shown that FAK regu-
lates TNFα-induced inflammation response via NFκB pathway; and FAK deficiency
in fibroblasts abolished TNFα-induced IL6 production by inhibiting NFκB signaling,
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but did not affect the activities of MAPKs [167]. Src activation also has been found
to be involved in in TNFα-stimulated NFκB signaling by upregulating IKK activ-
ity [168]. A recent study demonstrated that TNFα elevated phosphorylation of Src
and NFκB, as well as the production of MMP9; and the treatment of Src, MAPK,
or JNK1/2 inhibitor abolished TNFα-induced NFκB phosphorylation and translo-
cation. A study using Src-null and FAK-null mouse embryo fibroblasts showed that
FAK expression activates IL6 production, while Src expression was inhibitory to IL6
production [166]. This result provides the evidence for a Src-independent FAK sig-
naling pathway. Taken together, cytokine treatment elevates Src/FAK via NFκB,
MAPK and ERK signaling pathways [169], leading to elevated MMP expression.
Table 1.5: Chondrocyte intracellular activity in response to mechanical stimulation
Loading type Model Effect
Ultrasound Rabbit
↑ Integrin, MERK1/2, FAK/Src, ERK1/2, PI3K and Akt,
↑ Matrix synthesis, ↓ MMP [14,170]
Stress Rat
↑ FAK/Src, MEK1/2, ERK1/2, PI3K and Akt,
↑ Matrix synthesis, ↓ MMP [15,170]
Ultrasound Human ↑ FAK/Src, p130 Cas, CrkII and ERK phosphorylation [148]
Cyclic strain Human ↑ FAK, β-catenin and paxillin [171]
Compression Bovine ↑ Src and ERK, ↑ Cell spreading and contraction, ↑ MMP [16]
1.5.6 Mechanical loading-induced FAK/Src signaling
Mechanical environment changes and matrix binding initiate integrin-mediated
FAK/Src signaling. In chondrocytes, α5β1 integrin is the prominent integrin, and
highly expressed in OA chondrocytes [172]. The attachment of integrins to ECM
is essential for integrin signaling. A study found that the phosphorylation levels of
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FAK, Pyk2 and ERK were higher in adherent chondrocytes as compared to those in
suspended chondrocytes [173].
When chondrocytes are exposed to mechanical stimulus, FAK and Src are first
molecules to be concentrated to the newly formed FAC. Table 1.5 lists studies about
FAK/Src regulations by mechanical loading. A study demonstrated that the acti-
vation of integrin/FAK signaling is essential for ECM production by chondrocytes
in response to ultrasound [14]. Another study found the treatment of either inte-
grin or Src inhibitor reduced ultrasound-induced ERK phosphorylation level, which
indicates integrins and Src are upstream molecules of ERK [148]. The periodic me-
chanical stress has been shown could elevate chondrocyte proliferation and matrix
synthesis through Src-ERK1/2 signaling cascade [170]. The same group further eval-
uated the role of FAK in this Src-mediated signaling cascade. They found that the
reduction of FAK phosphorylation level attenuated the phosphorylation of ERK1/2
and consequently abolished periodic mechanical stress-induced chondrocyte prolifer-
ation and matrix production, but can’t affect Src activation [15]. Additionally, it
has been found that Src and FAK activities upregulate loading-induced MMP ex-
pression [16]. Under mechanical loading, there are two signaling pathways involved
in FAK and Src-mediated MMP regulation. Upon FAK autophosphorylation, Src
binds to FAK and phosphorylates FAK at Tyr 861 and Tyr 925. The phosphory-
lation of Tyr 925 leads to the binding of GRB2 to FAK, which activates Ras and
the ERK2/MAPK cascade, leading to elevated MMP expression [174]. The second
pathways involves in JNK signaling. The Src/FAK complexes phosphorylate p130Cas
and paxillin [175], and the phosphorylated p130Cas together with CrkII upregulate
the activity of Dock180, a Rac GEF. The elevated Rac activity by Dock180 activates
the JNK signaling and ultimately increases MMP2 and MMP9 activities [176]. Al-
though the known importance of FAK/Src in loading- and cytokine-induced cartilage
maintenance, whether different loading can differentially regulate Src/FAK and even
reverse cytokine-stimulated FAK/Src activation is unknown.
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1.5.7 The differential activities of FAK and Src at different microdomains
of plasma membranes
The lipid bilayer of the cell plasma membrane contains different subdomains: the
regions of plasma membrane that are rich in cholesterol and sphingolipids are termed
lipid rafts; and the surrounding regions are termed non-lipid rafts. It has been found
that most FAK may translocate to rafts upon cell adhesion [177]; the inhibition
of caveolin, a raft protein, blocked the FAK phosphorylation and integrin activa-
tion [178]; and the disruption of rafts by MβCD downregulated FAK activities [179].
On the other hand, Src is localized at lipid rafts as well as non-lipid rafts. It has
been found that Src concentrates at the non-lipid rafts at resting state, which can be
rapidly activated [180, 181]; and the other population of Src is stored in endosomes
and can be transported to lipid rafts via actin filaments upon stimulation [17]. Stud-
ies suggest that different microdomains of plasma membranes may function distinctly
as segregated signaling platforms [182], for example, Akt activities at different mi-
crodomains are regulated differentially [183]. The kinetic characteristics of Src [184]
and FAK [185] under growth factors are also different in and outside of lipid rafts;
and upon thermoactivation, Src at lipid rafts regulates PI3K/Akt signaling, while
Src at non-lipid rafts regulate MAPK/ERK pathways [186]. However, it remains un-
clear how FAK and Src activities in different microdomains respond to cytokine and
mechanical stimulations in chondrocytes.
1.5.8 Proline-rich tyrosine kinase 2 (Pyk2)
Pyk2 is highly similar to FAK in sequence (46 % identical and 65 % similar) and
structure, but its expression is not as ubiquitous as FAK. Pyk2 is not phosphorylated
in epithelial [173], neural [187] and smooth muscle cells [188]; but predominantly
expressed in macrophages and osteoclasts [189]. Upon activation, Pyk2 creates a
binding site for SH2 domain of Src, resulting in Src activation. Pyk2 shares some
functions with FAK [190], for example, in FAK-null fibroblasts, Pyk2 can compensate
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FAK activity to promote cell retraction [191]. Pyk2 also performs different functions
from FAK: it can impair GAP activity towards Cdc42 [192], but not FAK; FAK
is essential for Rho guanine nucleotide exchange factors (GEFs) localization to FA,
but not Pyk2 [191]. However, the roles of Pyk2 in chondrocyte activities are not
well studied, and how it interacts with FAK and Src under cytokine and mechanical
loading is also unknown.
1.6 AMPK signaling in osteoarthritis
In 1987, AMPK was first found as a protein kinase that was activated by the
increased amounts of AMP [193]. It is a sensor of cellular energy that maintains the
energy balance, both at the cellular level and at the whole body. Once activated by
rising ratio of (AMP+ADP)/ATP, AMPK phosphorylates multiple downstream tar-
gets to initiate catabolic regulatory pathways that generate ATP, whilst downregulate
anabolic signaling and other cellular activities that consume extra ATP [20]. Recent
studies indicate that, in addition to balancing energy metabolism, AMPK also co-
ordinates several other mechanisms, such as anti-inflammation and increasing tissue
stress resistance. Regarding its potent roles in human health, its dysfunction leads
to diverse disorders such as cardiovascular diseases, diabetes, cancer and OA. Widely
used drugs like metformin for diabetes II, and salicylates for anti-inflammation are
acting to activate AMPK, while its roles in OA is not very well clarified.
1.6.1 The structure of AMPK
AMPK exists throughout eukaryotes as a heterotrimer, consisting of α, β, and γ
subunits (Figure 1.6). The layout of all domains of AMPK is well understood. In
mammals, two genes code for α (α1, α2), two for β (β1, β2), and three for γ subunits
(γ1, γ2, γ3). The phosphorylation of Thr172 on α2 isoform by upstream kinases
triggers AMPK activation and are regarded as the sign for AMPK activation [194].
Start from the N-terminal end, the α subunit consists of the catalytic kinase domain
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(α-KD), a small auto-inhibitory domain (α-AID), a linker and the α-C-terminal do-
main (α-CTD) [195]. The catalytic activity of α-KD is compromised by α-AID, and
the reorientation of the α-AID contributes to the activation of AMPK. The pivot
phosphorylation site, Thr172 is located next to α-CTD. The active conformation
of α-CTD is required for the access of phosphatases to Thr172 to activate AMPK
activity [196]. The β subunits contain two domains, the carbohydrate-binding mod-
ule (β-CBM), and the β-CTD. The β-CBM is responsible for the binding of AMPK
to glycogen, but its physiological roles are not clear. The γ subunite contains four
repeats of cystathionine-β-synthase (CBS) sequence. The second CBS site remains
empty, the fourth site binds AMP, and the first and the third sites can bind AMP,
ADP or ATP to perform regulatory functions. The binding of AMP to the first site
promotes the kinase activity of AMPK, and the binding of AMP or ADP to the third
site suppresses Thr172 dephosphorylation [197].
1.6.2 The AMPK-related disease
The importance of AMPK is implicated in many diseases, and its activation is
suspected to extend healthspan by reducing risks for atherosclerosis, heart attack,
stroke, type II diabetes, overweight, cancers, autoimmunity and cartilage diseases. In
addition to several widely used drugs, regular consumption of vinegar, and moderate
alcohol ingestion has been found achieve health-protective AMPK activation.
Cardiovascular diseases (CVDs)
CVD includes a class of disease related to heart or blood vessels, and it is the
leading cause of death globally. A randomized clinical trial enrolling 156 patients
showed that the AMPK activator reduces chronic congestive heart failure [199], and
animal studies showed that the activation of AMPK has been shown can reduce risk
for heart attack, stroke and congestive failure [200]. Although the downregulation of
protein synthesis by AMPK play some roles in CVD prevention, the impact of AMPK
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activation on CVDs is prominently due to its ability to activate endothelial nitric-
oxide synthase (eNOS). The activation of eNOS preserves the structure and function
of the vascular system by increasing the concentration of NO [201]. The AMPK
also downregulates the activation of NF-κB and oxidative stress, two factors that
contribute to the atherogenesis and thrombosis [202]. However, excessive activation
of AMPK in the heart leads to deleterious impact. The heart disease Wolff-Parkinson-
White syndrome results from genetic mutation on AMPK genes in 2 isoform. This
mutation restricts the binding of ATP, and thus increases basal phosphorylation level
of Thr172, which results in constitutive activation of AMPK and over-accumulation
of glycogen in cardiomyocytes [203]. Interestingly, a study found that the exercise-
induced shear stress stimulates the expression of eNOS via AMPK signaling [204].
This is one of the very rare studies about the impact of physical stimulus on AMPK
activities.
Type II diabetes
Type II diabetes, a type of metabolic disorder featured high blood sugar and
insulin resistance, affects 29.1 million American in 2012, and costs 550 billion annually.
Obesity and lack of exercise are two primary factors contributing to this disease. The
number of patients suffered from type II diabetes has boomed markedly since 1960.
The insulin resistance is believed strongly associated with obesity, which leads to
excessive triacylglycerol in liver and skeletal muscle. In addition to triacylglycerol,
the increased level of diacylglycerol appears to downregualte the insulin-signaling
pathway by activating protein kinase C in muscle as well as in liver [205]. Treatments
to activate AMPK pathways are expected to prevent lipid accumulation in liver and
muscle by enhancing the degradation and inhibiting the synthesis of fat [206]. AICAR
mimics the activating effects of AMP on AMPK and reverses obesity and insulin
resistance in animal models [207,208]; A-769662, a direct AMPK activator, increases
the oxidation of fat and decreases body weight in rats [209]; metformin, a drug to
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treat type II diabetes, also highly activates AMPK [210]. Although AIRCAR regulate
AMPK activity indirectly, studies have confirmed their therapeutic effects on insulin
resistance and weight control are indeed mediated by AMPK [211].
Cancer
Types of cancer have been found related to AMPK signaling, including breast,
prostate, and colorectal cancer [212]. The downregulation of AMPK-α2 has been
found in hepatocellular carcinoma [213]. The most important link between AMPK
and cancer can be liver protein kinase B1 (LKB1), a classical tumor suppressor, which
is located at the upstream of AMPK. Peutz-Jeghers patients with the mutations that
lack of LKB1 activity are tend to develop malignant cancers [214]; and the mutations
in LKB1 gene are common in patients with cancer: up to 30 % of lung cancers, 20
% of cervical cancers, and 10 % of melanomas [215]. Although other AMPK-related
kinases are also regulated by LKB1, AMPK is the most pivot kinase because of its
ability to inhibit mTORC1. mTORC1 regulates various biosynthetic pathways to
enhance proliferation and inhibit apoptosis, leading to accumulation of mutations
and survival of pre-cancerous stem cells [216]. Drugs to activate AMPK activities,
such as metformin, phenformin, and A-769662 have been shown delayed the onset
of tumor in tumor-prone mice [217]. Moreover, diabetic patients on metformin had
lower incidence of cancer than those taking other medications [218].
Inflammatory disorders
Inflammatory disorders arise when inflammation mistakenly destroys healthy tis-
sue of the body, resulting in fever, rash, joint swelling, and potential fatal build up of
blood proteins in vital organs. AMPK has anti-inflammatory effects by attenuating
the production of inflammatory cytokines, and preventing the activation of immune
cells, including dendritic cells, neutrophils and T cell [219]. At inactive state, immune
cells utilized mainly oxidative metabolism; while upon activation, they tend to use
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aerobic glycolysis instead, and this process is inhibited by AMPK activation [220].
The AMPK-β1-deficient mice have suppressed fatty acid oxidation that consequently
increases the content of pro-inflammatory diacylglycerols. A-769662 has been found
an increase fatty acid oxidation [221]. AMPK activator, metformin, berberine, and
AICAR, can effectively prevent sclerosis and colitis in murine models [222–224], and
some of these inhibitory effects are stem from the inhibited activity of NF-κB. Sali-
cylate, the natural product, promotes fatty acid oxidation by activating AMPK ac-
tivity [225].
Neurodegenerative disorders
Neurodegeneration occurs when the structure or function of neurons is impaired.
In US, Alzheimers disease affects 5.4 million people, Parkinsons disease affects half
million, and Huntingtons disease affects 30 thousand people. These diseases are ir-
reversible and incurable, therefore, the prevention of neurodegeneration is crucial.
AMPK activation promotes autophagy, a crucial process to maintain healthy neu-
rons [226], suggesting preventive roles of AMPK in neurodegeneration. Additionally,
inflammation is suspected to contribute to this neurodegeneration. A study found
that AMPK activator suppressed inflammation on cultured microglia [227]. AMPK
activation has been shown to aid Alzheimers prevention by suppressing the expression
of BACE1 protease, which is required for the accumulation of extracellular amyloid-
β [228]. The possibility of developing dementia is reduced by 25 % in diabetic patients
on metformin as compared to those not taking medications [229].
Osteoarthritis
It has been discovered that the AMPK activity is highly activated in normal chon-
drocytes and cartilage, while its activity is suppressed in OA chondrocytes, injured
chondrocytes, and cytokine-treated chondrocytes [21]. The AMPK activator attenu-
ates catabolic pathways, and this response declines during ageing [230]. The LKB1
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is involved in the regulation of AMPK activity in chondrocytes. The silence of LKB1
activity enhances catabolic responses of chondrocytes to cytokine treatment [231].
The NAD+-dependent protein deacetylase silent information regulator 1 (SIRT1) is
a downstream mediator of AMPK regulating chondrocyte metabolism. Activation of
SIRT1 upregulates ECM production and inhibits chondrocyte apoptosis [232], and the
inhibition of SIRT1 enhances chondrocyte responses to cytokines [233]. Using mice
models, the knockout or the mutation of SIRT1 promotes OA progression [234]. More-
over, a positive feedback loop about SIRT1, LKB1 and AMPK has been discovered.
Activation of AMPK enhances the activity of SIRT1 by upregulating intracellular
NAD+, and the activated SIRT1 deacetylates and activates LKB1 that eventually
further promotes AMPK activation [230]. Recent studies found that AMPK activa-
tor notably suppress the IL-1 and TNFα-induced catabolic response of chondrocytes,
including the elevated production level of MMP-3, MMP-13, and NO [21,235].
1.6.3 The signaling properties of AMPK
What is the mechanism of AMPK activation? The AMPK signaling is switched on
by ATP depletion, and plays critical roles in maintaining the homeostasis of cellular
energy. The adenylate kinase reaction of 2ADP↔ATP + AMP is tightly controlled
to maintain equilibrium in most eukaryotic cells. In normal cells, the ratio of ATP :
ADP at 10 : 1 drives the adenylate kinase reaction to produce ADP and to maintain
the AMP at a low level. However, in stressed cells, the ATP : ADP ratio reduces by
driving the reaction towards AMP. Because the AMP basal concentration starts at
a very low level, the AMP concentration becomes a sensitive indicator of metabolic
stress. The activation of AMPK signaling promotes catabolic pathways to produce
more ATP, and simultaneously inhibits anabolic activities that consume ATP.
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The initiation of AMPK activity
The complex containing the LKB1, a tumor-suppressor gene, is the principal up-
stream kinase that phosphorylates Thr172 of AMPK [194, 236], and this is the first
evidence linked AMPK with cancer. The binding of AMP to AMPK promotes the
phosphorylation of Thr172 by LKB1 and inhibits the dephosphorylation by protein
phosphatase even in the presence of physiological concentration of ATP [237]. In
addition to LKB1, with the rise of intracellular Ca2+, which often indicate cellu-
lar stress, Ca2+/calmodulin-dependent kinase kinases (CaMKKs) further activates
Thr172, which is an alternate pathway to activate AMPK in the absence of changes
in AMP levels. This CaMKKs-mediated AMPK activation occurs in many cells. The
TAK1 and ataxia telangiectasia mutated (ATM) are also identified as upstream ki-
nases of AMPK, however, the physiological roles of these two kinases in regulating
AMPK phosphorylation are not well understood, and require further studies. For
instance, the TAK1 is involved in AMPK activation by tumor necrosis factor, but
not that induced by TNF or IL1β, suggesting TAK1 might partially regulate the
activation of AMPK [238].
The downstream of AMPK signaling
Researches have revealed several signaling pathways involved in AMPK signaling,
and many of them aid the regulation of autophagy and oxidative stress. CRTC-1, a
cytoplasmic co-activator of CREB, is a phosphorylation target located at the down-
stream of AMPK. The phosphorylation of CRTC-1 by AMPK prevents its nuclear
translocation and inhibits CRTC-CREB pathway, and consequently extends the lifes-
pan of C. elegans [239]. AMPK mediates caloric restriction- and heat stress-induced
CRTC inhibition, while its roles in some hormones-or phytochemicals-induced CRTC
inhibition needs to be clarified.
SIRT1, an enzyme that deacetylates proteins, regulates cellular energy metabolism
and cell survival. The AMPK activation elevates the intracellular concentration of
40
NAD+, which further stimulate the SIRT1 activity. SIRT1 has the ability to induce
mitochondrial biogenesis by activating PGC-1α, and it is capable to potentiate its
owns activity by promoting the expression of Nampt that increases NAD+ [240].
Interestingly, SIRT1 has been found to deacetylate LKB1 kinase, which consequently
stimulates the activation of AMPK. This positive feedback loop can potentiate AMPK
[241].
Forehead transcription factors (FoxOs) are involved in crucial cellular functions.
AMPK phosphorylates FoxO3, and further promotes the resistance of cells to oxida-
tive stress. The constitutively active AMPK extends the lifespan of C. elegans [242].
The AMPK-FoxO3 pathway are integrated with other signaling pathways. FoxO3 is
capable to inhibit NF-κB signaling by elevating the expression of inhibitory kappaB
genes. IKKα and IKKβ, upstream kinases of NF-κB, can phosphorylate FoxO3 and
initiate the degradation of FoxO3 [243]. Increased NF-κB activities are closely asso-
ciated with chronic inflammation. Both in vivo and in vitro data showed that the
activation of AMPK inhibits the activity of NF-κB. Metformin, an AMPK activator,
inhibits NF-κB signaling and alleviates inflammation in endothelial cells [244].
The mechanistic target of rapamycin (mTOR) is widely involved in regulatory
signaling induced by cytokines, excessive nutrients and energy, and is known to in-
hibit autophagy. Two mechanisms underlying how AMPK inhibits mTOR complex
have been revealed, either by directly phosphorylating the Raptor, or by phosphory-
lating the tuberous sclerosis protein 2 (TSC2) that can inhibit mTOR. In the first
mechanism, the phosphorylation of the Raptor component by AMPK triggers the dis-
sociation of mTORC1 from the ULK1 complex, which is required for the formation
of autophagosome. AMPK also has been found can directly binding to the ULK1
complex and activate autophagy [245]. However, the phosphorylation sites in the
ULK1 by AMPK havent been identified yet.
AMPK can phosphorylate the Rab-GTPase activator protein (Rab-GAP) TBC1D1
to accelerate glucose uptake. TBC1D1 is essential to insulin-mediated glucose uptake
in muscle cells. It binds to the glucose transporter GLUT4, and maintains the Rab
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family of small G proteins in their inactive state. The phosphorylation of TBC1D1
by AMPK alters its Rab-GAP activity, which promotes trafficking of the GLUT-4
vesicles to the plasma membrane and leads to the increase of glucose uptake [246].
Malonyl-CoA is critical for fatty acid synthesis, and also inhibits fatty acid uptake
by mitochondria. The reduced amount of malonyl-CoA inhibits fatty acid synthesis
and promotes fatty acid oxidation [247]. AMPK phosphorylates acetyl-CoA car-
boxylase that lowers the concentration of malonyl-CoA. A single injection of AICAR
significantly activates AMPK activity, which subsequently suppresses malonyl-CoA
activity and upregulates insulin-stimulated glucose uptake in muscle 24 h after injec-
tion [208].
1.6.4 The dark side of AMPK
While AMPK activation has been demonstrated act as a protective response to
various stresses, accumulating evidences indicate that excessive AMPK activity in
cancer cells can have deleterious effects. The silence of AMPK using siRNA di-
minishes the growth of LNCaP, an androgen-sensitive prostate adenocarcinoma cell
line [248]. The knockdown of AMPK in pancreatic cancer cells diminishes their ability
of resistance to glucose starvation [249]. In tumor cells with low pH, upregulated-
AMPK activity increases glucose consumption, resulting in the induction of oxygen-
sparing phenotypes [250]. More evidences support that AMPK activation is a strategy
used by tumor cells to adapt to nutrient-deprived and hypoxic tumor microenvi-
ronments [251–253]. The pro-tumorigenic ability of AMPK is also linked with Src
signaling, which will be described in details in the next section.
1.6.5 AMPK and integrin/Src/FAK
The proton beam irradiation inhibits the gene expression of β1integrin, FAK, Src,
and MAPK, and simultaneously, increases the phosphorylation of AMPK to inhibit
cell adhesion and spreading [254], and the mutation of integrin and the silence of β3
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integrin prevents tumor formation in liver [255], while the direct link between inte-
grin and AMPK is not clearly clarified in these studies. Emerging data indicates that
activation of integrin is required for the phosphorylation of AMPK. The neutraliza-
tion of β1 integrin using anti-integrin antibody completely reversed CCNI-stimulated
AMPK activation in endothelial cells. CCNI is known to highly express in cancer
cells and to promote angiogenesis in endothelial cells [256]. Interestingly, it has been
found that the activation of AMPK reduces the expression of β1 integrin and inhibits
the phosphorylation of β1 integrin signaling targets in colon cancer cells [257]; the
treatment of A-769662, an AMPK activator, reduces the abundance of β1-integrin on
cell surface [258]. These data suggest a negative loop between AMPK and integrin
that tightly controls and prevents its excessive activation. However, the adiponectin-
stimulated integrin activation is inhibited by the inhibitor and mutant of AMPK [259];
and the AMPKα2 is required for the phosphorylation of β3 integrin [260]. This dis-
crepancy in integrin activity in responses to AMPK might attributable to differences
in certain genetic traits among different cell line that used in researches. Additionally,
evidence supports a role of AMPK activity in integrin-related signaling. The expres-
sion of integrin-linked kinase (ILK), an adaptor connecting integrin to cytoskeleton,
is regulated via AMPK-mediated signaling [261].
Regarding the pivot roles of Src in cancer progression, emerging evidences revealed
the interaction between AMPK and Src in cancer development. AMPK activation
has been demonstrated as the result of c-Src activation independent of AMP level
human papillomavirus (HPV)-transformed cells [262], and the same group found that
the activation of c-Src signals through LKB1 to AMPK is the hallmark of cancer cell
transformation [263]. And the inhibition of Src activity abolished AMPK phospho-
rylation in breast cancer cells [264]. Fyn, another member of Src family kinase, has
been found increases AMPK activity by upregulating the expression of LKB1 [265].
Additionally, the Src has been found mediate AMPK signaling in aortic endothelial
cells [266] and tubular epithelia cells [267]. Several studies showed contradictory re-
sults indicating AMPK regulates the phosphorylation of Src: it is required for the
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phosphorylation of Src family kinase, Fyn [260]; Src is activated by metformin in a
AMPK-dependent manner [268]; and the inhibition of AMPK by selective AMPK
inhibitor, compound C, impairs Src activity [269]. The interplay between AMPK and
Src is still unclear, and requires further studies.
Very few studies about FAK and AMPK have been performed. Mulberry have
been identified to inhibit the migration of vascular smooth muscle cells by two distinct
pathways: AMPK-mediated and FAK-mediated, while crosslink between these two
signaling is not clear [270].
1.6.6 The AMPK activities at various subcellular compartments
AMPK regulate various cellular functions, one solution to perform multi-task
within the different cellular spaces is compartmentalization. It has been known that
several environmental factors stimulate AMPK travels between the nucleus and cy-
tosol. After heat shock or oxidant exposure, AMPK translocate from cytosol to nuclei
with the assistance of nuclear exporter Crm1, and this shuttling behavior is abolished
in high-density cell culture, for which AMPK is only exist in cytoplasm [271]. AMPK
containing different units has been found in different compartments. AMPK with
α2β1 is confined in cytoplasm, while upon the stimulation of fatty acid oxidation,
α2β2 is capable to rapidly translocate to the nucleus [272]. In addition to nucleus
and cytoplasm, several studies revealed that in response to stress, AMPK could ac-
cumulate near plasma membrane [273, 274], mitotic apparatus [275], and the basal
bodies of primary cilia [276]. To visualize the dynamic activities of AMPK at various
subcellular microdomains without cell lysis, the FRET-based AMPK biosensors with
modifications to target specific compartments have been developed. In 2011, Tsou
and colleagues successfully designed Cyto-AMPK and Nuc-AMPK to monitor the
AMPK activities in cytoplasm and nuclei, correspondingly [277]. Recently, a series of
AMPK biosensors that can target ER, mitochondria, Golgi apparatus, plasma mem-
brane and lysosome have been developed with improved specificity, gaining insights
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into the dynamic signaling activities at subcellular levels with high spatiotemporal
precision [278]. Thus, we employed these biosensors to evaluate the activities of
AMPK in response to mechanical or chemical stimulations and their interaction with
integrin/FAK/Src signaling at different compartments.
1.7 3D culture alters cellular cues
The direct effects of mechanical loads on intracellular signaling that lead to pro-
gression of OA cannot be investigated over time in patients, so numerous studies were
performed based on in vivo, ex vivo and in vitro models.
In living animal experiments, application of mechanical loading generates strain
within the whole matrix, and impacts cells via natural cell-matrix connections. With
the development of various genetic modified mice, it becomes possible to correlate
changes in cartilage structure with specific molecule activities in chondrocytes. While
in vivo studies provide valuable data, it shows drawbacks, including the uncontrolled
parameters within the whole animal, the variability among animals, and the raised
ethical and economical issues. Experiments using ex vivo cartilage explants have been
shown to be able to maintain cell 3D morphology, provide native ECM, and simplify
the complexities of in vivo experiments. Results suggest that cells in the explant
exhibit similar loading-induced cellular responses to those measured in vivo [279]. in
vitro monolayer cell culture is a highly simplified experiment model widely used in
cell-based studies. However, the flat and hard plastic or glass surfaces fail to allow
cells to keep their physiological morphology and native interactions with ECM and
other cells [280]. Many cell types, including chondrocytes that isolated from tissues
become excessively flatter, function aberrantly, and lose their phenotype when placed
on 2D substrates [281, 282]. To narrow the gap between 2D cell culture and in vivo
studies, 3D cell culture has been developed to mimic in vivo 3D environments and
is regarded as an appealing approach to improve the traditional in vitro cell culture
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model [280]. It has been shown that cultured cells in 3D culture could maintain some
tissue-specific phenotypes [22].
The 3D culture can be categorized into two culture systems, scaffold-free or
scaffold-based. In the scaffold-free system, cell spheroids generate their own ECM,
and has been shown to promote cell survival and maintenance of stem cell pheno-
type [283]. This spheroid system is highly popular in cancer and stem cell studies,
however, due to the lack of standardized procedures to produce uniform and consis-
tent spheroids, the scaffold-free system cant be widely used in drug development. In
the scaffold-base system, scaffolds can made of a wide range of natural or synthetic
materials to extend the options available to researchers. Several cell types have been
found can regain their physiological morphology and cellular function when seeded in
3D scaffolds: encapsulation of dedifferentiated chondrocytes in agarose gels regains
their spherical morphology and phenotype [284]; dedifferentiated mammary epithelial
cells redifferentiate when maintained on floating collagen membranes [285]. Several
microenvironmental cues that presented in 3D versus cultures are known to affect cell
function.
1.7.1 Cell adhesion, Cell morphology and cytoskeleton
All animal cells are in constant close contact with the surrounding ECM and
neighboring cells. Studying biological processes on flat, 2D plastic or glass substrates
does not consider the importance of natural 3D environment on cellular functions.
Cells in 2D and 3D are very different in morphology (Figure 1.7). Cells grown on 2D
substrates are flat and spreading one the plate due to no support for spreading in the
vertical dimension. One consequence of this is that monolayer cells have an artificial
lower and upper surface polarity. This polarity is required to functions of some cell
types, such as epithelial cells, but for most of other cell types, like chondrocytes,
the 2D substrate failed to provide the microenvironment that cells experience in
vivo [287]. This apical-basal polarity directly impact cell function by increasing the
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resistance to apoptosis [288]. Beyond this forced polarity, the flattening cells growing
on 2D substrates can better respond to stimulations as a result of increased exposure
of membrane receptors to the activators (increase the surface-to-volume ratio) [289].
Contradictory to 2D monolayer culture, cells growing in 3D culture systems form
aggregates or spheroids within the matrix, and maintain their spherical morphology
that resembles its natural shape in vivo. The formation of aggregates also allows cell-
cell interactions and cell-ECM interactions, such that cells embedded in 3D culture
can closely emulate the cellular processes in the body [290].
The organization, composition and the number of adhesions are important for
tissue phenotype, tissue mechanical stability, tissue repair, cell motility, proliferation,
differentiation, morphogenesis, and intra/intercellular signaling [291]. For the in vitro
studies, cells are isolated from native cell-cell and cell-ECM interactions, and are
placed into a artificial enviroment that provided by substrates. The 2D culture system
provides adhesions to the ECM on one face of the cell, while the 3D model allows
adhesions all around the cell surface [292]. This variation could result in the different
cellular responses in 2D versus 3D culture. However, how adhesions in varying culture
models impact cell signaling and function remains unclear.
The importance of cytoskeleton in 2D cell culture has been well established. How-
ever, different from that in 2D model, cells in vivo as well as in 3D gel culture, having
much less dense actin stress fibers. And the organization of microtubular cytoskeleton
is also distinct in different culture models [293]. As to the cytoskeletal networks in
3D matrix are very different to cells on 2D culture, how the differential cytoskele-
tal organization, in turn, influence cell signaling and function can be topics to be
examined.
1.7.2 Materials for 3D scaffold-based cell culture
The 2D culture usually grows cells on glass or tissue culture plastic dishes, while
3D cultures utilize different methods to support cells in 3D, including forced-floating,
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hanging drop, agitation-based approaches, matrices and scaffolds, and microfluidic
cell culture platforms (Figure 1.8) [294]. Scaffold-based 3D cultures are most widely
used and can be produced by mixing a cell suspension with a liquid matrix followed
by cross-linking of the network [295]. The cross-linking process can be regulated
by temperature, pH, chelating agents, and the exposure to ultraviolet light [296].
Hydrogels are popular scaffolds for 3D cell culture due to their high water content
(>90 %), macroporous structure, controlled shapes and sizes, and the wide range
of chemical/mechanical properties for various applications [297]. Synthetic materials
have well-controlled chemical composition and tunable degradability, while naturally
derived materials are biocompatible and are capable to provide cell adhesion sites.
Natural biomaterials includes collagen, fibrin, HA, agarose, are of particular interest
to researchers thanks to their generally good biocompatibility, and low toxicity [298].
Collagen
Collagen is a type of elongated fibril that plays crucial roles in most connective
tissues. The highly organized 3D collagen network is required for the integrity of
ECM and is undergoing constant dynamic remodeling. It is a widely used natural
component in tissue engineering. The three most common types of collagen are: Type
I (skin, tendon and bone), Type II (cartilage), Type III (blood vessel walls). Type
II collagen is the most abundant collagen in articular cartilage. Findings showed
that small type II collagen fibers with diameter of <10 nm widely exist in all three
zones; larger fibers with diameter of ∼34 nm are organized parallel to the surface
and only exist in superficial zone; fibers with diameter of 70-100 nm distribute in
the middle zone; and fibers with diameter of ∼140 nm are only exist in the deep
zone [299]. Glutaradehyde (GA) is commonly used to crosslink collagens to prevent
contraction of matrices during cell growth, but its existence leads to cytotoxicity
[300]. The advantages and disadvantages of collagen crosslinking techniques have been
extensively examined [301]. The cross-linked collagen is more resistant to deformation
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and flow than that was not crosslinked. Many studies of cell activities show that the
existence of collagen alters cell migration, attachment, adhesion and differentiation
[302].
Alginate
Alginates are linear anionic polysaccharides consisting of β-D-mannuronic acid
and C5-epimer α-L-guluronic acid. It is extracted from the cell walls of brown algae,
and will form a viscous gum when bind with water. Although the production process
will significantly affect properties of alginate, well-processed alginates with high purity
are capable to maintained consistent mechanical properties for cell growing. Alginate
has been used to maintain various types of cells for its ability to provide physiological
conditions, easy dissolution to harvest cells, transparency for imaging, and porous
structure that allows diffusion [303].
Chitosan
Chitosan is a linear polysaccharide made of β-linked D-glucosamine and N-acetyl-
D-glucosamine, and has molecular weight ranged from 300 kD to 1000 kD. It is
produced by treating shells of shrimp with the alkali. It is soluble in organic acids
and can be easily accessed in chemical reactions. The physical and chemical properties
of chitosan are highly dependent on the number of protonated amino groups in the
polymer chain, and are controlled different process conditions. These features make
it an attractive option for wide applications in researches [304].
Agarose gel for chondrocyte studies
Synthetic and natural polymers, such as polyethylene glycol, alginate, and agarose,
are allowing the creation of 3D models [305]. The agarose gel has been extensively
used in cartilage study for maintaining long-term chondrocyte suspension cultures.
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It is able to mimic the nature of cartilage tissue as to high water content and the
presence of pores where offer a gentle and cyto-compatible condition for chondro-
cytes. Numerous studies demonstrated that agarose is capable to maintain the chon-
drocyte phenotypes [99, 306–309] and improve ECM synthesis [310, 311]. Moreover,
agarose provides a similar load-support mechanism as articular cartilage [312, 313].
These properties of agarose enable the investigation of the response of chondrocytes
to chemical and mechanical stimulus.
1.8 FRET based biosensors
Live cell imaging using FRET-based biosensors becomes increasingly appealing
due to its high spatial and temporal resolution in visualizing dynamic intracellular
molecular activities in live cells [314]. Two different types of FRET-based biosensors
are available in terms of their design strategies, intramolecular and intermolecular
FRET biosensors. Intramolecular FRET-based biosensors are advantageous in live
cell imaging because they allow the use of simple ratiometric imaging approach to
monitor and analyze FRET changes [315]. They are constructed by fusing donor and
acceptor fluorescent proteins (FPs) to interacting molecules, for example, a FRET-
based Cyto-Src biosensor consists of a cyan fluorescent protein (CFP), a SH2 binding
domain, a Src substrate peptide, and a yellow fluorescent protein (YFP) (Fig. 1.9a).
When the Src substrate does not bind to SH2 (inactive state), the cyan excitation (at
433nm) gives yellow emission (at 530nm). Upon phosphorylation of Src substrate, the
intramolecular binding of the Src to the SH2 domain leads to a conformational change
of the biosensor, which abolishes the strong FRET from CFP to YFP (Figure 1.9b).
Thus, by monitoring the changes in FRET between CFP and YFP, we can measure the
Src activities [184]. Biosensors targeting different subcellular microdomains also have
been developed. To observe the FAK and Src activities at lipid raft regions, the Lyn-
FAK and Lyn-Src were constructed by fusing myristoylation and palmitoylation sites
derived from Lyn at the N-terminus of the Cyto-Src and Cyto-FAK biosensors; and
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the KRas-Src and KRas-FAK were constructed by attaching polybasic-geranylgeranyl
to the C-terminus of the Cyto-Src and Cyto-FAK biosensors [17, 185].
Similar to the structure of Cyto-Src, cytosolic AMPK (Cyto-AMPK) biosensor
consists of the ECFP, an FHA1 domain, an AMPK substrate motif, and Venus
cpV E172. To specifically bind to different subcellular locations, different sequences
are fused to Cyto-AMPK: plasma membrane (PM-AMPK), Golgi apparatus (Golgi-
AMPK), endoplasmic reticulum (ER-AMPK), nucleus (Nuc-AMPK) and mitochon-
dria (Mito-AMPK). The phosphorylation of the AMPK substrate will lead to the
binding of FHA1 substrate to the binding domain, resulting in the fluorescence reso-
nance transfer from the donor (ECFP) to the acceptor (YFP variant Venus). Hence,
AMPK activities can be visualized as changes of the emission ratio of the YFP/CFP.
The specificity of the biosensors has been characterized thoroughly in earlier stud-
ies [278, 316].
With the similar strategy, other biosensors such as RhoA [317], Ras [318], Rac1,
Cdc42 [319] GTPases, Ca2+ [320], proteases [321], cyclic adenosine monophosphate
(cAMP) [322], phosphor-lipids [323], integrin [324] have been developed. FRET-based
biosensors can be used as a powerful tool in visualizing the spatiotemporal activation
map in live cells under cytokines and mechanical loading.
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Fig. 1.5.: A schematic showing FAK interact with integrin at focal adhesion sites.
The binding of integrins to ECM stimulates integrin-binding proteins, like paxillin
and talin, to recruit FAK and vinculin to the focal adhesion sites. The complex
binds to actin cytoskeletal filaments and is mediated in the transduction of physical
stimulus. The focal adhesion is a dynamic structure and is undergoing constantly




Fig. 1.8.: 2D versus 3D culture models [286]. (A) The 2D monolayer culture or
co-culture on flat and rigid substrates. (B) The forced floating spheroid culture on
nonadhesive surfaces. (C) The 3D scaffolds culture in 3D matrix.
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2. DISTINCTIVE SUBCELLULAR INHIBITION OF
CYTOKINE-INDUCED SRC BY SALUBRINAL AND
FLUID FLOW
2.1 Introduction
In healthy cartilage, chondrocytes play an essential role in maintaining the balance
between anabolism and catabolism. However, injurious loading and excessive secre-
tion of cytokines lead to ECM degradation [16,162,163]. TNFα and IL1β contribute
to cartilage matrix degradation by increasing activities of proteolytic enzymes, in-
cluding MMPs and ADAMTS [37]. Moreover, these cytokines inhibit the production
of proteoglycans and type II collagen [47]. Therefore, blocking the action of these cy-
tokines is a potential strategy to prevent cartilage degradation. Besides proinflamma-
tory cytokines, excessive mechanical loading is another factor that contributes to OA
progression [101]. However, physiological mechanical loading is capable to promote
cartilage homeostasis [87]. Application of gentle loading has been shown to inhibit
IL1-induced matrix degradation as well as expression of MMPs and ADAMTS [96].
In addition of moderate loading, the reduction of ER stress using salubrinal, a chem-
ical agent, has been shown inhibits TNFα- and IL1β-induced MMP activities by
inhibiting eIF2α phosphorylation [115]. Src activities are known to be involved in
ECM regulation by chondrocytes, and play critical roles in mechanotransduction and
inflammatory signaling [144,145]. Recent reports indicate that they can be activated
at different subcellular locations [17,185]. Although studies about how Src activities
regulate downstream signaling cascades in response to inflammatory cytokines and
loading have improved our understanding of the role of Src in OA progression, little
is known about whether the site-specific activities of Src are differentially regulated
by mechanical loading or cytokines; whether their activities are loading magnitude
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dependent; whether mechanical loading suppresses cytokine-induced signaling activ-
ities. To visualize Src activities at different subcellular locations, two FRET-based
Src biosensors were used: Lyn-Src FRET biosensor targeting lipid rafts and Cyto-Src
FRET biosensor existing around cell membrane.
2.2 Materials and methods
2.2.1 Src and FAK biosensors
FRET-based, cyan fluorescent protein (CFP)-yellow fluorescent protein (YFP)
biosensors were used for monitoring Src and FAK activities in the cytosol (Cyto-Src),
lipid rafts of the plasma membrane (Lyn-Src and Lyn-FAK), and non-lipid rafts of
the membrane (KRas-Src and KRas-FAK). The Cyto-Src biosensor consists of CFP,
a binding domain of an effector protein (SH2 domain), a truncated Src substrate
peptide and YFP. The lipid rafts-targeted Src and FAK biosensors were produced
by fusing acylation substrate sequences derived from Lyn kinase to the N-terminal
of Cyto-Src and Cyto-FAK biosensors, respectively. The non-lipid rafts-targeted Src
and FAK were produced by attaching polybasic-geranylgeranyl to the C-terminus
of the Cyto-Src and Cyto-FAK biosensors, respectively. The activation promotes
the intramolecular binding of the SH2 domain to the truncated Src or FAK domain
within the biosensor, which leads to a conformational change of the biosensor and the
decrease of FRET efficiency from CFP to YFP. Hence, Src and FAK activities can
be visualized as changes of the emission ratio of the CFP/YFP. The specificity of the
biosensors has been well characterized previously [17, 18, 184].
2.2.2 Chemical reagents and siRNAs
Two types of proinflammatory cytokines, TNFα (Sigma; 10 ng/ml) and IL1β
(Sigma; 1 ng/ml), were used. Salubrinal and guanabenz (both from Tocris Bio-
science), inhibitors of eIF2α phosphatase, were used to test the effect of phosphoryla-
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tion of eIF2α on Src activity. We also used Pyk2 siRNA (Santa Cruz), eIF2α siRNA
and non-specific control (NC) siRNA (Origene). Cytochalasin D (Sigma; 1 μg/ml)
was used to disrupt actin filaments. Methyl-beta-cyclodextrin (MβCD; Sigma; 10
mM) was used to extract cholesterol from the lipid rafts of the plasma membrane.
PP2 (Sigma; 10 μM) was used to block Src activities, and PF228 (Sigma; 1 μM)
was used to inhibit FAK activities. The 3D agarose gels were produced by using
SAPHAPHA (Sigma) to conjugate agarose gel (Sigma) with Type I collagen (Sigma).
2.2.3 Cell culture, transfection, and western blotting
The human chondrocyte cell line C28/I2 was used. Cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM; Lonza) containing 10 % FBS (Hyclone)
and 1 % penicillin/streptomycin (Lonza), and maintained at 37 ◦C and 5 % CO2 in
a humidified incubator. Neon transfection system (Invitrogen) was used to transfect
Src biosensors into the cells. After transfection, the cells were transferred to a type
II collagen-coated glass bottom dish or μ-slide cell culture chamber (Ibidi) and incu-
bated in serum-free, antibiotic-free DMEM for 2436 h before imaging experiments.
For Western blotting, cells were grown in the presence and absence of salubrinal or
guanabenz and lysed in a radioimmunoprecipitation assay (RIPA) buffer. Isolated
proteins were fractionated using 10 % SDS gels and electro-transferred to Immobilon-
P membranes. The membrane was incubated for 1 h with primary antibodies fol-
lowed by 45 min incubation with secondary antibodies conjugated with horseradish
peroxidase (Cell Signaling). We used antibodies against eIF2α (Cell Signaling), phos-
phorylated eIF2α (p-eIF2α; Thermo), and β-actin (Sigma). Signal intensities were
quantified with a luminescent image analyzer (LAS-3000, Fujifilm).
2.2.4 Shear stress application
Fluid flow-induced shear stress has been shown to play a crucial role in the de-
velopment and progression of osteoarthritis. During imaging, a unidirectional flow
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was applied to the cells grown in the -slide cell culture chamber (Ibidi) at 37 ◦C. The
chamber was perfused with HEPES-buffered (20 mM), phenol red-free DMEM with-
out serum to maintain the pH at 7.4. Because the shear stress of 2 to 10 dynes/cm2
has been shown to affect chondrocyte signaling and metabolism either positively or
negatively, we used this flow range in this study. The shear stress was applied to
the cells by controlling the flow rate of a peristaltic pump (Cole-Parmer). A pulse
dampener (Cole-Parmer) was used to minimize pulsation of the flow due to the pump.
2.2.5 3D agarose-chondrocytes constructs
The collagen-coupled agarose gels were prepared as stated before [325]. The col-
lagen solution was reacted with 10-fold molar excess of the sulfo-SANPAH in PBS at
room temperature for 4 h in the dark room to produce 1.2 mg/ml collagen solution.
The 4 % agarose solution was prepared using sterile PBS, autoclaved, and cooled to
40 ◦C. Three parts of 4 % agarose solution were combined with one part of collagen-
sulfo-SANPAH solution to yield the mixture 3 % agarose and 0.3 mg/ml collagen.
The mixture was exposed under UV light for 20 min to allow the activation of the
photoreactive groups of the sulfo-SANPAH, and conjugate the collagen to CH groups
in the agarose. After conjugation, the agarose mixture cooled down and washed with
10-folds excess sterile PBS for five times over 3 days to remove the unbound collagen
and sulfo-SANPAH. Collagen + agarose gels were prepared as described previously
but without addition of the sulfo-SANPAH. Agarose gels were prepared without ad-
dition of collagen and sulfo-SANPAH. Before transfection, 3 % modified agarose gels
were melted at 45 ◦C and cooled to 37 ◦C. Two parts of 3 % agarose gel were mixed
with one part of 3 × DMEM to produce the mixture of 2 % agarose and 0.2 mg/ml
collagen. Transfected chondrocytes were suspended in the 2 % agarose-collagen gel;
and the mixture was injected into a flow chamber. The cell-gel construct was cooled
at room temperature for 30 min to allow gelling, and then the gel was supplemented
with fresh DMEM and transferred to incubator for 24 hours before imaging.
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2.2.6 Bovine cartilage explant culture and transfection
The stifle joints from bovine were received from local slaughterhouse. The skin and
synovial membrane were removed to expose cartilage surface. During this process, the
exposed cartilage surface should be constantly rinsed with sterile PBS. Thin cartilage
slice were harvested by scalpelling the outer layer of cartilage and washed five times
with PBS. The clean explants were cultured in 24 well plates with DMEM medium
(supplemented with 10 % serum and 1 % antibiotics) and incubated overnight. The in
vivo-jet PEI (Polyplus) was used to transfect chondrocytes in cartilage explant with
Src and FAK biosensors following manufactures manual. 12 hours after transfection,
explants were mixed with 2 % agarose-collagen gels supplemented with DMEM. The
explant-agarose constructs were incubated overnight before imaging.
2.2.7 Microscopy and image analysis
Images were obtained by using a Nikon Ti-E inverted microscope equipped with
an electron-multiplying charge-coupled device (EMCCD) camera (Evolve 512; Pho-
tometrics), a filter wheel controller (Sutter Instruments), and a Perfect Focus System
(Nikon) that maintains the focus during time-lapse imaging. The following filter
sets (Semrock) were used: CFP excitation: 438/24 (center wavelength/bandwidth in
nm); CFP emission (483/32); YFP (FRET) emission: 542/27. To minimize photo-
bleaching, cells were illuminated with a 100 W Hg lamp through an ND64 (∼1.5 %
transmittance) neutral density filter. Time-lapse images were acquired at intervals of
2 min with a 40 × (0.75 numerical aperture) objective. FRET images for Src activity
were generated with NIS-Elements software (Nikon) by computing an emission ratio of
CFP/YFP for individual cells over time. The FRET ratio images were scaled accord-
ing to the color bar. To quantify the kinetics of the FRET responses of Src biosensors,
the discrete time derivatives of the emission ratios, Y, were calculated and the associ-
ated curves were fitted using the Gaussian functions: Y = A ·exp[−0.5 · ((t−μ)/σ)2].
The parameter A represents the maximal rate of FRET ratio change upon stimu-
61
lation, μ the time point where the rate of FRET ratio change reaches the maximal
value, and σ the duration of the rate of FRET ratio change. The rate of FRET ratio
change in response to cytokines was assumed to follow a Gaussian distribution. This
assumption was tested by the D’Agostino-Pearson (omnibus K2) normality test.
2.2.8 Statistical analysis
Statistical data are presented as the mean ± standard error of the mean (SEM).
One-way ANOVA followed by Dunnett’s post hoc test was used to determine the
statistical differences. Student’s t-test was used to compare two groups. Statistical
analyses were conducted using Prism 5 software (GraphPad Software). p<0.05 was
considered significant. In the time course data, * indicates the time point after which
the Src activity becomes significantly different from that at 0 min.
2.3 Results
2.3.1 2.3.1 Activation of Src at different subcellular locations by TNFα
and IL1β
To determine whether the cytokines would differently affect Cyto-Src in the cytosol
and Lyn-Src in the lipid rafts of the plasma membrane, we transfected either Cyto-Src
or Lyn-Src biosensor into C28/I2 cells and plated the cells on a type I collagen-coated
glass bottom dish. The spatiotemporal activities of Src in the cells were assessed by
monitoring changes in the emission ratio of CFP/YFP of the biosensors [184, 326].
Cells were imaged for 10 min without treatment, and then were imaged for 2 hours
with TNFα (10 ng/ml) or IL1β (1 ng/ml). Cyto-Src activities were increased by the
treatment of TNFα or IL1β and reached a maximal at 90 min by TNFα (10.0 %) and
at 80 min by IL1β (7.1 %). Its activities after 10 min of the cytokine treatment were
significantly different from those at time 0, and the activation level was maintained
for 2 hours (Figure 5.1A). Lyn-Src activities were also activated by TNFα or IL1β
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application, while they showed a slower increase than that of Cyto-Src (Figure 5.1B).
The FRET ratio increased and reached the peak value at 120 min by TNFα (10.2 %)
and at 110 min by IL1β (11.6 %). The Lyn-Src activities after 50 min of the cytokine
treatment were significantly different from those at time 0. We also observed that
cytokine induced Lyn-Src activities were initially decreased (Figure 5.1B). However,
the decreased Src activity following cytokine application was not significantly different
from that at 0 min.
Since the temporal profiles of Cyto-Src and Lyn-Src activities were different, we
further determined the kinetics and magnitudes of the FRET response of Src biosen-
sors. t 1
2
is the amount of time required for Src to reach the half-maximal activity
level. Notably, the mean and standard deviation of t 1
2
values of Cyto-Src (TNFα: t 1
2
= 16.25±2.63 min; IL1β: t 1
2
= 22.22±6.24 min) were significantly lower than those of
Lyn-Src (TNFα: t 1
2
= 53.33±5.87 min; IL1β: t 1
2
= 53.33±3.23 min) (Figure 5.2A).
To evaluate a rate of activation changes in response to TNFα and IL1β, we computed
time derivatives of activation levels and the estimated rate was fitted to a Gaussian
function. Based on the DAostino-Perason (omnibus K2) normality test, the p values
for all experimental conditions were higher than the cut-off value, 0.05, indicating
that the data follow a Gaussian distribution. In the fitting curve, the rate of the
changes in Cyto-Src activity reached the maximal value earlier than that in Lyn-Src
(Figure 5.2B). Compared to Lyn-Src, Cyto-Src activities showed significantly lower
mean time parameters in the Gaussian curves (Cyto-Src + TNFα: 17.59 ± 2.51;
Cyto-Src + IL1β: 20.02 ± 7.78; Lyn-Src + TNFα: 60.11 ± 3.87; Lyn-Src + IL1β:
63.19 ± 4.37). However, differences in the level and duration of Src activation were
not statistically significant (Figure 5.2C-D).
Study has shown that activation of Src is associated with its translocation to
the plasma membrane via the actin cytoskeleton [327]. To determine the roles of
the actin cytoskeleton and lipid rafts in these differential Src activation at different
microdomains by cytokines, cells were pretreated with Cytochalasin D (CytoD) for
1 h to disrupt the actin cytoskeleton or with MβCD for 1 h to extract cholesterol
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Fig. 2.1.: TNFα and IL1β activate both Cyto-Src and Lyn-Src. The FRET ratio im-
ages and time courses of Src activities under fluid flow. Color bars represent emission
ratio of CFP/YFP of the biosensor, an index of Cyto-Src activation. The FRET ra-
tio images were scaled according to the corresponding color bar. For each time-lapse
imaging experiment, the images from the same cell were taken. The CFP/YFP emis-
sion ratios were averaged over the whole cell and were normalized to time 0. (A,B)
The FRET ratio images and time courses of Cyto-Src activities (A) and Lyn-Src ac-
tivities (B) under treatment with TNFα (grey) and IL1β (black). N=8 (TNFα), 9
(IL1β) cells in (A); 6 (TNFα), 9 (IL1β) cells in (B). Scale bars, 10 μm. * p<0.05.
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from the plasma membrane. CytoD partially blocked Cyto-Src activation, and it
completely inhibited Lyn-Src activation (Figure 2.2E). MβCD reduced both Cyto-
Src and Lyn-Src activations, although to a lesser degree to Cyto-Src. Collectively,
these data suggest that the actin cytoskeleton and lipid rafts are essential components
for cytokine-induced Lyn-Src activation (Figure 2.2A-E).
2.3.2 Magnitude-dependent regulation of Lyn-Src by fluid flow
To determine the effect of fluid flow on Src activities in chondrocytes, cells trans-
fected with either Lyn-Src or Cyto-Src biosensor were plated on flow chamber. Dur-
ing imaging, the cells were subjected to no flow for 10 min, and then flow-induced
shear stress at 2, 5, or 10 dyne/cm2 for 1 h. Lyn-Src was responsive to fluid flow
in a magnitude-dependent manner (Figure 2.3B). In response to shear stress at 5
dyne/cm2, a rapid Lyn-Src inhibition occurred (9.7 % decrease). In contrast, shear
stress at 10 dyne/cm2 led to marked Lyn-Src activation (14.9 % increase). How-
ever, Cyto-Src activity was not altered under flow induced shear stress in all magni-
tudes (Figure 2.3A). These differential activity patterns and time-courses of Src by
shear stress suggest that mechanotransduction mechanisms for Src activities might
be different depending on the magnitude of the applied loading and compartmental
localization of Src.
To further explore the potential contribution of eIF2α in Src activity in response to
shear stress, cells cotransfected with Src biosensor and either eIF2α or NC siRNA were
subjected to 10 dyne/cm2 shear stress for 1 h. Cyto-Src in C28/I2 cells transfected
with eIF2α or NC siRNA failed to respond to shear stress (Fig. 2.4C). The cells
transfected with eIF2α siRNA showed Lyn-Src activation (3.9 % FRET increase)
in a less degree than that of NC siRNA treated cells (9.6 % FRET increase) (Fig.
2.4D). These results demonstrate that eIF2α siRNA partially prevents the activation
of Lyn-Src in response to 10 dyne/cm2 shear stress.
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Fig. 2.2.: Differential dynamics of Cyto-Src and Lyn-Src activation by TNFα and
IL1β. (A) The t 1
2
values of Src response to TNFα and IL1β. * p<0.05 between Cyto-
Src and Lyn-Src. (B) Gaussian function curves determined by curve fitting of the rate
of mean FRET changes over time under cytokine treatment. (C, D) The parameter
A represents maximal velocity, μ represents the time point that reach the maximal
velocity, and σ represents reaction duration for Lyn- or Cyto-Src. The normalized
values of A, μ, and σ for Cyto-Src and Lyn-Src activities that were calculated by
parameter fitting in cells under treatment with TNFα (C) or IL1β (D). n>6 cells. *
p<0.05 between Cyto-Src and Lyn-Src. (E) The response of Src activities to cytokines
in cells pretreated with CytoD (1 μg/ml, 1 h) to disrupt actin filaments or MβCD
(10 mM, 1 h) to extract cholesterol from the plasma membrane. The Src activities
at 2 hours after cytokine treatment were normalized to time 0. n>9 cells. * p<0.05
compared to the group treated with a corresponding cytokine alone.
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Fig. 2.3.: Fluid flow induces magnitude-dependent Lyn-Src activities. (A) Cyto-Src
activity is not altered by fluid flow. n>7 cells. (B) Selective Lyn-Src activities in
response to different magnitudes of fluid flow. n>7 cells. Scale bars, 10 μm. *
p<0.05.
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Fig. 2.4.: eIF2α is partially involved in fluid flow-induced Lyn-Src activation. C28/I2
cells were cotransfected with either Lyn-Src or Cyto-Src biosensor and eIF2α or NC
siRNA, and then subjected to fluid flow (10 dynes/cm2) during FRET imaging. (A)
Cyto-Src with siRNA under fluid flow. n>7 cells. (B) Lyn-Src with siRNA under
fluid flow. n>7 cells. * p<0.05.
To observe the inhibitory effect of fluid flow at 5 dyne/cm2 on Lyn-Src activities,
we pretreated cells with IL1β or TNFα for 2 h before the application of fluid flow.
Shear stress at 5 dyne/cm2 substantially reduced the activation level of cytokine-
induced Lyn-Src activities (TNFα: 10.1 % decrease at 60 min; IL1β: 6.5 % decrease
at 60 min) (Fig. 2.5A).
2.3.3 The inhibitory effect of salubrinal and guanabenz on Cyto-Src
Western blotting revealed that incubation with 10 μM salubrinal and 10 μM
guanabenz elevated the phosphorylation level of eIF2α by 40 ± 9 % and 29 ± 19
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Fig. 2.5.: Lyn-Src activity in cytokine-treated cells under fluid flow (5 dynes/cm2).
Cells transfected with a Lyn-Src biosensor were pretreated with cytokines for 2 hour
before FRET imaging. n>7 cells. Scale bars, 10 μm.* p<0.05.
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%, respectively (Figure 5.6A,B). Salubrinal decreased Cyto-Src activity in a dose-
dependent manner (Figure 2.6C). Although a lower concentration (1 and 2 μM) did
not detectably alter Cyto-Src activity, salubrinal at 5, 10, and 20 μM significantly
decreased it (5 μM: 10.9 %; 10 μM: 10.0 %; and 20 μM: 11.7 % after 60 min). Guan-
abenz at 10 and 20 μM also decreased Cyto-Src activity, while lower concentrations
did not affect it (10 μM: 9.7 %; 20 μM: 10.1 % at 60 min). In contrast to Cyto-Src that
was inhibited by the application of salubrinal or guanabenz, Lyn-Src activity was not
altered by either salubrinal or guanabenz (Figure 2.6D), suggesting that salubrinal
and guanabenz may differentially affect Src activity depending on the compartmental
location of Src within the cell.
The treatment of salubrinal and guanabenz is known to increase phosphorylation
of eIF2α (as shown in Figure 2.6A, B) [114, 328]. To further examine whether the
inhibition of Src by salubrinal is associated with eIF2α, we cotransfected C28/I2 cells
with either eIF2α or negative control (NC) siRNA and Src biosensor. The FRET
changes of the transfected cells were visualized under 10 M salubrinal. Silencing
eIF2α by siRNA abolished the inhibitory effect of salubrinal on Cyto-Src as compared
to the NC siRNA (Figure 2.7A). Salubrinal did not alter Lyn-Src activity in C28/I2
cells cotransfected with the eIF2α or NC siRNA (Figure 2.7). Moreover, we measured
the basal level of Src activity before salubrinal treatment. Bar graph demonstrated
that the silencing of eIF2α significantly decreased the basal level of Cyto-Src activity
(* p < 0.01), but not the basal level of Lyn-Src activity as compared to the negative
control siRNA treated cells (Fig. 2.7C).
We further investigated the effect of salubrinal and guanabenz on Src activities in
C28I2 cells that were pretreated with IL1β or TNFα. C28/I2 cells incubated with one
of the cytokines for 2 hours before the application of salubrinal or guanabenz. Both
salubrinal and guanabenz substantially reduced cytokine-induced Cyto-Src activities
(Figure 2.8A). After 6 min of drug application, Cyto-Src activities are statistically
significant different from those at 0 min. However, salubrinal and guanabenz failed
to inhibit Lyn-Src activation (Figure 2.8B).
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Fig. 2.6.: Salubrinal (Sal) and guanabenz (Gu) increase phosphorylation of eIF2α
and decrease Cyto-Src activities. (A) Western blots showing the elevated level of p-
eIF2α by salubrinal and guanabenz. (B) Staining intensity of p-eIF2α, normalized by
intensity of eIF2α. (C) Cyto-Src activity by salubrinal and guanabenz. (D) Lyn-Src
activity by salubrinal and guanabenz. Scale bars, 10 μm. n>7 cells. * p<0.05.
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Fig. 2.7.: Involvement of eIF2α in salubrinal-driven Cyto-Src activity. C28/I2 cells
were cotransfected with Cyto-Src or Lyn-Src biosensor, and eIF2α or NC siRNA, and
then treated with 10 μM salubrinal for 1 hour during imaging. (A) eIF2α siRNA
blocks inhibitory effect of salubrinal on Cyto-Src activity. (B) Lyn-Src activity is not
altered by eIF2α siRNA. Scale bars, 10 μm. n>7 cells. (C) The basal level of Src
activity in C28/I2 cells expressing NC or eIF2α siRNA. n>7 cells. * p<0.05 compared
to the corresponding NC group.
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Fig. 2.8.: Salubrinal and guanabenz inhibit cytokine-induced Cyto-Src activity.
C28/I2 cells transfected with either Cyto-Src or Lyn-Src biosensor were pretreated
with TNFα or IL1β for 2 hours before incubating with salubrinal or guanabenz.
(A) Effect of salubrinal and guanabenz on cytokine-induced Cyto-Src activity. (B)
Cytokine-induced Lyn-Src activity is not altered by salubrinal or guanabenz. Scale
bars, 10 μm. n>7 cells. * p<0.05.
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2.4 Discussion
We employed live cell imaging in conjunction with FRET-based Src biosensors to
determine the spatiotemporal activities of Src in C28/I2 human chondrocytes. Lyn-
Src biosensor targeting lipid raft of the plasma membrane and Cyto-Src biosensor
existing in cytosol were used to monitor Src activities in different microdomains. We
first demonstrated that Src proteins in the cytosol and lipid rafts were activated by
TNFα and IL1β with distinct dynamic patterns. Although the role of the inflamma-
tory cytokines in regulating Src activation has been documented, its spatiotemporal
activation pattern has not been known. We observed that the cytokine-induced Src
activation occurred earlier in the cytosol than that in the lipid raft region of the
plasma membrane. Since it is considered that Src activation requires its transloca-
tion to the plasma membrane via the actin cytoskeleton, our observations suggest
that upon stimulation, Src moves quicker to the non-lipid rafts than to the lipid rafts
of the plasma membrane. Taken together, the result is consistent with previous stud-
ies showing that translocation of Src from the cytosol to the non-raft region is faster
than that to the raft region of the plasma membrane.
It has been reported that TNFα and IL1β differently affect degenerative joint
diseases such as osteoarthritis. However, their differential effects on Src activity
are not known. We observed that Cyto-Src activities by TNFα were significantly
higher than those by IL1β, while Lyn-Src activities under the two cytokines were
not significantly different. Although the exact mechanism is not clear, it is possible
that Cyto-Src and Lyn-Src would differently interact with inflammatory signaling
components, such as TNF receptor DEATH domain (TRADD), TRAF2, and GRB2.
Another possibility is that TNFα would stimulate the release of IL1β, which may
further increase TNFα-induced Cyto-Src activity. In this study, however, the primary
aim was to evaluate the role of mechanical force and salubrinal in the cytokine-induced
Src. Investigating Src responses to different cytokines or interaction between TNFα
and IL1β is an important subject. Further consideration is necessary to elucidate the
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molecular mechanism underlying the differential Src activities at different subcellular
locations in response to various cytokines.
There are several lines of evidence that Src can be activated at the different loca-
tions within the cell, such as in the cytoplasm, along the actin cytoskeleton, or on the
plasma membrane. Thus, we evaluated the possibility that Src may be activated in
the cytoplasm before it is mobilized to the cell periphery or plasma membrane upon
cytokine stimulation. To test this possibility, we disrupted the actin cytoskeleton
and monitored Src activity in the cytosol and lipid rafts of the plasma membrane.
While disruption of the actin cytoskeleton using CytoD blocked Src activation in the
lipid rafts, it did not completely inhibit cytosolic Src activation, suggesting that some
population of cytosolic Src may be activated in the cytoplasm, without transloca-
tion through the actin cytoskeleton (Figure 2.9). These results support the previous
findings that activation of Src at the lipid rafts of the plasma membrane requires its
translocation through the actin cytoskeleton and that Src can be activated in the cy-
toplasm. However, our data cannot distinguish whether cytosolic Src near the plasma
membrane outside the lipid rafts, which may not require translocation, is activated or
other focal adhesion proteins at the plasma membrane, such as vinculin or talin, are
involved in this cytosolic Src activation. Further studies are needed to elucidate the
underlying mechanism for this dynamically distinct Src activation at different cellular
compartments.
Fluid flow-induced shear stress (5 dynes/cm2) was able to significantly inhibit the
cytokine-induced Src activity at the lipid rafts. This result is consistent with previous
findings that lipid rafts of the plasma membrane are involved in Src mechanotrans-
duction. On the contrary, cytosolic Src was not responsive to the shear stress. We
previously reported that local mechanical force applied from the cell surface using
a small (4.5 mm in diameter) magnetic bead induces highly localized cytosolic Src
activity and does not yield global FRET changes of the Src biosensors within the cy-
toplasm. We do not know whether cytosolic Src does not respond to shear stress that
is evenly distributed over the cell surface, or activation of the cytosolic Src by shear
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stress is not sufficient to yield detectable FRET changes from a substantial pool of Src
biosensors in the cytosol. We also observed that Src activities at the lipid rafts of the
plasma membrane are selectively up- or down-regulated by different magnitudes of
shear stress; moderate (5 dynes/cm2) and high (10 dynes/cm2) shear stress decrease
and increase Src activity in the lipid rafts, respectively. This result is consistent
with previous reports on fluid flow magnitude-dependent small GTPase RhoA activ-
ities and MMP13 activities in chondrocytes. We have previously reported that the
inhibition of ER stress through eIF2α phosphorylation can decrease expression and
activity of degrading enzymes such as MMP13 in C28/I2 human chondrocytes. Here,
we used two inhibitors for eIF2α dephosphorylation, salubrinal and guanabenz, and
tested whether alleviating ER stress by eIF2α phosphorylation could attenuate the
inflammatory cytokine-induced Src activation. In contrast to the nonresponsive Src
activity in cytosol under shear stress, we observed that the cytokine-induced Src in
the cytosol, but not in the lipid rafts of the plasma membrane, was inhibited by salu-
brinal or guanabenz. This result suggests that Src at different compartments within
the cell may be regulated by different mechanisms; cytosolic Src is downregulated by
eIF2α phosphorylation, but Src in the lipid rafts may not be a critical signaling node
within an ER stress signaling pathway (Figure 2.9). Our results further suggest that
these distinct responses of Src activities are differently regulated by fluid flow.
In summary, our findings of the distinct activation patterns of Src kinases suggest
the critical role of mechanical loading and inhibition of ER stress through phosphory-
lation of eIF2α in arthritic cartilage (Figure 2.9). By selectively regulating subcellular
Src kinases, fluid flow and a chemical agent that inhibits ER stress appear to interact
with Src-dependent regulatory pathways important for chondrogenesis and cartilage
maintenance. The work herein suggests that a proper combination of chemical and
mechanical stimuli may present a potential therapeutic strategy for prevention of car-
tilage loss in joint diseases such as OA. Further studies on the interaction between Src
and FAK, and signaling pathways connecting subcellular Src/FAK kinases to FAK in
chondrocytes may benefit in developing a therapeutic strategy for joint diseases.
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3. DISTINCT SUBCELLULAR ACTIVATION PATTERNS
OF SRC AND FAK BY INTERSTITIAL FLUID FLOW
AND CYTOKINES
3.1 Introduction
FAK and Src are tyrosine kinases that play crucial roles in fundamental cellular
functions that include cell motility, cycle progression and survival [329–331]. They
also serve as crucial signaling nodes in integrin-mediated signaling cascades [332].
Because integrins are cell surface receptors and FAK and Src are closely associated
with them, it is expected that FAK and Src are activated at the plasma membrane.
For example, in response to flow-induced shear stress, FAK is activated at focal
adhesions [333]. Direct activation of integrin 1 alone is shown to be sufficient to
activate FAK [334]. Localized mechanical force using a bead coated with fibronectin,
which is known to bind to integrins, induces Src activation at the plasma membrane
[184]. Therefore, the plasma membrane is believed to be the primary activation site
for FAK and Src [332]. However, recent evidence suggests that FAK and Src can
be differently regulated depending on their location within the membrane domains
such as lipid rafts and non-lipid rafts [17, 185]. The molecular relationship between
FAK and Src and their roles in the signaling pathways are also shown to be distinct
depending on the membrane microdomains [17, 185]. For example, Src in the lipid
rafts regulates the phosphoinositide 3-kinase (PI3K)/Akt sigaling, whereas Src in
the non-lipid rafts regulates mitogen-activated protein kinase/extracellular signal-
regulated kinase (MAPK/ERK) signaling [186]. The response of FAK in the lipid
rafts to platelet-derived growth factor (PDGF) is much stronger and faster than that
of FAK in the non-raft regions [18]. Therefore, the mechanism of their domain-specific
regulation by external stimuli, including mechanical force and growth factors, as well
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as their relationship, seems very complex and there is a need to understand this
mechanism in various physiological conditions.
In addition to the responsiveness of FAK and Src to mechanical force and growth
factors, they are known to respond to inflammatory cytokines. We have recently
reported that Src is upregulated by inflammatory cytokines such as tumor necrosis
factor α (TNFα) and interleukin 1β (IL1β) and that its temporal activation profiles
are different in the cytosol and plasma membrane [19]. Because of the involvement
of FAK and Src in inflammatory signaling, they are important in cartilage pathology.
For example, phosphorylation of Src and FAK elevates the gene transcription of ma-
trix metalloproteinases (MMPs) [145,146]. FAK is upregulated in both osteoarthritis
and rheumatoid arthritis tissues [335]. Inhibition of FAK [11] and Src [336] decreases
chondrocyte proliferation and promote gene expression, thus maintaining chondro-
cyte phenotype. They also contribute to osteoarthritis progression by significantly
elevating the expression of matrix degrading enzymes while inhibiting the gene ex-
pression of proteoglycan and type II collagen [37, 47, 48]. Despite the importance of
FAK and Src in the inflammatory signaling, the detailed mechanism of the interac-
tion among FAK and Src activities, mechanical stimuli, and inflammatory cytokines
in the different membrane domains (i.e., lipid rafts and non-rafts) is not known.
Current understanding of the cell behavior and signaling has been derived pri-
marily from studying cells cultured on two-dimensional (2D) surfaces. However, it
has been recently recognized that there are considerable differences in various cell
functions between 2D and 3D extracellular environments, such as cell shape, dif-
ferentiation, adhesion, migration, and force sensing [337, 338]. For example, when
chondrocytes are isolated from articular cartilage and kept in planar 2D culture, they
become flat and lose their cartilage phenotype [281]. Surprisingly, when these dedif-
ferentiated cells are cultured in 3D matrices, they become spherical, similar to their
cell shape in vivo, and restore the differentiated cartilage phenotype [284]. Similarly,
focal adhesion proteins, which play critical roles in mechanotransduction signaling
and cytoskeletal organization, are highly expressed in 2D cultures, but are much less
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apparent in vivo and in 3D cultures [337,339]. Therefore, the 3D culture model may
more closely capture the physiological behavior of cells.
Herein we addressed several questions: 1) Whether/how mechanical force and
inflammatory cytokines similarly or dissimilarly regulate Src and FAK activities at
different subcellular locations? 2) How FAK interacts with Src under various stimu-
lations? 3) As proline-rich tyrosine kinase 2 (Pyk2) is known to be similar to FAK in
sequences and structure [190], what is the role of Pyk2 in the Src and FAK signaling
in response to loading and inflammatory cytokines? 4) Whether mechanical loading
can alter inflammatory cytokine-activated Src and FAK activities? To monitor FAK
and Src activities with high spatiotemporal resolution, we employed FRET-based
biosensors: the lipid rafts-targeting (Lyn-FAK and Lyn-Src), and the non-lipid rafts-
targeting (KRas-FAK and KRas-Src). C28/I2 chondrocytes transfected with one of
the biosensors were mixed with type II collagen-coupled agarose gel to produce 3D
chondrocytes-gel constructs that allow integrin activation. During imaging, fluid flow
or cytokines was applied to cells in 3D gel constructs. To examine the interactions
between Src and FAK, we used pharmacological drugs to specifically inhibit Src or
FAK activities. The role of Pyk2 in Src/FAK signaling in response to mechanical
or inflammatory cytokine stimulations was examined by silencing the Pyk2 activity
using siRNA. A 3D cartilage explant system in conjunction with 3D FRET imaging
was developed to further examine the effect of moderate loading on inflammatory
cytokine-activated FAK/Src signaling.
3.2 Materials and methods
3.2.1 Integrin, Src and FAK biosensors
The β1 integrin was monitored using mCherry-Integrin-Beta1-N-18 biosensor (Ad-
dgene). FRET-based biosensors were used for monitoring Src and FAK activities. The
Src biosensor consists of a cyan fluorescent protein (CFP), a binding domain of an
effector protein (SH2 domain), a truncated Src substrate peptide and a yellow fluo-
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rescent protein (YFP). The FAK biosensor consists of a CFP, a SH2 domain, a FAK
substrate peptide and a YFP. The lipid raft-targeting biosensors (Lyn-Src and Lyn-
FAK) were produced by fusing acylation substrate sequences derived from Lyn kinase
to the N-terminal of Src and FAK biosensors. The non-lipid raft-targeting biosensors
(KRas-Src and KRas-FAK) were produced by attaching polybasic-geranylgeranyl se-
quences to the C-terminus of the Src and FAK biosensors. The activation of the Src or
FAK substract promotes the intramolecular binding of the SH2 domain to the trun-
cated Src or FAK domain, which leads to a conformational change of the biosensor
and a decrease of FRET efficiency from CFP to YFP. Hence, Src and FAK activities
can be visualized as changes of the emission ratio of the CFP/YFP. The specificity
of the biosensors has been well characterized previously [17, 18, 184].
3.2.2 Cell culture and transfection
The human chondrocyte cell line C28/I2 was used. Cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM; Lonza) containing 10 % FBS (Hyclone)
and 1 % penicillin/streptomycin (Lonza); and maintained at 37 ◦C and 5% CO2 in
a humidified incubator. Neon transfection system (Invitrogen) was used to trans-
fect Src and FAK biosensors into the cells. After transfection, cells were cultured in
serum-free and antibiotic-free DMEM for 24 hours before imaging.
3.2.3 Chemical reagents and siRNAs
Sulfo-SANPAH (Sigma) were employed to crosslink agarose gel (Sigma) with Type
II collagen (Sigma). Agarose (low melting temperature agarose; Lonza) was used to
prepare 3D agarose gels. Two types of proinflammatory cytokines, tumor necrosis
factor (TNFα; Sigma; 10 ng/ml) and interleukin 1 beta (IL1β; Sigma; 1 ng/ml) were
used. Anti-integrin β1 antibody (Santa Cruz Biotechnology; 10 μg/ml) was used to
block integrin activities. Methyl-beta-cyclodextrin (MβCD; Sigma; 10 mM) was used
to extract cholesterol from the lipid rafts of the plasma membrane. PP2 (Sigma; 10
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μM) was used to block Src activities, and PF228 (Sigma; 1 μM) was used to inhibit
FAK activities. We also used Pyk2 siRNA and non-specific control (NC) siRNA
(Santa Cruz) to study the role of Pyk2 in Src and FAK activities.
3.2.4 3D agarose-chondrocytes constructs
The collagen-coupled agarose gels (AG-Col) were prepared as stated before [325].
Briefly, the collagen solution was reacted with 10-fold molar excess of the sulfo-
SANPAH in PBS at room temperature in the dark room for 4 h to produce 1.2
mg/ml Type II collagen solution. The 4 % (wt/vol) agarose solution was prepared
using sterile PBS, autoclaved, and cooled to 40 ◦C. Three parts of 4 % agarose were
combined with one part of collagen-sulfo-SANPAH solution to yield the mixture con-
taining 3 % agarose and 0.3 mg/ml collagen. The mixture was exposed under UV light
for 20 min to allow the activation of the photoreactive groups of the sulfo-SANPAH
that conjugate the collagen to CH groups in the agarose. After conjugation, the
agarose mixture was cooled down and washed with 10-folds excess sterile PBS for five
times over 3 days to remove the unbound collagen and sulfo-SANPAH. Agarose gels
+ collagen (AG+Col) were prepared as described previously but without addition of
the sulfo-SANPAH. Agarose gels (AG) were prepared without addition of collagen
and sulfo-SANPAH. Before transfection, 3 % modified agarose gels were melted down
at 45 ◦C and cooled to 37 ◦C. Two parts of 3 % agarose gel were mixed with one part
of 3 × DMEM containing transfected cells to produce the mixture of 2 % agarose and
1 × DMEM containing cells. The mixture was injected into an Ibidi flow chamber
(Ibidi) and cooled at room temperature for 30 min to allow gelling. The gel was
supplemented with fresh 1 × phenol red-free DMEM and transferred to incubator for
24 hours before imaging.
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3.2.5 Flow velocity measurement
The operating principle underlying our permeability assay is to measure the rate at
which the fluorescently labeled molecule travel through the agarose gel. The fluores-
cent solute used is Alexa Fluor 594-conjugated bovine serum albumin (BSA; Thermo
Fisher). Place a drop of BSA-594 in DMEM on a glass coverslip, and measure the
average fluorescence light intensity. Repeat this step with different concentrations of
BSA-594 to create a standard curve of fluorescence intensity vs. solute concentra-
tion. The solute concentration (50 μg/ml; Invitrogen) that was used in subsequent
sections is within the linear range of this curve. As shown in SFigure 1a, the back-
ground fluorescence images were captured before the addition of fluorescent media.
The initial fluorescence images were captured right after the addition of fluorescent
media. Time-lapse images were obtained every minute to monitor the perfusion of
fluorescent solute. The maximum fluorescence images were captured after the imag-
ing regions are uniformly perfused with fluorescent medium, which can be obtained
after 10-30 min depending on the fluid rate. Draw the region of interest (ROI), and




(Imax − Ib)(t1 − t2) (3.1)
where L is the length of the ROI along the loading application direction, t2 and
t1 are the time points taken the first and the second images, correspondingly.
3.2.6 Permeability measurements and shear stress estimation
Permeability of agarose gel prepared within an open cell scaffold was measured
using a custom-designed, gravity-driven permeameter. Agarose solutions were poly-
merized (30 minutes at 37 ◦C) within disks (0.125 thick, 0.5 diameter) of hydrophilic
polyethylene foam (1545 μm pore size; Small Parts Incorporated, Miami, FL). Silicone
rings fitted around the polyethylene disks formed a tight seal between the disk and
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walls of the permeameter. A specified volume (approximately 15 mL) of PBS, pH 7.4
was added on top of each collagen/polyethylene composite and fluid flow monitored
over time.
The shear stress over the cell surface imposed by interstitial fluid flow can be










Where τ is the average shear stress, μ is the viscosity of the fluid, Q is the time-
averaged volumetric flow rate, A is the cross sectional area of the gel sample, k is the
Darcy permeability.
3.2.7 Immunostaining and confocal microscopy
C28/I2 cells were mixed with AG, AG+Col, or AG-Col gels and cultured for 24 h
before staining. The cell-gel constructs were fixed with 4 % paraformldehyde. After
rinsing, the cells were permeabilized with 0.5 % Triton X-100 (Sigma) in PBS for 45
min at room temperature, and then incubated with blocking buffer (5 % BSA, serum,
20 % Polyvinylpyrrolidone (Amresco, Solon, OH, USA) in PBS combined into 1:1:1
ratio) overnight at 4 ◦C. The samples were incubated with primary antibodies against
activated β1 integrin (1:500; Millipore, Billerica, MA, USA), or total β1 integrin
(1:100; Santa Cruz Biotechnology, Dalla, TX, USA) overnight at 4 ◦C, and then
with Alex Fluor 488 anti-mouse IgG (1:1000; Invitrogen) overnight at 4 ◦C. Finally,
cell nuclei were labeled by DAPI (Sigma). An Olympus Fluoview FV1000 confocal
microscope was used to visualize activated/total β1 integrins and cell nuclei. Images
were acquired using a 60 × objective lens (1.2 numerical aperture; Olympus).The
fluorescence images were selected randomly. The fluorescence signal was quantified
by measuring average intensity in individual cells using Fluoview Viewer software
(Olympus).
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3.2.8 Confocal microscopy and colocalization analysis
An Olympus Fluoview FV1000 confocal microscope was used to visualize β1 in-
tegrins and Lyn-FAK activity in chondrocytes co-transfected with β1 integrin and
Lyn-FAK biosensors. Images were acquired using a 60 × objective lens (1.2 numer-
ical aperture; Olympus). Colocalization of β1 integrins and Lyn-FAK activity was
calculated from 10 randomly picked cells. Same cells were imaged before and af-
ter loading application. The Pearsons correlation coefficient was done with ImageJ
plugin called JACoP. Representative images were produced by smooth filter and back-
ground subtraction to reduce noise, setting a threshold to highlight high activities,
and merged to produce merged view using ImageJ (NIH).
3.2.9 Fluid flow-induced shear stress application
Fluid flow-induced shear stress has been shown to play crucial roles in the devel-
opment and progression of osteoarthritis. During imaging, the agarose gel construct
was perfused with phenol red and serum-free DMEM. The DMEM was supplemented
with 20 mM HEPES to maintain the pH at 7.4. A syringe pump (Harvard Appara-
tus) was employed to apply shear stress to cells by controlling the flow rate through
the chamber. Chondrocytes encapsulated in the agarose gel were exposed to pulsatile
flow (0.2 Hz) at 2, 5, 10, and 20 μl/min in an Ibidi flow chamber (Ibidi) for 1 hour
during imaging (Figure 3.1D).
3.2.10 Mouse cartilage explant culture and transfection
The skin and synovial membrane of mouse joints were removed to expose the
cartilage surface. The operation process was accompanied by constantly rinsing the
exposed cartilage surface with sterile PBS at 4 ◦C. Thin cartilage slices were harvested
by scalpelling the outer layer of cartilage and were washed five times with steril PBS.
The clean explants were transferred to 24 well plates and incubated overnight with
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DMEM supplemented with 10 % serum and 1 % penicillin/streptomycin. The in
vivo-jet PEI (Polyplus) was used to transfect chondrocytes in cartilage explants with
Src and FAK biosensors following manufactures manual. 12 hours after transfection,
explants were mixed with 2 % Col-AG gels that supplemented with DMEM to produce
3D explant-agarose constructs. These constructs were incubated for another 12 hours
before imaging.
3.2.11 FRET Microscopy and image analysis
Images were obtained by using a Nikon Ti-E inverted microscope equipped with
an electron-multiplying charge-coupled device (EMCCD) camera (Evolve 512; Pho-
tometrics), a filter wheel controller (Sutter Instruments), and a Perfect Focus System
(Nikon) that maintains the focus during time-lapse imaging. The following filter
sets (Semrock) were used: CFP excitation: 438/24 (center wavelength/bandwidth in
nm); CFP emission (483/32); YFP (FRET) emission: 542/27. To minimize photo-
bleaching, cells were illuminated with a 100 W Hg lamp through an ND64 (∼1.5 %
transmittance) neutral density filter. Time-lapse images were acquired with a 40×
(0.75 numerical aperture) objective. FRET images for Src and FAK activities were
generated with NIS-Elements software (Nikon) by computing an emission ratio of
CFP/YFP for individual cells over time. The FRET ratio images were scaled accord-
ing to the color bar.
3.2.12 Statistical analysis
Statistical data are presented as the mean ± standard error of the mean (SEM).
One-way ANOVA followed by Dunnett’s post hoc test was used to determine the
statistical differences. Student’s t-test was used to compare two groups. Statistical
analyses were conducted using Prism 5 software (GraphPad Software). p<0.05 was
considered statistically significant. In the time course data, * indicates the time point
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after which the Src or FAK activity become significantly different from that before
stimulation.
3.3 Result
3.3.1 3D cells-agarose gel constructs allow Lyn-Src and -FAK activation
under loading
The activation of α5β1 integrin is required for the initiation of loading-induced
Src/FAK signaling. To determine our gel systems can enable integrin activation, im-
munostaining was employed to measure the β1 integrin activation levels of C28/I2
cells in agarose gels with different modifications: agarose (AG) gel, collagen-added
agarose (AG+Col) gel and collagen-coupled agarose (AG-Col) gel (SFig. 1). The
average GFP intensity (integrin) over the whole cell was quantified and normalized
to that in the AG gel (SFig. 1B, C). The collagen conjugation significantly elevated
the integrin activation level (180.3 % increase) (SFig. 1B), while the total integrin
levels in different gels were not significantly different among each other (SFig. 1C).
As to Lyn-Src that targeting lipid rafts in chondrocytes is highly responsive to shear
stress in 2D cell culture37, to examine whether our gels allow Src/FAK regulation
by loading, we mixed chondrocytes transfected with either Lyn-Src or Lyn-FAK with
one of three types of gels. To apply loading on C28/I2 chondrocytes in 3D matrix,
the cell-gel mixture was injected into a flow chamber. During imaging, chondrocytes
were subjected to no flow for 10 min, and then 5 μl/min or 10 μl/min fluid flow for 1
hour. The velocities of flow through agarose gel (2 to 28 μm/min corresponds to 2-20
μl/min flow rate) (SFig. 2A, B), the Darcy permeability (∼10−14 m2) and estimated
shear stress experienced by chondrocytes (2-20 dyne/cm2 corresponds to 2-20 μl/min
flow rate) were characterized (SFig. 3.2C). The Src and FAK activities were assessed
by monitoring changes of the emission ratios of CFP/YFP of the biosensors. Z-stack
images of Lyn-Src activities were captured to generate orthogonal views (SFig. 3.3A),
suggesting similar activity level and uniform activation patterns over the cell. In lat-
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ter experiments, the Src or FAK activities were determined by capturing a single
z slice through the central region midline of each cell. After the application of 10
μl/min fluid flow, fluid flow failed to regulate the Lyn-Src or Lyn-FAK activities in
chondrocytes in either AG or AG+Col gels, while the activities of Lyn-Src as well as
Lyn-FAK were elevated significantly (Lyn-Src: 21.5 %, Lyn-FAK: 17.1 %) in AG-Col
gels (SFig. 3.3b). Moreover, 5 μl/min fluid flow inhibited activities of Lyn-Src (10.7
% decrease at 14 min) and Lyn-FAK (22.7 % decrease at 59 min) (SFig. 3.3C) in
AG-Col gels. AG-Col gels were used for latter experiments in this study.
3.3.2 Fluid flow regulates Src and FAK activities in a magnitude-dependent
manner
To determine the Src and FAK activities at different subcellular locations, we
transfected chondrocytes with one of these four biosensors: Lyn-Src and Lyn-FAK
targeting lipid rafts, and KRas-Src and KRas-FAK targeting non-lipid rafts. 2 μl/min
fluid flow did not detectably alter Lyn-Src activity, notably, the intermediate fluid flow
reduced the Lyn-Src activity (10.7 % decrease at 14 min) and this inhibitory effect
was reversed to basal level at 30 min; while higher intensities significantly elevated
Lyn-Src activities (10 μl/min: 21.6 % increase at 59 min; 20 μl/min: 15.0 % increase
at 59 min)(Figure 3.1A). KRas-Src activities were upregulated by 10 μl/min (18.5
% increase at 60 min) and 20 μl/min (20.7 % increase at 60 min), while activities
were downregulated by 5 μl/min (20.7 % decrease at 60 min) (Figure 3.1B). Lyn-FAK
activities were also regulated by fluid flow. 10 μl/min fluid flow significant activated
Lyn-FAK (17.1 % increase at 4 min); 20 μl/min fluid flow activated Lyn-FAK and
maintained this activation for 1 h (24.0% increase at 59 min); and 5 μl/min fluid flow
substantially downregulated Lyn-FAK activities (21.4 % decrease at 60 min) (Figure
3.1C). KRas-FAK activities were not altered by 2, 5 and 10 μl/min fluid flow, but
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Fig. 3.1.: FAK and Src activities at different subcellular locations are regulated by
fluid flow distinctively in a magnitude-dependent manner. The FRET ratio images
were scaled according to the corresponding color bar, which represent emission ratio of
CFP/YFP of the biosensor. (A) Lyn-Src activities under fluid flow. n=9 (2 μl/min);
n=5 (5 μl/min); n=9 (10 μl/min); n=4 (20 μl/min) cells. (B) KRas-Src activities
under fluid flow. n=5 (2 μl/min); n=10 (5 μl/min); n=8 (10 μl/min); n=10 (20
μl/min) cells. (C) Lyn-FAK activities under fluid flow. Scale bar, 10 μm. * p<0.05.
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slowly upregulated at latter time points by 20 μl/min fluid flow (15.3 % increase at
60 min) (Figure 3.1D).
We further investigated the role of integrin in Src/FAK signaling. We transfected
cells with Lyn-Src or Lyn-FAK biosensor. Before imaging, cells were incubated with
10 μg/ml anti-integrin antibody for 1 hour to block integrin activities. By comparing
the Src or FAK activities before and after 1 h application of 10 μl/min fluid flow, it
showed that the flow-induced Lyn-Src and Lyn-FAK activities were totally abolished
by anti-integrin antibody (Figure 3.2A). As to activated integrin clustering in the lipid
rafts38 and FAK is closely linked with integrin39, we co-transfected cells with Lyn-
FAK and mCherry-β1 integrin biosensors. Using confocal microscopy, the images of
FRET CFP, FRET YFP, and RFP were captured before and after 1 h application of
10μl/min fluid flow from the same cell. We observed colocalization of β1 integrin and
Lyn-FAK (Figure 3.2C), with Pearson coefficient averaging R = 0.737 (5 μl/min at 0
min), 0.735 (5 μl/min at 60 min), 0.773 (20 μl/min at 0 min), and 0.771(20 μl/min at
60 min) (Figure 3.2B). No significant differences in localization were observed among
groups (Figure 3.2B). The representative images in Fig. 2c showed that 5 μl/min fluid
flow didnt alter the activation patterns of Lyn-FAK and integrin, but decreased their
activation levels; while 20μl/min fluid flow increased the activation level of Lyn-FAK
and integrin, and also induced spot activation as shown in enlarged images (Figure
3.2D).
The interactions between Src and FAK in response to fluid flow were explored.
Cells transfected with one of Src biosensors were pretreated with 1 μM PF228 (selec-
tive FAK inhibitor) for 1 hour. The activities of Src and FAK at 0 and 60 min were
recorded, and were normalized to those at 0 min. The fluid flow-induced Lyn-Src and
KRas-Src activities were abolished by the treatment of PF228 (Figure 3.3A). On the
other hand, with the treatment of PP2, the Lyn-FAK activities were still regulated by
fluid flow (5 μl/min: 10.0 % decrease at 60 min; 10 μl/min: 8.6 % increase at 20 min;
20 l/min: 5.5 % increase at 20 min); KRas-FAK activities were not higly responsive
to fluid flow (Figure 3.3A). We further examined whether Lyn-FAK activities in lipid
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rafts are required for Src activities in non-lipid rafts under fluid flow. Cells transfected
with Kras-Src biosensor were pretreated with 10mM MβCD for 1 hour to destroy the
lipid rafts of the plasma membrane. The fluid flow-driven KRas-Src activties were
blocked by the destruction of lipid rafts (Figure 3.3B). These results demonstrated
that Lyn-FAK activity is essential for Src activities in response to fluid flow.
3.3.3 Activation of Src and FAK at different subcellular microdomains
by TNFα and IL1β
C28/I2 cells transfected with one of FRET biosensors were imaged for 2 hours
under the treatment of IL1β (1 ng/ml) or TNFα (10 ng/ml). Lyn-Src activities were
not significantly altered under cytokines (Figure 3.4A). KRas-Src activities increased
very fast under IL1β and reached the peak value at 25 min (8.4 % increase); with
the treatment of TNFα, its activities increased slower and reached the maxima at
120 min (10.2 % increase) (Figure 3.4B). Activities of Lyn-FAK and KRas-FAK were
also substantially activated by cytokines (Lyn-FAK + TNFα: 15.8 % at 120 min;
Lyn-FAK + IL1β: 19.0 % at 120 min; KRas-FAK + TNFα: 10.9 % at 120 min;
KRas-FAK + IL1β: 16.8 % increase at 115 min) (Figure 3.4C and D).
We determined the interaction between Src and FAK under the stimulation of
cytokines using the selective inhibitor of FAK or Src. Before the addition of cytokines,
cells transfected with Src biosensor were incubated with PF228 for 1 hour to inhibit
FAK activities. The activities of Src and FAK at 0 and 120 min were recorded, and
were normalized to those at 0 min. As shown in Fig. 3.5A, with the pretreatment of
PF228, the activities of KRas-Src were still upregulated by TNFα and IL1β (TNFα:
10.3 %; IL1β: 9.2 % increase at 120 min), and Lyn-Src is not highly activated by
cytokines. However, the activations of Lyn-FAK and KRas-FAK by cytokines were
blocked by the PP2 treatment. Results suggested that Kras-Src activity is essential
for FAK activities under cytokines.
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Fig. 3.2.: Integrin activation is required for Lyn-FAK activity under loading. (A)
C28/I2 cells transfected with Lyn-Src or Lyn-FAK biosensor were pretreated with
10 μg/ml anti-integrin antibody for 1 hour before subjected to 10 μl/min fluid flow.
n>7 cells. (B) C28/I2 cells were co-transfected with Lyn-FAK and mCherry-integrin
biosensors. Images taken before and after loading application were analyzed using
ImageJ Software to obtain Pearson Coefficient. n>10 cells. (C) Representative images
shown integrin (red) merged with Lyn-FAK (green). The enlarged images show the
corresponding boxed areas at × 3 magnification. Scale bar, 10 μm.
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Fig. 3.3.: FAK in lipid rafts is essential for Src activation in response to fluid flow.
(A) C28/I2 cells transfected with either Lyn-Src or KRas-Src were pretreated with 1
μM PF228 (selective FAK inhibitor) for 1 h before subjected to different magnitudes
of fluid flow. C28/I2 transfected with either Lyn-FAK or KRas-FAK were pretreated
with 10 μM PP2 for 1 h before subjected to fluid flow. Bar graph showed Src and
FAK activities at 60 min after the application of fluid flow. Activities were normalized
to those at 0 min. (B) C28/I2 cells transfected with KRas-Src were pretreated with
10mM MβCD for 1 h to disrupt lipid rafts in plasma membrane. The regulation of
KRas-Src by fluid flow was abolished by the treatment of MβCD. Scale bar, 10 μm.
n>7 cells. * p<0.05.
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Fig. 3.4.: TNFα and IL1β activate FAK and Src activities. During imaging, C28/I2
chondrocytes were treated with either 10 ng/ml TNFα or 1 ng/ml IL1β for 2 h. (A)
Lyn-Src activities under cytokines. (B) KRas-Src activities under cytokines. (C)
Lyn-FAK under cytokines. (D) KRas-FAK under cytokines. n>7 cells. Scale bar, 10
μm.* p<0.05.
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Fig. 3.5.: Src is essential for FAK activation under cytokines. (A) C28/I2 cells trans-
fected with either Lyn-Src or KRas-Src were pretreated with PF228 for 1 h before the
treatment of cytokines. C28/I2 transfected with either Lyn-FAK or KRas-FAK were
pretreated with PP2 for 1 h before the treatment of cytokines. Bar graph showed
Src and FAK activities at 60 min after the application of fluid flow. Activities were
normalized to those at 0 min. n>7 cells. Scale bar, 10 μm.* p<0.05.
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3.3.4 Pyk2 is necessary for cytokine-induced FAK and Src activation
Pyk2 is highly similar to FAK in sequences (46 % identical and 65 % similar)
and structures, and has the binding site SH2 domain for Src40. Recent reports have
presented conflicting data regarding the interactions between FAK and Pyk259,60.
In FAK-null fibroblasts, Pyk2 compensate FAK activity to promote cell retraction35,
while it performs different functions from FAK in cell progression40-42. In addition
to FAK-Pyk2 interaction, the Pyk2-Src binding plays major roles in monosodium
urate monohydrate-induced NO production and MMP-3 expression of chondrocytes
61. To investigate the role of Pyk2 in the loading-driven Src and FAK activities, cells
were co-transfected with one of FRET biosensors and Pyk2 siRNA to abolish Pyk2
activities. Src or FAK activities were recorded at 0 or 60 min after flow application,
and normalized to those at 0 min. No significant difference was observed between
control and Pyk2 siRNA groups, suggesting the silence of Pyk2 failed to block the
regulation of FAK and Src by fluid flow (Figure 3.6A). We further examined the
role of Pyk2 in Src and FAK activation by cytokines. Fig. 6B shows the Src and
FAK activities 2 hour after cytokine treatment. The silence of Pyk2 activity totally
blocked the activation of KRas-Src, Lyn-FAK, and KRas-FAK by cytokines; and
Lyn-Src activities were still not highly responsive to cytokine stimulation. Results
demonstrated that Pyk2 is involved in cytokine-induced Src/FAK signaling.
3.3.5 Intermediate fluid flow suppresses cytokine-induced FAK and Src
activation in bovine cartilage explants
To monitor the inhibitory effect of 5 μl/min fluid flow on cytokine-induced FAK
and Src activities, we transfected chondrocytes in mouse cartilage explants with one
of the FRET biosensors. The transfected explants were mixed with Col-AG gel, and
were injected into flow chambers. During imaging, explants were treated with IL1β
for 2 hours and then were subjected to 5 μl/min fluid flow for another 1 hour. After 30
min of cytokine treatment, the Lyn-Src activity was significantly upregulated, while
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Fig. 3.6.: Pyk2 is involved in cytokine-induced FAK and Src regulation. C28/I2
cells were co-transfected with Pyk2 siRNA to block Pyk2 activity and one of FRET
biosensors. (A) Transfected cells were subjected to 5 or 20 μl/min fluid flow for
1 hour. Bar graph showed Src and FAK activities at 60 min after the addition of
cytokines. Activities were normalized to those at 0 min. (B) Transfected cells were
treated with TNFα or IL1β for 2 hours. Bar graph showed Src and FAK activities
at 120 min after the addition of cytokines. Activities were normalized to those at 0
min. Scale bar, 10 μm. n>7 cells. * p<0.05.
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Fig. 3.7.: IL1β-stimulated activation of Lyn-Src, KRas-Src and Lyn-FAK can be
reversed by intermediate fluid flow. Chondrocytes in mouse cartilage explants were
transfected with one of FRET biosensors. During imaging, cells were treated with
IL1β for 2 hours and then subjected to 5 μl/min fluid flow for 1 hour. (A,B) Effect
of 5 μl/min fluid flow on IL1-induced Src activity. (C,D) Effect of 5 μl/min fluid flow
on IL1β-induced FAK activity. Scale bar, 10 μm. n>7 cells. * p<0.05.
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this activation was substantially reduced as compared to that at time 120 min by 5
μl/min fluid flow (Figure 3.7A). The increased activities of KRas-Src and Lyn-FAK
by cytokine treatment were also downregulated by 5 μl/min fluid flow (Figure 3.7B
and C). KRas-FAK activity was not highly responsive to fluid flow (Figure 3.7D).
These results demonstrated that moderate loading might suppress cytokine-induced
inflammatory signaling via distinct mechanism.
3.4 Discussion
In this study we employed a 3D type II collagen-conjugated agarose gel-chondrocytes
construct in conjunction with live cell imaging to determine the real-time activities
of FAK and Src at different microdomains of plasma membrane in C28/I2 human
chondrocytes. The agarose gel has been extensively used as 3D cell culture scaffolds
due to its nature of high biocompatibility, high water content and the presence of
porous structure. Agarose has been found can maintain chondrocyte phonotypes and
improve ECM synthesis31 [307, 309, 311]. Although the protein-conjugated agarose
gel was also used as a 3D model in chondrocyte studies [341, 342], the effect of col-
lagen conjugation on integrin activation has not been shown. Here we demonstrated
that the integrin activation level in chondrocytes that seeded in AG-Col gels was
significantly higher than those in AG and AG + Col gels. As to the clustering and
activation of integrin are closely associated with lipid rafts [343–345], we used FRET-
based Lyn-Src and Lyn-FAK biosensors targeting lipid rafts to determine which gels
can enable integrin-mediated Src and FAK activities under loading. Results showed
that Lyn-Src and Lyn-FAK activities were regulated by fluid flow in AG-Col gels, but
not in AG and AG + Col gels, indicating the conjugation of collagen is required for
integrin activation and integrin-mediated Src/FAK signaling. The AG-Col gel was
used as the 3D scaffold.
The interstitial fluid flow in knee cartilage is ranged from 6-30 μm/min in vivo
[346]; and 1.5 body weight generated 12 μm/min interstitial fluid flow in human car-
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tilage ex vivo [3]. To characterize the flow velocity that experienced by chondrocytes
under various rates of fluid flow that applied on gels, BSA-594 was added to cul-
ture medium to perfuse agarose gels. The intensity change of the region of interest
over time determined the flow velocity in agarose gels (Supplementary Figure 3.2A).
Corresponding to 2 to 20 μl/min fluid flow, the flow velocities through agarose gels
were ranged from 4.75 to 29.4 μm/min (Supplementary Figure 3.2B), which cover the
velocity range in knee cartilage in vivo. The estimated shear stress experienced by
chondrocytes in agarose gels under 2-20 μl/min flow is ranged from 2 to 20 dyne/cm2,
which is the range widely used in chondrocyte studies in vitro [19, 347].
FRET microscopy is a powerful and widely-accepted tool for studying the dy-
namics of molecular pathways [348]. FRET biosensors employed in this study are
designed based on spectral ratiometric methods which distinguish molecular activi-
ties in concentration changes and rarely impaired by the out-of-focus signals due to
cell thickness [349]. The microscope shifts its focus through the depth of the cell and
captures images of various focus planes. After deconvolution, ImageJ compiles the
images into a coherent 3D redenring. The Src activity in three different orthogonal
planes as shown in Figure 3.2 indicates homogenous distribution and activation level
of Src in 3D. Therefore, the Src/FAK activity in the middle plane of the cell was
captured and represented the average Src/FAK activity over the whole cell.
Src and FAK are crucial signaling nodes in loading-driven chondrocyte activi-
ties3 [15]. Recent studies have shown that Src and FAK at different sub-cellular
locations might function distinctly [184]. However, their differential spatiotemporal
activities at different microdomains of plasma membrane under different magnitudes
of fluid flow are not known. In this study, we observed that the activities of Lyn-Src,
KRas-Src and Lyn-FAK were up- or downregulated by fluid flow in a magnitude-
dependent manner: moderate (5 μl/min) fluid flow decreased activities, and high
(20 μl/min) fluid flow increased activities. This result is consistent with previous
reports on loading magnitude-dependent small GTPase RhoA activities [347], Src
activities [19], and MMP13 activities 57 in chondrocytes. In contrast to Lyn-FAK,
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loading did not alter KRas-FAK activity. What might be the mechanism responsible
for the dissimilar activities of FAK at different subcellular domains? Earlier work
demonstrated that integrin mobilized to lipid rafts upon activation [22]. Our results
showed that the activity of integrin has been found as required for Src and FAK ac-
tivities in lipid rafts in response to loading, and the activities of FAK in lipid rafts are
highly colocalized with integrin activities. We further observed that FAK is required
for Src activities in the lipid rafts as well as in the non-lipid rafts in response to load-
ing, while Src inhibitor did not alter FAK activities under loading. It appears that
FAK in lipid rafts that closely interacts with integrin, not that in non-lipid rafts, is
essential in loading-induced Src/FAK signaling(Figure 3.8A). This proposed mecha-
nism is further confirmed by pretreating cells with MβCD to disrupt lipid rafts, which
consequently blocked KRas-Src activity under 5 and 20 μl/min fluid flow. To further
validate Src in non-rafts, not that in lipid rafts, is crucial in inflammatory signaling,
specifically blocking Src in lipid rafts and monitoring Src/FAK signaling under cy-
tokines are preferred. However, at the present time, there are no techniques or drugs
available that have the capability to inhibit Src at designated subcellular locations.
In the future, drugs with higher specificity will contribute to the study of subcellu-
lar signaling activities, and more importantly, can target molecules responsible for
diseases with fewer side effects.
TNFα and IL1β are known to activate proinflammatory signaling cascades and
promote OA progress [37]. Our result is the first time to show that FAK and Src
activities in different domains of plasma membrane have different activation patterns
under TNFα and IL1β. We further demonstrated that upon the stimulation of cy-
tokines, phosphorylated Pyk2 creats a binding site for SH2 domain of Src, resulting in
Src activation in non-lipid rafts, which consequently activates FAK activities (Figure
3.8B). To the best of our knowledge, the schematic in Figure 3.8 have illustrated the
first time the fundamentally new mechanisms that regulating Src and FAK activities
at different microdomains in responds to different stimulus.
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The 3D gel-cells system used in present study mimics physiological microenvi-
ronment experienced by cell in vivo, while the cell-ECM interaction, matrix stiffness
and cell-cell interaction are still very different from those in vivo. Because imaging
subcellular signaling activities in vivo is very challenging, to narrow the gap between
3D in vitro and in vivo, the chondrocytes in mouse cartilage explants embedded in
agarose gel were transfected Src or FAK biosensor to test the effect of moderate load-
ing on cytokine-induced Src/FAK activation. As to collagen in cartilage is a strong
fluorophore, cartilage were cut to very thin slices to reduce strong autofluorescence
and background noise [343,344,350]. Before mixed with gels, cartilage slices were fur-
ther minced to small pieces to minimize its effect on flow conditions in gels. During
imaging, only cells residing at the surface of the explant will be imaged. Interest-
ingly, moderate loading (5 μl/min) reversed cytokine-induced Lyn-Src, KRas-Src and
Lyn-FAK activation. These results suggest that moderate mechanical stimuli may be
considered as a potential therapeutic strategy for prevention of OA progression due
to excessive cytokine expression. We observed a discrepancy between 3D in vitro and
ex vivo data of Lyn-Src activtiy by cytokine application: the Lyn-Src activity is not
highly responsive to cytokine in vitro, while it get activated rapidly and strongly in
the ex vivo model. Two possible factors might contribute this discrepancy. C28I2 is a
human chondrocytic cell line, but the explants employed in this study were harvested
from mouse. The variances between species might results in these different responses
to cytokines. Second factor might be the different microenvironment that experienced
by chondrocytes. The cell-ECM interaction, matrix stiffness, cell-cell interaction, and
the mechanical loading applied on chondrocytes can leads to different activation pat-
tern of Lyn-Src. Besides Lyn-Src, other Src/FAK activities obtained using the ex vivo
model are highly similar to those from the 3D in vivo model, suggesting the collagen-
coupled agarose gel system provides reliable data with much simpler experimental
setup.
In summary, our findings of the distinct activation patterns of FAK and Src at
different microdomains of plasma membrane first time suggested the different mech-
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anisms of mechanical loading- and cytokine-induced signaling activities (Figure 3.8).
By down-regulating cytokine-initiated Src and FAK activation, moderate fluid flow
and Pyk2 depletion appear to promote cartilage health. Further study on the con-
nection between Src/FAK signaling and ECM reorganization by chondrocytes under
cytokine or loading stimulation may benefit in developing a therapeutic strategy for
OA.
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Fig. 3.8.: A proposed model of Src and FAK regulation under fluid flow and cytokines
at different subcellular locations. (A) Fluid flow activates FAK in lipid rafts that
closely linked with integrin, which subsequently activates Src in lipid rafts and Src
in its adjacent non-lipid rafts. (B) TNFα and IL1β activate KRas-Src with the
assistance of Pyk2, and eventually activate FAK activities.
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Fig. S 3.1.: Collagen-conjugated agarose gels enable fluid flow-induced Lyn-Src and
Lyn-FAK activities via activated integrin. (A) Immunostaining images show that the
level of activated and total integrin in collagen-conjugated agarose (AG-Col) gels,
collagen-added agarose (AG+Col) gels and agarose (AG) gels. Scale bar, 10 μm.
(B,C) The mean GFP values of activated β1 integrin (B) and total β1 integrin (C)
in various types of agarose gels were obtained by measuring GFP intensity averaged
over the whole cell, and mean values of each type of gels were normalized to the mean
values of AG gels. n>6 cells. * p<0.05.
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Fig. S 3.2.: Characterization of collagen-conjugated agarose gels. (A) Images illus-
trate the measurement of flow velocity (μm/min) through agarose gels under specific
flow rate (μl/min). (B) The flow velocity through agarose gels corresponds to flow
rate that applied. (C) The permeability of collagen-coupled agarose gels, and the
shear stress experienced by C28/I2 cells in gels. Corresponding to 2-20 μl/min fluid
flow that applied on gels, the shear stress generated is ranged from 2-20 dyne/cm2.
Sample number>7. Scale bar, 100 μm.
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Fig. S 3.3.: Src activities from different orthogonal views have similar activation levels
and patterns. (A) C28/I2 cells were transfected with the Lyn-Src biosensor. z-stack
images were obtained to generate 3D cell constructs. The activities of Src from each
orthogonal view were normalized to that from xy plane. (B) Src and FAK activities in
response to 10 μl/min fluid flow in different types of gels. Activities were normalized
to those at 0 min in AG-Col gels. (C) Src and FAK activities in response to 5 or 10
μl/min fluid flow in different types of gels. n>7 cells. Scale bar, 10 μm. * p<0.05.
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4. THE DIFFERENTIAL ACTIVITIES OF AMPK IN
VARIOUS CELLULAR ORGANELLES IN RESPONSE TO
MECHANICAL LOADING
4.1 Introduction
It is increasingly recognized that cells growing on 2D flat and rigid substrate
sometimes exhibit abnormal cellular functions, whereas 3D culture provides a more
physiologically relevant microenvironment for cells. It has been found that the cell
culture dimensionality is a crucial fate determinant that influences signaling activi-
ties, gene expression and functions of living cells [295]. Evidences have demonstrated
that cells in 3D cultures function more similar to cells in vivo, as compared to 2D
cultured cells [351]. Nevertheless, the mechanisms underlying how culture dimension-
ality alters cellular behavior is not well understood. One prevailing factor is changes
in the cell-matrix interaction, leading to altered cell morphology, cell polarity [352],
effective surface-to-volume ratio [289], and integrin-mediated adhesions [353] in 2D
culture. The other factor is the mechanical microenvironment experienced by cells
and the way of signaling transduction from the outside to the inside of cells are very
different in 2D versus 3D culture [354,355]. Cytoskeletal filaments are key mediators
in transmission of mechanical signals and their networks are distinct in 2D versus 3D
environment [293]. But so far, experimental evidence showing how culture dimen-
sionality influences subcellular signaling activities in response to loading is lacking.
We hypothesized that the culture dimensionality affect cellular signaling by changing
the cytoskeletal structure.
AMP-activated protein kinase (AMPK) is a sensor and regulator of ATP lev-
els that maintains the energy homeostasis [193]. Upon activation, AMPK phospho-
rylates multiple downstream signaling pathways to generate ATP whilst inhibiting
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ATP-consuming cellular activities [356]. AMPK has been shown to play crucial roles
in inhibiting tumor development [212,213,357], cardiovascular diseases [200,358,359],
Type II diabetes [206, 360, 361], inflammatory disorders [219–221], neurodegenera-
tive disorders [226,227,229] and most recently, OA [231,233,362], a progressive joint
disease that is initiated by overuse of joint and progresses with inflammatory re-
sponses. It has been discovered that the highly elevated AMPK activity in healthy
chondrocytes is suppressed with the progression of OA, and the activation of AMPK
substantially downregulates the IL-1 and TNF-induced inflammatory signaling in
chondrocytes by inhibiting NFκB signaling [235,362,363]. The inhibition of NFκB is
known to preserve the cartilage matrix integrity [231].
AMPK performs various cellular functions and compartmentalization of AMPK is
required for execution of multi-task within various cellular locations [273,316,364,365].
Recently, FRET-based AMPK biosensors targeting different subcellular compart-
ments were developed to investigate the dynamics of AMPK at varying subcellular
spaces of living cells, including endoplasmic reticulum (ER), mitochondria, nuclear,
cytosol, plasma membrane and Golgi apparatus [278]. Although mechanical loading
has been found to play pivot roles in OA development [366], the effect of mechanical
forces on AMPK signlaing has been studied best in the context of skeletal muscle
physiology, while how forces regulate compartmentalized AMPK activities in chon-
drocytes is unknown. We hypothesized that mechanical loading upregulates AMPK
activities in chondrocytes.
In the current study, we employed six fluorescence resonance energy transfer
(FRET)-based biosensors that selectively target different subcellular locations to vi-
sualize compartmentalized AMPK signaling of cells in a 2D culture or a 3D agarose
gel-based model in response to physical stimulation. The cytoskeleton inhibitors, a
integrin blocking antibody and a plasma membrane inhibitor were used to study how
the signal transduction pathways in the 2D culture different from that in the 3D
culture. Four types of siRNA were co-transfected with a AMPK biosensor to abolish
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the linker of nucleoskeleton and cytoskeleton (LINC) complex, and the connection
between cytoskeleton filaments and nucleus was examined.
4.2 Materials and Methods
4.2.1 AMPK biosensors
FRET-based biosensors were used for monitoring AMPK activities. The cytosolic
AMPK (Cyto-AMPK) biosensor consists of the ECFP, an FHA1 domain, an AMPK
substrate motif, and Venus cpV E172. Different sequences are fused to Cyto-AMPK
to produce biosensors targeting various organelles: plasma membrane (PM-AMPK),
Golgi apparatus (Golgi-AMPK), endoplasmic reticulum (ER-AMPK), nucleus (Nuc-
AMPK) and mitochondria (Mito-AMPK). The phosphorylation of the AMPK sub-
strate leads to the binding of FHA1 substrate to the binding domain, resulting in
the fluorescence resonance transfer from the donor (ECFP) to the acceptor (YFP
variant Venus). Hence, AMPK activities can be visualized as changes of the emis-
sion ratio of the YFP/CFP. The specificity of the biosensors has been characterized
previously [278,316].
4.2.2 Cell culture and transfection
The human chondrocyte cell line C28/I2 was used. Cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM; Lonza) containing 10 % FBS (Hyclone)
and 1 % penicillin/streptomycin (Lonza), and maintained at 37 ◦C, 5 % CO2 in a
humidified incubator. Neon transfection system (Invitrogen) was used to transfect
AMPK biosensors and siRNA into the cells. After transfection, cells were cultured in
serum-free and antibiotic-free DMEM for 24 hours before imaging.
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4.2.3 Chemical reagents, antibodies and siRNAs
Sulfo-SANPAH (Sigma) was employed to crosslink agarose gel (Sigma) with Type
II collagen (Sigma). Agarose (low melting temperature agarose; Lonza) was used to
prepare 3D agarose gels. integrin β1 antibody (Santa Cruz Biotechnology; A-4, 10
g/ml) was used to block integrin activities. Methyl-beta-cyclodextrin (MβCD; Sigma;
10 mM) was used to extract cholesterol from the lipid rafts of the plasma membrane.
Cytochalasin D (Enzo life sciences; 1 μg/ml) was used to disrupt actin filaments.
Blebbistatin (Toronto research chemicals; 50 μM) was used to inhibit myosin II. ML-
7 (Biomol; 25 μM) was used to inhibit myosin light chain kinase. Nocodazole (Sigma;
1 μM) was used to inhibit microtubule. α-Tubulin-Alexa Fluor 488 was used to
label microtubule and DyLight 554 Phalloidin was used to label actin filaments (Cell
Signaling Technology). Plectin siRNA, Lamin A/C siRNA, SUN1 siRNA, and SUN2
siRNA (Santa Cruze Biotechnology) were used to selectively silence their activities.
4.2.4 Shear stress application in 2D
Fluid flow-induced shear stress regulates chondrocyte signaling and metabolism
[367]. Because the shear stress of 2-20 dyne/cm2 has been found to influence chon-
drocyte activities either positively or negatively [368–370], in this study, we used 5
and 20 dyne/cm2 shear stress to stimulate chondrocytes growing on 2D culture. Dur-
ing imaging, an oscillatory flow at 2 Hz was applied to cells growing in the μ-slide
cell culture chamber (Ibidi) [371]. The chamber was perfused with HEPES-buffered
(20 mM), phenol red-free DMEM without serum. The fluid flow-induced shear stress
was controlled by a peristaltic pump (Cole-Parmer) and two pulse dampeners (Cole-
Parmer) were used to minimize pulsation of the flow.
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4.2.5 3D agarose-chondrocytes constructs
The collagen-coupled agarose gels (AG-Col) were prepared as detailed described in
Chapter 3. Briefly, the collagen solution was reacted with the sulfo-SANPAH to pro-
duce 1.2 mg/ml Type II collagen-sulfo-SANPAH solution. The 4 % (wt/vol) agarose
solution was prepared, autoclaved, and cooled to 40 ◦C. Three parts of 4 % agarose
were combined with one part of collagen-sulfo-SANPAH solution. The mixture was
exposed under UV light for 20 min to conjugate the collagen to the agarose. After
conjugation, the agarose mixture was washed with PBS thoroughly. Before trans-
fection, 3 % modified agarose gels were melted down at 45 ◦C and cooled to 37 ◦C.
Two parts of 3 % agarose gel were mixed with one part of 3 × DMEM containing
transfected cells to produce the mixture of 2 % agarose and 1 × DMEM with cells.
The mixture was injected into an flow chamber and cooled at room temperature for
30 min. The gel was supplemented with fresh 1 × phenol red-free serum-free DMEM
and transferred to incubator for 24 hours before imaging.
4.2.6 Fluid flow application in 3D
Fluid flow-induced shear stress has been shown to play crucial roles in the devel-
opment and progression of OA [372]. During imaging, the agarose gel construct in
a flow chamber was perfused with HEPES buffered, phenol red-free and serum-free
DMEM. During imaging, a syringe pump (Harvard Apparatus) was employed to ap-
ply pulsatile flow (0.2Hz) at 5, 10, and 20 μl/min for 1 hour, which will produce 5 to
20 dyne/cm2 shear stress experienced by cells as characterized in Chapter 3.
4.2.7 FRET microscopy and image analysis
During imaging, cells were maintained at 37 ◦C and 5 % CO2 using the gas incu-
bation and heating system (Ibidi). Images were obtained using a Nikon Ti-E inverted
microscope equipped with an electron-multiplying charge-coupled device (EMCCD)
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camera (Evolve 512; Photometrics), a filter wheel controller (Sutter Instruments), and
a Perfect Focus System (Nikon) that maintains the focus during time-lapse imaging.
The following filter sets (Semrock) were used: CFP excitation: 438/24 (center wave-
length/bandwidth in nm); CFP emission (483/32); YFP (FRET) emission: 542/27.
To minimize photobleaching, cells were illuminated with a 100 W Hg lamp through
an ND64 (∼1.5 % transmittance) neutral density filter. Images were acquired with
a 40 × (0.75 numerical aperture) objective. FRET images for AMPK activities were
generated with NIS-Elements software (Nikon) by computing an emission ratio of
YFP/CFP for individual cells over time. For 3D images, the representative FRET
ratio images were produced using ImageJ (NIH). All FRET images were scaled ac-
cording to the color bar.
4.2.8 Immunostaining and confocal microscopy
C28/I2 cells cultured in collagen-conjugated agarose gels or on collagen-coated
glass bottom dishes were incubated for 24 h before staining. For the 3D culture,
gels were washed with PBS three time to remove medium. The cells were fixed
with 4 % paraformldehyde for 45 min. After rinsing, the gels were permeabilized
with 0.5 % Triton X-100 (Sigma) in PBS for 45 min at room temperature, and
then incubated with blocking buffer (5 % BSA, serum, 20 % Polyvinylpyrrolidone
(Amresco) in PBS combined into 1:1:1 ratio) for 2 hours at RT. For the 2D culture,
cells were fixed following protocol from Cell Signaling Technology. Briefly, cells in the
2D culture were fixed with 4 % paraformldehyde for 15 min. After rinsing, cells were
treated with blocking solution for 60 min. After fixation, samples were incubated
with primary antibodies-conjugated with fluorescent dyes overnight at 4 ◦C. Before
imaging, cell nuclei were labeled by DAPI (Sigma). An Olympus Fluoview FV1000
confocal microscope was used to visualize actin and microtubule structure. Images
were acquired using a 60 × objective lens (1.2 numerical aperture; Olympus).
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4.2.9 Statistical analysis
Statistical data is presented as the mean ± standard error of the mean (SEM).
One-way ANOVA followed by Dunnett’s post hoc test was used to determine the
statistical differences. Student’s t-test was used to compare two groups. Statisti-
cal analyses were conducted using Prism 5 software (GraphPad Software). p<0.05
was considered statistically significant. In the time course data, * indicates AMPK
activity is significantly different from that before stimulation.
4.3 Results
4.3.1 AMPK activities at different subcellular organelles are substan-
tially activated by shear stress in 2D culture
We first tested whether AMPK at various subcellular compartments of living
chondrocytes respond to different magnitudes of shear stress in 2D environment.
We transfected chondrocytes with one of the six FRET-based AMPK biosensors:
Cyto-AMPK targeting cytosol, PM-AMPK targeting plasma membrane, Nuc-AMPK
targeting nucleus, ER-AMPK targeting ER, Mito-AMPK targeting mitochondria,
and Golgi-AMPK targeting Golgi apparatus. The AMPK activities were assessed by
monitoring changes of the emission ratios of YFP/CFP of the biosensors in response
to stimulus in the same cell. The AMPK activities were quantified over the whole cell
and normalized to the ratio value at 0 min. In C28/I2 human chondrocytes growing
on a 2D flow chamber, Cyto-AMPK activities were increased by the application of 5
and 20 dyne/cm2 shear stress and reached its maximal at 18min by 5 dyne/cm2 (7.5
% increase) and at 60 min by 20 dyne/cm2 (12.8 % increase) (Figure 4.1A). The PM-,
Nuc-, ER-, Mito- and Golgi-AMPK activities were also upregulated by shear stress
application and reached a maximal by 5 dyne/cm2 (PM: 14.5 % increase at 60 min;
Nuc: 11.7 % increase at 12 min; ER: 17.0 % increase at 58 min; Mito: 4.1 % increase at
6 min; and Golgi: 8.8 % increase at 14 min), and by 20 dyne/cm2 (PM: 8.3 % increase
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at 38 min;Nuc: 11.0 % increase at 58 min; ER: 12.5 % increase at 20 min; Mito: 7.8
% increase at 20 min; and Golgi: 9.8 % increase at 26 min), correspondingly (Figure
4.1B-F). However, the activities of Mito-AMPK failed to maintain the activation
and were returned to basal levels at latter timepoints. Statistical results showed
that, except Mito-AMPK, 60 min after 5 dyne/cm2 and 20 dyne/cm2 shear stress
stimulation, the activities of AMPK were significantly different from those at time 0
min (p<0.05).
4.3.2 AMPK activities in plasma membrane and nucleus are substantially
activated by fluid flow-induced shear stress in 3D
We further investigated AMPK activities of C28/I2 cells embedded in 3D type
II collagen-conjugated agarose gel scaffolds. The detailed characterization of the 3D
agarose gel-based loading system was described in Chapter 3. The transfected cells
were mixed with agarose gel, and the mixture was injected into a flow chamber. Dur-
ing imaging, we applied 5, 10 and 20 μl/min fluid flow through the chamber, which
generate 5, 10 and 20 dyne/cm2 shear stress experienced by chondrocytes, respec-
tively. Results showed that only Nuc- and PM-AMPK activities were upregulated by
loading, and reached maximum activities (Nuc + 5 μl/min: 9.9 % increase at 54 min;
Nuc + 10 μl/min: 9.8 % increase at 26 min; Nuc + 20 μl/min: 11.0 % increase at 58
min; PM + 5 μl/min:16.0 % increase at 58 min; Nuc + 10 μl/min: 15.3 % increase at
36 min; and Nuc + 20 μl/min: 15.2 % increase at 56 min) (Figure 4.2B, C). However,
the activities of Cyto-, ER-, Golgi and Mito-AMPK were not significantly altered
by loading (Figure 4.2A, D-F). To characterized the temporal profiles of Nuc- and
PM-AMPK in 2D versus in 3D, we determined t 1
2
, which measured the time required
for Nuc- and PM-AMPK to reach their half-maximal activity levels (Figure 4.2G, H).
The results showed that the mean and standard deviation of t 1
2
of Nuc-AMPK in
2D (5 dyne/cm2: 4.89 ± 0.56; and 20 dyne/cm2: 4.15 ± 0.66) were not significantly
different from those in 3D (5 μl/min: 4.22 ± 0.62; and 20 μl/min: 5.75 ± 0.75). The
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Fig. 4.1.: AMPK activities at differential subcellular organelles are upregulated by
the application of shear stress in 2D culture. The YFP/CFP ratio images were scaled
according to the corresponding color bar. (A-F) Cyto-AMPK, PM-AMPK, Nuc-
AMPK, ER-AMPK, Mito-AMPK and Golgi-AMPK activities under shear stress in
2D. n>7 cells. Scale bar, 10 μm. * p<0.05.
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mean and standard deviation of t 1
2
of PM-AMPK in 2D (5 dyne/cm2: 21.33 ± 2.23;
and 20 dyne/cm2: 18.50 ± 2.19) were also not significantly different from those in 3D
(5 μl/min: 20.25 ± 1.90; and 20 μl/min: 18.67 ± 1.95).
4.3.3 Cytoskeletal structure and integrin activity play roles in the regu-
lation of AMPK activities by loading in 2D culture
Since the activation patterns of AMPK activities in 2D were different from those
in 3D culture, we hypothesized cytoskeletal structure may be responsible for these al-
tered signaling responses to loading in different culture dimensions. Immunostaining
images showed actin and microtubule structure in C28/I2 human chondrocytes grow-
ing on a 2D plate (Figure 4.3A) or embedded in the 3D agarose gel (Figure 4.3B).
In 2D, the chondrocyte generates strong actin fibrils through the whole cell, and
has microtubules protruding away. However in 3D environment, microtubule tightly
encapsulates the cell neuclei, and actin mostly concentrates near plasma membrane
and only sparsely distributed as bright dots in cytosol. We hypothesized that the
strengthened cytoskeletal networks on 2D substrates enhance the sensitivity of cells
to mechanical loading.
To investigate factors contributing to the discrepancies of cellular signaling be-
tween cells in 2D and 3D model, cells transfected with one of AMPK biosensors
were seeded on 2D flow chambers. Before imaging, cells were pretreated with one
of reagents for 1 hour (integrin blocking antibody to silence integrin activity, MβCD
to disrupt the lipid rafts of plasma membrane, CytoD to disrupt actin cytoskeleton,
Bleb to inhibit myosin II, ML7 to inhibit myosin light chain kinase, and Nocodazole
to disrupt microtubule). During imaging, cells were exposed to 10 dyne/cm2 shear
stress for 1 hour, and the AMPK activities before and after loading application were
recorded. The AMPK activities at 60 min were normalized to the activity value at
0 min and ∗ denotes AMPK activities at 60 min are significantly different from their
activities at 0 min (Figure 4.3C-H). The disruption of lipid rafts of plasma membrane
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Fig. 4.2.: AMPK activities at plasma membrane and nucleus are upregulated by the
application of shear stress in 3D culture. (A) Cyto-AMPK activities under shear
stress in 3D. (B) PM-AMPK activities under shear stress in 3D. (C) Nuc-AMPK
activities under shear stress in 3D. (D) ER-AMPK activities under shear stress in
3D. (E) Mito-AMPK activities under shear stress in 3D. (F) Golgi-AMPK activities
under shear stress in 3D. n>7 cells. Scale bar, 10 μm. * p<0.05.
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and actin cytoskeleton prevented Cyto-AMPK activation by shear stress (Control: 5.7
% increase; Anti-integrin: 6.5 % increase; MβCD: 0.2 % decrease; CytoD: 0.1 % in-
crease; Bleb: 6.5 % increase; ML7: 5.1 % increase; and Nocodazole: 4.2 % increase);
the silence of integrin activity and the disruption of plasma membrane abolished
PM-AMPK activation by shear stress (Control: 8.2 % increase; Anti-integrin: 1.4
% decrease; MβCD: 0.1 % decrease; CytoD: 10.4 % increase; Bleb: 7.4 % increase;
ML7: 8.0 % increase; and Nocodazole: 6.7 % increase); the integrin activation, the
existence of lipid rafts as well as the integrity of cytoskeletal structure are required
for the activation of Nuc-AMPK by shear (Control: 8.4 % increase; Anti-integrin:
1.1 % increase; MβCD: 0.1 % decrease; CytoD: 0.1 % increase; Bleb: 0.1 % decrease;
ML7: 2.7 % increase; and Nocodazole: 0.7 % increase); the disruption of microtubule
and plasma membrane prevented ER-AMPK activation by shear stress (Control: 10.3
% increase; Anti-integrin: 7.7 % increase; MβCD: 0.2 % decrease; CytoD: 6.1 % in-
crease; Bleb: 7.4 % increase; ML7: 6.8 % increase; and Nocodazole: 0.5 % increase);
the activities of Mito-AMPK are still not highly responsive to loading W/O treat-
ments (Control: 3.1 % increase; Anti-integrin: 0.3 % increase; MβCD: 0.3 % decrease;
CytoD: 1.2 % increase; Bleb: 0.4 % increase; ML7: 0.1 % decrease; and Nocodazole:
2.4 % increase); and microtubule is not required for Golgi-AMPK regulation by shear
stress (Control: 8.3 % increase; Anti-integrin: 0.1 % increase; MβCD: 0.1 % decrease;
CytoD: 0.3 % increase; Bleb: 2.5 % increase; ML7: 0.8 % increase; and Nocodazole:
7.5 % increase).
4.3.4 The integrin, cytoskeleton structure and LINC complex play roles
in the regulation of Nuc-AMPK signaling by loading in 3D
While the integrin activity level and cytoskeletal structure in 3D are lower and
weaker than those in 2D cultures, their potential roles in mechanotransduction have
been studied [373]. To examine the importance of cytoskeleton and integrin activity
in AMPK activation by mechanical loading in 3D cultures, chondrocytes transfected
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Fig. 4.3.: The roles of integrin and cytoskeleton in the regulation of AMPK by shear
stress in 2D culture. (A) Immunostaining images showing the structure of actin and
microtubule in the 2D culture. (B) Immunostaining images showing the structure of
actin and microtubule in the 3D culture. The Max. int. proj. image generated from
z-stack images showing the highest intensity of each XY coordinate along the Z-axis
in a 2D image. (C-H) C28/I2 chondrocytes transfected with one of AMPK biosensors
were pretreated with one of reagents for 1 hour before subjected to 10 dyne/cm2 shear
stress. n>7 cells. * p<0.05.
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with one of AMPK biosensors were mixed with agarose gel to produce 3D cell-gel
constructs in 3D flow chamber. Before imaging, cells were incubated with one of
reagents for 1 hour. During imaging, cells were subjected to 10 μl/min fluid flow
for 1 hour, and the AMPK activities at distinct subcellular locations at 0 and 60
min were recorded. The AMPK activities at 60 min were normalized to those at 0
min and ∗ denotes AMPK activities at 60 min are significantly different from their
activities at 0 min. The PM-AMPK activation by fluid flow was abolished by the
silence of integrin and the disruption of plasma membrane (Figure 4.4B) (Control:
10.8 % increase; Anti-integrin: 1.4 % decrease; MβCD: 0.1 % increase; CytoD: 11.8
% increase; Bleb: 8.2 % increase; ML7: 10.1 % increase; and Nocodazole: 13.9 %
increase); the Nuc-AMPK activation by flow requires integrin activation, the integrity
of lipid rafts as well as complete cytoskeletal structure (Figure 4.4C) (Control: 8.3 %
increase; Anti-integrin: 1.1 % increase; MβCD: 1.6 % increase; CytoD: 1.8 % increase;
Bleb: 2.5 % increase; ML7: 1.4 % increase; and Nocodazole: 2.6 % decrease); and
Cyto-, Mito-, Golgi-, ER-AMPK activities were still not substantially altered by flow
(Figure 4.4A, D-F).
LINC complex physically associates cytoskeletal filaments with the nuclear enve-
lope [374]. To evaluate roles of LINC complex in Nuc-AMPK regulation by loading
in 3D, chondrocytes co-transfected with one of siRNAs and one of AMPK biosensors
were embedded in agarose gels. During imaging, cells were exposed to 10 μl/min
fluid flow for 1 hour. The AMPK activities at 60 min were normalized to those at 0
min and ∗ denotes AMPK activities at 60 min are significantly different from their
activities at 0 min. The silence of Lamin A/C, Plectin, SUN1 and SUN2 totally abol-
ished Nuc-AMPK activation by fluid flow (Control: 8.3 % increase; Plectin siRNA:
0.1 % increase; SUN1 siRNA: 0.6 % increase; SUN2 siRNA: 0.1 % decrease; and
Lamin A/C siRNA: 0.3 % decrease), while the activation of PM-AMPK by fluid flow
was not significantly altered by the treatment of siRNAs (Control: 10.8 % increase;
Plectin siRNA: 9.2 % increase; SUN1 siRNA: 8.9 % increase; SUN2 siRNA: 9.8 %
increase; and Lamin A/C siRNA: 10.0 % increase). The Cyto-AMPK activities were
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still not highly responsive to loading (Control: 1.5 % increase; Plectin siRNA: 0.1 %
increase; SUN1 siRNA: 1.5 % increase; SUN2 siRNA: 1.4 % increase; and Lamin A/C
siRNA: 1.6 % increase) (Figure 4.4G). The silence of LINC components didn’t affect
PM-AMPK activation by loading, and Cyto-AMPK activities were still not highly
responsive to fluid flow.
4.4 Discussion
In this study, we used FRET-based AMPK biosensors targeting distinct subcellu-
lar compartments in conjunction with live cell imaging to investigate the spatiotem-
poral activities of AMPK at different subcellular locations in C28/I2 human chon-
drocytes cultured in a 2D or a 3D culture system. We employed six types of AMPK
biosensors that specifically label AMPK activities in the cytosol, plasma membrane,
nuclei, ER, mitochondria, and Golgi apparatus. Although the diverse-functions of
AMPK at various cellular organelles have been documented [375–377], its responses
to physiological stimuli at different compartments is poorly understood. Cells grow-
ing on 2D culture were exposed to 5 and 20 dyne/cm2 shear stress for 1 hour. We
found that AMPK at all five locations is upregulated by shear stress, but Mito-AMPK
is not highly responsive to loading. AMPK has been found as a major regulator of
mitochondrial biogenesis in response to AMPK signaling [378, 379], and the exact
mechanism underlying why Mito-AMPK activity is not substantially activated by
forces is not clear. Since in skeletal muscle cells, the physiological stimuli has been
found to regulate AMPK signaling in a different way than nutrients [380], we hypoth-
esized that mechanical loading and nutrients regulate AMPK activities via different
mechanisms in chondrocytes. In this study, we mainly focused on the comparison be-
tween the 2D culture and the 3D culture. Future investigation of AMPK responses to
different types of stimuli is an important subject and requires further consideration.
Using the 3D agarose-chondrocytes constructs described in the Chapter 3, we in-
vestigated compartmentalized AMPK activities under fluid flow-induced shear stress.
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Fig. 4.4.: The roles of integrin, cytoskeleton structure and LINC complex in the regu-
lation of Nuc- and PM-AMPK by fluid flow in 3D culture. (A-F) C28/I2 chondrocytes
transfected with one of AMPK biosensors were pretreated with one of reagents for
1 hour before subjected to 10 μl/min fluid flow for another 1 hour. n>7 cells. *
p<0.05. (G) C28/I2 cells co-transfected with one of AMPK biosensors and one of
siRNAs were subjected to 10 μl/min fluid flow for 1 hour.
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The forces experienced by cells in 3D culture are characterized in the Chapter 3:
5-20 μl/min fluid flow in 3D generates 5-20 dyne/cm2 shear stress on 2D and the cell
deformation is negligible (Figure S3.2). Thus, the results obtained from 3D loading
model are comparable with those obtained from the 2D model. We observed that
only PM- and Nuc-AMPK were significantly activated by fluid flow, while AMPK
at other locations were not altered by loading. Since it has been found that AMPK
translocates from cytoplasm to nucleus upon the application of stress, such as heat
shock and oxidant exposure [381], it is possible that upon the application of forces,
AMPK moves to nucleus via cytoskeleton and is activated. Another possibility is that
mechanical signals transmit from plasma membrane to nucleus via the cytoskeleton
and LINC complex, and activate the AMPK in nucleus [382]. AMPK has been shown
to closely interact with integrin activity [383–385]. Our finding that the inhibition
of integrins prevent PM-AMPK activation by loading in 3D suggests that integrins
regulate the activation of AMPK near plasma membrane by forces and this activa-
tion is independent of the cytoskeleton. The activation pattern and level of Nuc- and
PM-AMPK in 3D culture are highly similar to those in 2D culture, suggesting the
factors (e.g. integrins and cytoskeleton) that control the AMPK activation in plasma
membrane and nucleus might maintained their functionality in different culture di-
mensions. It is also possible that there are compensatory mechanisms involved, which
requires further studies.
There are several reports suggesting that culture dimensions regulate cellular func-
tions [386, 387] and cytoskeletal structures [388]. We imaged actin and microtubule
structure of chondrocytes in 2D and 3D environment. Immunostaining images showed
distinct cytoskeleton patterns in different dimensional cultures: in the 3D, micro-
tubules wrap cell nucleus, and actin is mostly concentrated in the plasma membrane
and sparsely distributed near the nucleus; while in 2D, both actin and microtubules
are well developed and extend across the cytoplasm.
We further specifically disrupted cytoskeletal components or plasma membrane
using drugs and monitored the loading-induced compartmentalized AMPK activities
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of chondrocytes in 2D culture. The disruption of plasma membrane and actin cy-
toskeleton prevented the activation of AMPK in cytosol, suggesting the integrity of
plasma membrane and actin fibrils are required for the mechanical signal transduc-
tion through cytosol. Our observation is consistent with the previous findings that
mechanical forces distort membrane cortex and transmit physical signals to the cy-
tosol [389] via actin cytoskeleton [390](Figure 4.5A). The silence of integrin and the
disruption of plasma membrane prevented the activation of AMPK in plasma mem-
brane. Integrin is reponsible for mechanochemical conversion near the plasma mem-
brane. The integrin in plasma membrane is the key receptor of mechanical signals,
and is capable of transmiting mechanical signals to regulate signaling molecules near
cell surface without the assistance of cytoskeleton (Figure 4.5A). Both intact plasma
membrane and cytoskeletal support are required for the regulation of AMPK activity
in nucleus by loading (Figure 4.5A), which supports the earlier finding that integrins
are physically connected to nuclear scaffolds via cytoskeletal networks [373,391]. The
regulation of ER-AMPK activities by loading in the 2D culture requires intact plasma
membrane and microtubule (Figure 4.5A). Since ER is highly correlated with micro-
tubule [392], it either slides along or attaches to microtubules [393], we proposed the
model that the distortion of plasma membrane transmit signals to ER through mi-
crotubule (Figure 4.5A). We did noticed that the inhibition of actin filaments, myosin
kinase and myosin light chain II slightly reduced activation levels of ER-AMPK as
compared to the control group, while they are not significantly different. The Mito-
AMPK is not highly responsive to shear stress, suggesting that its regulation may
be preferentially influenced by nutrients, not mechanical loading. The activation
of Golgi-AMPK requires integrin, plasma membrane, actin filaments, myosin kinase
and myosin light chain II, while microtubules are not involved (Figure 4.5A). We
also observed that except Nuc- and PM-AMPK, the activation of Cyto-, ER- and
Golgi-AMPK is independent of integrin activity. Although there are many differ-
ences between 2D and 3D conditions, our results suggest that the altered cytoskeletal
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networks is a critical factor that contributes to the differential cellular signaling in
the 2D versus the 3D culture.
While the cytoskeltal structure in 3D is dissimilar to that in 2D culture, it plays
crucial roles in mechanotransduction of chondrocytes in 3D culture. The AMPK
activation near plasma membrane requires integrins and intact plasma membrane;
and the AMPK activation in nucleus requires integrins, plasma membrane as well
as the cytoskeleton (Figure 4.5B). These results are consistent with those found in
the 2D culture, suggesting that cells in the 2D model share similarities with cells
in 3D environment. It has been known that SUN family members are inner nuclear
membrane proteins that transmit signals to Lamins [394], and Lamins are an extended
part of the LINC complex that transmit forces across the nuclear envelope to regulate
signaling cascades and gene transcription [395]. However, most studies have been
performed using the 2D model, and to our knowledge, this is the first study on the
physical connection between cytoskeleton filaments and nucleus in 3D.
In summary, our findings of the distinct compartmentalized AMPK activation pat-
terns in 2D and 3D cultures suggest the importance of culture dimensions on cellular
signaling activities. By selectively inhibiting integrins, plasma membrane and cy-
toskeletal networks, we observed that the altered cytoskeletal structures influence the
differential cellular activity of chondrocytes in 2D versus 3D culture. The LINC com-
plex physically links the cytoskeleton and nucleus, and transmit mechanical signals
to the nucleus. The work herein suggests that the different culture dimensions may




5. CONCLUSIONS AND FUTURE DIRECTIONS
Osteoarthritis aggressively affects millions of people worldwide. Conservative
treatments include physical therapy and occupational therapy. In physical therapy,
patients learn how to stretch stiff joints without damage them further; and in oc-
cupational therapy, patients learn how to change their living environment to reduce
unnecessary motions that may further irritate joints. When conservative therapies
no longer help, patients will be recommended to have joint replacement, in which the
damaged joint will be replaced with plastic or metal materials. However, the surgical
risks carried with this procedure, like infections, blood clots, and unsatisfied joint
performance, as well as months pain, limited mobility, and vigorous rehabilitation,
make it as a option only for severe symptomatic OA patients [396]. Although OA is
common with aging and is a irreversible process, it is not inevitable. Doctors recom-
mend individuals to maintain healthy weight, control blood sugar, take 30 minutes
exercise five times a week and have healthy lifestyle. The importance of exercise and
healthy weight is recognized in OA prevention [81], while the mechanism underlying
how mechanical forces alters cartilage metabolism is not clearly understood.
Cartilage consists of ECM, chondrocytes and tissue fluid. Two most important
ECM components in cartilage are proteoglycans and type II collagen, which generate
ECM network responsible for retaining tissue fluid within cartilage and maintain the
mechanical property of cartilage. Chondrocyte is the only cell type in healthy cartilage
and is capable to maintain the balance of ECM synthesis and degradation. In the
healthy cartilage, the degr adative and raparative activities are strictly controlled by
chondrocytes, while due to aging, overweight or injuries-induced inflammation, this
delicate balance will be broken and the cartilage degeneration happens [397]. In early
studies, forms of arthritis are classified into rheumatoid arthritis (RA) and OA based
on the existence of significant inflammatory cells. However, this definition has been
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regarded as misnomers with the advancing understanding of the basic mechanisms
behind arthritis. Recently, aberrant mechanical forces-induced cartilage inflammation
at the molecular level is accepted as a major factor contributing to OA progression
[398].
The abnormal mechanical loading experienced by chondrocytes in cartilage ma-
trix, due to obesity, excessive exercise or injuries, has been identified to alter the
biosynthetic activity of chondrocytes. In the first stage, chondrocytes upregulate
MMPs/ADAMT expression to cleave collagen/aggrecans and downregulate matrix
synthesis [399]. The breakdown of ECM network leads to swelling and soft cartilage
tissue that is more sensitive and less resistant to mechanical loading. The second
stage involves the increased expression of cytokines and chemokines as well as reac-
tive oxygen species. Those molecules further elevate the gene expression of MMPs.
The third stage involves chondrocyte death by necrosis or apoptosis. It has been
discovered that the number of apoptotic cell death is positively correlated with OA
grades, and it may responsible for irreversible progression of OA [400]. Interestingly,
contrast to overloading, moderate loading has been identified as effective prevention
therapy of OA [101]. However, the mechanisms underlying how chondrocytes sense
different magnitudes of forces and determine their fates are not well understood.
Numerous efforts have been made to elucidate how mechanical loading and cy-
tokines regulate OA at cellular levels. NF-κB is one main downstream signaling
pathway that excessively activated by mechanical stress and inflammatory mediators
in OA chondrocytes. The high activation of NF-κB is required for the excessive ex-
pression of MMPs, NOS2, COX2, and IL-1.The cleaved and released ECM molecules
will further activate NF-κB signaling cascade. This positive feedback loop promotes
the development of OA [401]. ERK/JNK/p38 kinase cascades is another important
pathway in response to injurious loading and inflammatory stimuli in OA. The activa-
tion of this pathway upregulates catabolic activity and initiates inflammatory events
by induction of trascription factors, like AP-1, ETS, and C/EBP [402]. Integrin-
mediated signaling has been found as a key upstream mediator of ERK/JNK/p38
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Fig. 5.1.: Integrin-mediated signaling pathways in chondrocytes. The integrin inter-
acts with ECM and transduce mechanical signals to intercellular molecules to initiate
downstream signaling pathways, including ERK/JNK/p38 AND NFκB. These acti-
vated pathways stimulate chondrocytes to produce pro-inflammatory cytokines and
mediatros. [13]
as well as NFκB signaling pathways via FAK/Src [403] (Figure 5.1). While the
importance of integrin-mediate signaling in OA, how integrin/FAK/Src signaling in
response to different magnitudes of loading and inflammatory cytokines at subcellular
level is unknown.
In the chapter 2, we evaluated how loading, cytokines and ER stress inhibition
regulate integrin-mediated Src activity in cytosol or in lipid-rafts of plasma mem-
brane. We firstly found the activities of Src at different subcellular locations exhibit
differential activation temporal profiles under cytokine treatment. Upon the stimu-
lation of cytokines, Src in cytosol reaches non-lipid rafts of plasma membrane faster
than lipid-rafts. We hypothesized that the activation of Src at the lipid rafts requires
its translocation from cytosol to lipid rafts through the actin cytoskeleton, while some
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population of Src arriving at non-lipid rafts via diffusion and get activated quicker
upon cytokine treatment. The ER inhibitor only downregulated Src in cytosol and
failed to alter Src activity in lipid-rafts, indicating only cytosolic Src but not Src
in the lipid rafts is a critical signaling node within an ER stress signaling pathway.
ER stress inhibitors were capable to reverse cytokine-activated Src activity in cytosol,
which provides a potential therapy target for OA prevention and treatment. The roles
of shear stress on Src activities were investigated. Only the activity of Src in lipid
rafts was regulated by loading in a magnitude-dependent manner, while Src in cytosol
was not highly responsive to loading. The moderate loading substantially downregu-
lated cytokine-stimulated Src activities in lipid rafts. These results provide evidences
that moderate loading and ER inhibitors contribute to inflammation of OA, and Src
at distinct subcellular compartments execute different cellular functions via different
mechanisms. A combination of mechanical stimuli and subcellular location-targeting
chemicals may present a potential therapeutic strategy for prevention of cartilage loss
in OA.
The 2D monolayer culture on flat and rigid surfaces is popular in cell-based assays,
while its limitations, including lack of ECM, abnormal cell morphology and unnatural
polarity, have been increasingly recognized. As compared to 2D culture models, 3D
culture systems mimic the microenvironment that cells experienced in tissues, and
cells in the 3D culture are more morphologically and physiologically relevant to cells
in vivo [295]. To obtain more predictive data for future in vivo tests, we developed a
chondrocytes-agarose gel construct in the Chapter 3 and evaluated how mechanical
loading and cytokines regulate FAK and Src activities at distinct subcellular locations.
Agarose gel is a type of hydrogel having porous structure and is widely used in
chondrocyte studies [99]. We conjugated type II collagen with agarose gel to enhance
the adhesion and activation of integrins on chondrocytes. Results shown that the con-
jugation of type II collagen with agarose is required for the regulation of Src and FAK
activity by mechanical loading. We found that only Src and FAK in lipid rafts are
responsive to loading. Since integrins concentrate to lipid rafts upon activation, we
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hypothesized that the activation of Src and FAK in lipid rafts requires integrins. The
treatment of integrin blocking antibody prevented Lyn-Src and FAK activation by
flow, and the integrins were colocalized with FAK in lipid rafts, providing evidences
that integrins in lipid rafts are required for FAK/Src signaling. The moderate load-
ing reduced Src and FAK activities, which is consistent with the results in Chapter 2
that Src in lipid rafts can be inhibited with moderate loading in 2D model. Cytokines
activate Src and FAK, except Src in lipid rafts. This finding, again, suggests differen-
tial signaling mechanism of Src and FAK at various locations. While the interaction
between Src and FAK is increasingly recognized, most studies are performed at a
cellular level, whether Src and FAK at different subcellular compartments interact
via distinct mechanisms is unclear. We found that under mechanical stimulation,
FAK in the lipid rafts is the key upstream mediator of Src; while under cytokine
treatment, the Src is required for the FAK activation. Although the 3D agarose
gel-based scaffold in this study provided a physiologically relevant microenvironment
for chondrocytes, while the artificial ECM structure is still different from what cells
experienced in vivo. We employed ex vivo cartilage explant to further test the effect
of cytokines and mechanical loading on Src/FAK signaling at different compartments
of plasma membrane, and found that moderate loading reversed cytokine-induced
Src/FAK activation.
The current studies found that in 2D culture, Src activities were up- or down-
regulated by physical forces depending on loading magnitudes, and moderate loading
reversed cytokine-activated signaling activities. In the 3D culture, similarly, the ac-
tivities of Src and FAK are regulated in a magnitude-dependent manner. One model
for the role of membrane receptors (e.g. integrins) in mechanotransduction is that
forces is transmitted through the receptors to regulate cellular signaling pathways and
genetic programs [404], which is consistent with our results showing colocalization of
integrins and FAK activities under loading. However, how integrins sense different
loads and selectively activate or inhibit Src/FAK activities will need further studies.
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We did observed discrepancies between data obtained from the 3D gel model and
the ex vivo explant. The Src in lipid rafts in the 3D gel model was not significantly
activated by cytokines, while it was upregulated by cytokine treatment in cartilage
explant. Additionally, different from the 2D loading data in Chapter 2, in which the
Src activity in lipid rafts was substantially reduced by loading, in 3D gel model, the
Src in lipid rafts was slightly downregulated at earlier timepoints, but its activity
returned back to basal level later. To further investigate the effect of dimensionality
on cellular signaling, we compared signaling in chondrocytes in 2D versus 3D model
in the Chapter 5.
AMPK is another upstream key mediator of NFκB and p38 [259, 405, 406]. It
is closely linked with integrin/FAK/Src signaling [258]. It regulates cellular energy
balance, and the malfunction of AMPK contributes to diabetes, atherosclerosis, car-
diovascular diseases, cancers and OA. AMPK activity is decreased in OA chondro-
cytes, which promotes the catabolic activities in response to cytokines or injuries.
To perform multiple tasks at different subcellular locations, AMPK has been shown
to accumulate within specific compartments, like mitochondria, cytosol, nucleus, and
plasma membrane [278]. However, the AMPK activities at various subcellular com-
partments in response to mechanical forces are not well understood. In Chapter 5,
we employed six FRET-based AMPK biosensors targeting ER, mitochondria, Golgi
apparatus, plasma membrane, nucleus and cytosol, to investigate potential factors
contributing to differential cellular signaling in the 2D versus 3D culture.
In 2D culture, AMPK activities at different compartments were activated by me-
chanical loading, while in the 3D culture, only activities of AMPK in nucleus and near
plasma membrane could be upregulated by loading. The flat and rigid substrates of
2D cultured changed cell morphology and cytoskeleton networks [295], while how
these changes influence cell function is still under investigation. We found in 2D en-
vironment, different organelles required varying cytoskeletal filament to respond to
physical stimulation. We further demonstrated that the altered cytoskeletal struc-
ture in the 2D model was a factor that enhances sensitivity of cells to loading in 2D
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Fig. 5.2.: A model illustrating the LINC complex and its extended molecules. Plectins
connect cytoskeletal filaments to LINC complex. The KASH domains are associated
with the outer membrane of the nucleus and the SUN domains are located at the
inner membrane of the nucleus, which interact with Lamin A/C [408]
culture. In addition to cell membrane receptors and cytoskeleton, the LINC complex
and Lamin A/C are key mediators of mechanotransduction to nucleus. The LINC
complex consists of KASH domain proteins in the outer nuclear membrane and SUN
proteins in the inner nuclear membrane. The interaction of KASH and SUN domains
transmit mechanical signals to Lamins [407]. The linkage between plasma membrane
and nucleus is maintained similarly in cells in different culture dimensions.
Although there are several evident lines showing the interaction between AMPK
and integrin/Src/FAK signaling: activation of AMPK reduced the abundance of β1-
integrin on the cell surface [409, 410]; Src mediates the activation of AMPK in en-
dothelial cells [411]. However, there is a study demonstrated the modulation of FAK
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or Src failed to change AMPK sigaling correspondingly in cancer cells [412]. These
results are obtained using different cell types and donor species, which might con-
tribute to the discrepancy, while the relation between AMPK and integrin/Src/FAK
signaling remains unclear. In our study, we found that different from Src and FAK
activities by loading in Chapter 3 and 4, AMPK activities didn’t show magnitude-
dependent activation patterns, suggesting distinct regulation mechanisms of AMPK
and Src/FAK. In addition to membrane surface receptors, ion channels can sense
the membrane distortion produced by forces and alter the opening and closing rates,
which consequently changes downstream signaling cascades [413]. It is possible that
the ion channels and integrins synergistically regualte AMPK activities.
There are two types of 3D culture methods: cell aggregates that do not adhere to
any culture substrates, and cell culture scaffolds that embed cells in gels. Although
3D biodegradable culture scaffolds (e.g. agarose gel) mimic in vivo microenviron-
ment experienced by cells, those materials are prone to cause immune reactions and
future infections in vivo. Various attempts have been made to develop scaffold-free
engineered tissue [414]. During the incubation, chondrocytes have been found can
produce collagens and proteoglycans in vitro, and this ECM production is acceler-
ated under 3D culture environment [415, 416]. In the future study, chondrocytes
spheroids can be placed in a specific culture mold, and incubate to allow the forma-
tion of ECM. Earlier study using spheroids produced cartilage tissue that has similar
properties to native cartilage [417, 418]. Imaging techniques in conjunction with the
cartilage-like construct that produced using cell spheroids will provide a novel model
to study the signaling pathways in vitro.
Studies about the effects of moderate loading on the organization of ECM will
provide direct evidence supporting moderate exercise as potential therapy of OA.
Since the excessive degradation of ECM is the first sign of OA development and the
type II collagen is the most abundant component of ECM, which is highly dynamic
and under constant remodeling by chondrocytes [46, 47]. In the future studies, we
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